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The major function of the adult kidney is to filter blood. This task requires a complex 
vasculature that must be accurately assembled during development. To better understand 
renal endothelial development, I imaged the vascular tree of embryonic kidneys in 3D. From 
this, I detailed the origins of the first renal blood vessels and demonstrated that endothelia 
patterned in cycles alongside the splitting of the cap mesenchyme (nephron progenitor 
population) and branching of the ureteric bud. Notably, endothelia avoided the cap 
mesenchyme throughout development. Based on their gene expression patterns, I identified 
the anti-angiogenic molecule, semaphorin-3f, and its receptor, neuropilin-2, as signalling 
candidates that may control this endothelial patterning; however, these proteins were not 
required for endothelial avoidance from the cap mesenchyme. I demonstrated how renal 
vascularisation occurs in synchrony with the two major processes involved in renal 
organogenesis: branching morphogenesis and nephrogenesis. Moreover, I showed that 
angiogenesis predominates in kidney vascularisation and that the role of vasculogenesis is 
minimal (at most). 
I next investigated whether macrophages may facilitate renal vascularisation. Kidney 
macrophage origins have been defined, but their functions during development remain largely 
unknown. Macrophages arrived in the caudal part of the mouse embryo between E9.5-E10.5, 
as nephron precursors began collecting at the caudal end of the Wolffian duct. From this stage 
onwards, macrophages largely avoided populations of nephron progenitors. Instead, most 
mature macrophages interacted with the vasculature in the renal interstitium. Perivascular 
macrophages wrapped around, but were not carried within, blood vessels. As well as 
interacting with the vasculature, these macrophages engulfed erythrocytes and apoptotic 
endothelia during development. I also identified many galectin-3+ (Mac2+) cells within the 
kidney, which co-expressed the macrophage/monocyte-restricted marker, Csf1r, and were 
often carried within the vasculature. Mac2+ cells were present in the kidney from E11.5 
onwards, dramatically increasing in number later in development. Single cell RNA-sequencing 
and subsequent gene over-representation testing indicated that mature F4/80hiCD206hi 
macrophages, but not Mac2hi cells, were enriched for mRNA transcripts linked to vascular 
development. Accordingly, kidney macrophage-depletion resulted in abnormal renal 
vascularisation, characterised by fewer endothelial anastomoses. These results suggest that 





Kidneys are specialised organs that clean the blood, removing waste while retaining what is 
useful. This requires a complex vasculature, and its formation as a foetus develops is poorly 
understood.  
Here, I used advanced microscopy techniques to visualise how kidney blood vessels form in 
three-dimensions. In doing so, I identified when and from where the first blood vessels come, 
and how blood vessels develop at the edge of the kidney. At the edge of the kidney, blood 
vessels pattern around a special collection of cells – the cap mesenchyme.  
The cap mesenchyme contains cells that eventually become the cleaning tubes of the kidney, 
the nephrons. The cap mesenchyme undergoes rounds of splitting at the edge of the kidney 
and blood vessels migrate into the newly opened regions. This occurs in cycles throughout 
kidney development.  
I then investigated a specialised cell type known as the macrophage (macro = big; phage = 
eater) in the developing kidney. I found that many macrophages are present within the 
developing kidney, where they encourage connections between blood vessels. 
The results presented here increase our understanding of kidney development and may 
improve our understanding of kidney disease and be informative for building kidneys from 
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“Recognizing that we have the kind of internal environment we have 
because we have the kind of kidneys that we have, we must acknowledge 
that our kidneys constitute the major foundation of our physiological 
freedom. Only because they work the way they do has it become possible 
for us to have bones, muscles, glands, and brains. Superficially, it might 
be said that the function of the kidneys is to make urine; but in a more 
considered view one can say that the kidneys make the stuff of philosophy 
itself.”  
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1. Introduction chapter 
1.1. Thesis structure and aims 
1.1.1. Overview | This thesis contains investigations of blood vessels and 
macrophages in the developing kidney and is split into 2 main sections:  
• Section 1 is about the development of the renal vasculature (containing 
Results Chapters 1 and 2). 
• Section 2 is about macrophages in the developing kidney (containing 
Results Chapter 3). 
Introduction, Methods, and Conclusions chapters are also included.   
 
1.1.2. Introduction chapter purpose | This thesis contains investigations of 
endothelia and macrophages in the developing kidney. 
An understanding of the kidney is necessary to put the results chapters of this 
thesis in context with what is already known. Thus, the purpose of this 
introductory chapter is to provide information regarding the evolution, anatomy, 
and function of the adult kidney, before then describing how it develops 
embryonically. 
Most of the experimental work in this thesis is focused on mouse kidney 
development; therefore, this chapter concentrates on describing the murine 
kidney, unless otherwise stated. Details regarding endothelia and 
macrophages in the developing kidney are largely omitted from this chapter, 






1.2. Vertebrate kidneys 
The primary characteristic of the vertebrate kidney is that its functional unit is 
the nephron. Nephrons filter and process substances from blood plasma, 
excreting waste while recovering what is useful. Amongst different vertebrate 
species, there is remarkable variability in nephron morphology (Dantzler, 2016; 
Figure 1.1a). This variability has been shaped by evolution, as nephrons of 
different species have been challenged with distinct selective pressures (for 
example, the nephron of a saltwater fish evolved to overcome different 
environmental challenges than that of a freshwater fish). As well as the 
morphological differences in the nephron, there are distinct types of kidneys 
possessed by vertebrate organisms.  
There are three kidney types: the pronephros, mesonephros, and 
metanephros (Saxén, 1987). Of these, pronephroi are the most primitive, 
consisting of a small number of nephrons connected to a structure called the 
Wolffian duct (also known as the nephric duct). The pronephros is the primary 
functioning kidney type in larvae of teleost fish and amphibians, adult 
agnathans (jawless fish, such as lamprey and hagfish), and adult cartilaginous 
fish (such as sharks; Figure 1.1b; Dantzler, 2016). Relative to the pronephros, 
the mesonephros is a more caudal structure and consists of a linear array of 
nephrons connected individually to the Wolffian duct (Davies, 2002). The 
mesonephros functions in adult agnathans, cartilaginous fish, lobe finned fish, 
and amphibians (Figure 1.1b; Dantzler, 2016). The metanephros, the final 
kidney type to have evolved, is unlike the pronephros and mesonephros in the 
sense that its nephrons form away from the Wolffian duct, arranging instead 
around a single collecting duct tree (Davies, 2002). This arrangement allows 
many nephrons to form in a compact three-dimensional space. Metanephric 
kidneys are found in all adult amniotes (reptiles and mammals; Figure 1.1b). 
Although adult amniotes use only metanephric kidneys, the pronephros and 
mesonephros also form in amniotic embryos, but degenerate before birth 
(except from some parts of the male mesonephroi, which contribute to testis 
development; Buehr et al., 1993; Martineau et al., 1997). In amniotic embryos, 
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the pronephros is thought to be a non-functional vestigial structure (Brennan, 
et al., 1998; Seville et al., 2002). The mesonephros, in contrast, can function 
transiently as an excretory organ during development (Lawrence et al., 2018). 
From here on, the terms ‘renal’ and ‘kidney’ are used to refer only to the 
metanephric kidney.        
 
 
Figure 1.1. Nephron and kidney diversity. (a) Drawings depicting nephron 
variability in different vertebrate species (nephron drawings modified from Dantzler, 
2016). (b) Cladogram showing the kidney types used by different vertebrate clades. 








1.3. The Metanephric kidney                                              
1.3.1. Mammalian metanephric kidney types | Depending on their structure, 
mammalian kidneys fall into one of the following three categories: unipapillary, 
compound multirenculated, or discrete multirenculated (Figure 1.2a; Oliver, 
1968; Dantzler, 2016). 
Unipapillary kidneys have one renal papilla, from which urine is drained. This 
kidney type is present in species such as mice and bats (Figure 1.2a-b). 
Multirenculated kidneys have multiple papillae, which are either fused together 
(compound multirenculated kidneys) or are separated (discrete 
multirenculated kidneys; Figure 1.2a). Compound multirenculated kidneys 
have a continuous cortical region enclosing all papillae, and this is the kidney 
type of species such as humans and beavers (Figure 1.2a, c). Discrete 
multirenculated kidneys, on the other hand, can be thought of as groupings of 
unipapillary kidneys that connect to a single draining point (as a bunch of 
grapes connect to a single stalk; Figure 1.2a). Each renculus of a discrete 
multirenculated kidney has its own blood supply and is individually capsulated 
(Dantzler, 2016). This kidney type is used by species such as bears and 
marine mammals. As an idea of scale, it has been calculated that the common 
dolphin has approximately 269 renculi per kidney, whereas the right whale has 
5,377 (Kamiya, 1958; Figure 1.2d).  
Whether a kidney is unipapillary or multireculated is not based on phylogeny, 
but instead corresponds more closely to body mass (Sperber, 1944; Oliver, 
1968). Small mammals, such as rodents, have unipapillary kidneys, whereas 
larger mammals, such as elephants and whales, have multirenculated kidneys 





Figure 1.2. Metanephric kidney types. (a) Cartoons depicting the different types of 
mammalian metanephric kidneys. (b-d) Kidney types of the (b) mouse, (c) human, 
and (d) dolphin (dolphin kidney image taken, with permission, from the Online 
Veterinary Anatomy Museum: 
http://www.onlineveterinaryanatomy.net/content/kidney-dolphin). 
 
1.3.2. Gross anatomy of the mouse kidney | Adult mouse kidneys are paired 
retroperitoneal organs situated at the dorsal limit of the abdominal cavity on 
each side of the vertebral column (Vize et al., 2003). Kidneys are the most 
rostral component of the adult urinary system (from rostral-to-caudal: kidney 
 ureter  urinary bladder  urethra; Figure 1.3a).  
Each kidney is capsulated and comprised of two major parenchymal divisions: 
the cortex and medulla. The kidney’s fibrous capsule is surrounded by 
perinephric fat/fascia and in contact with other organs such as the adrenal 
gland (Figure 1.3b). The renal cortex is at the periphery of the kidney, situated 
between the capsule and medulla, and this is where blood plasma is ultra-
filtrated. The cortex contains nephrons (excepting part of the loop of Henle, 
which plunges into the medulla), all glomeruli, and cortical collecting tubules. 
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The renal medulla is the inner portion of the kidney, which contains loops of 
Henle and medullary portions of collecting ducts (Vize et al., 2003).  
 
 
Figure 1.3. Gross anatomy of the adult mouse kidney. (a) Regional anatomy. (b) 
The kidney is comprised of an outer cortex, where blood is filtered, and an inner 
medulla, where urine is collected before being drained via the ureter.  
 
1.3.3. Blood supply | Despite only comprising ~1% of total body weight, 
murine kidneys receive 9-22% of total cardiac output (Stott et al., 1983; Sarin 
et al., 1990; Wang et al., 1993). A great percentage of this blood flows into the 
cortex (Geraghty et al., 1992; Bentley et al., 1994) so that metabolic waste, 
excess fluids and ions, and foreign and harmful substances can be filtered 
from the blood for subsequent processing and removal. Many filtered 
molecules, such as glucose, sodium, amino acids, and water, must be 
reabsorbed from the nephron tubules into the blood; accordingly, blood 
vessels are arranged around nephron tubules to facilitate this reabsorption.  
Blood flows into and out from the kidney through a stereotyped series of 
vessels (Figure 1.4a-b), which were primarily named based on early 
assumptions of vessel function in the human kidney. The mouse kidney 
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vasculature is not arranged in the exact same manner as in the human 
(considering, for example, that the human kidney has multiple lobes for the 
vasculature to skirt around, whereas the mouse kidney has only one); 
however, the arrangement and function of most, if not all, blood vessels 
between the two species are analogous (Moffat and Fourman, 1963; Kriz and 
Kaissling, 2013). 
Blood flows into the kidney at the hilum through a renal artery that branches 
from the aorta. The renal artery branches into segmental arteries, which further 
divide as they transverse the medullary portion of the kidney (Moffat and 
Fourman, 1963). Vessels then extend through the cortex of the kidney, where 
they carry blood via arterioles and capillaries to individual nephrons (Figure 
1.4a-b). Blood is carried away from nephrons via venules, which transport 
blood into a series of veins that transport blood away from the kidney (Kriz and 
Kaissling, 2013; Figure 1.4a). The renal vein connects with the inferior vena 
cava, which returns blood to the heart.  
 
1.3.4. Nephrons and their vasculature | Adult mouse kidneys contain 
approximately 14,000 nephrons, though this number varies depending on 
strain (Merlet-Benichou et al., 1999; Short et al., 2014). A nephron consists of 
intricately arranged tubules that receive filtrate from glomerular capillaries at 
one end and drain processed filtrate (urine) into a collecting duct at the other 
end.  
Filtrate is received at the renal corpuscle at the proximal end of the nephron, 
which is composed of Bowman’s capsule, glomerular capillaries, mesangial 
cells, and podocytes. Afferent arterioles direct blood flow into the glomerular 
capillaries, and filtered blood exits via efferent arterioles (Figure 1.4b). Due to 
the glomerular filtration process, the blood in efferent arterioles has little fluid 
and a high oncotic pressure (Bencsáth et al., 1983). This is remedied by 
peritubular capillaries, which align closely with renal tubules (Speller and 
Moffat, 1977) and reabsorb essential substances such as water, glucose, 
amino acids, and sodium from tubular epithelia into the blood.  
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For a substance to enter the Bowman’s space (the first part of the nephron) 
from glomerular capillaries, it must pass through three size-selective filtration 
barriers: the fenestrae of endothelia, the glomerular basement membrane, and 
the slit diaphragm of podocytes (specialised mesenchyme-derived cells; 
(Boyle et al., 2008; Kobayashi et al., 2008). This layered filtration barrier allows 
only small molecules to pass. Larger molecules such as albumin remain in the 
blood. Although some non-renal endothelia are also fenestrated, the 
fenestrations of glomerular endothelia are structurally unique as they do not 
have a diaphragm but retain a basal lamina (Satchell and Braet, 2009). Once 
in the Bowman’s space, the filtrate journeys through, and is modified by, each 
of the functionally distinct nephron segments: the proximal tubule, the loop of 
Henle, and the distal tubule (Figure 1.4d). 
Most of the proximal tubule is in the outer renal cortex. Its epithelial tubules are 
initially convoluted but straighten prior to encountering the loop of Henle. The 
epithelia of the proximal tubule are highly endocytic, have dense brush 
borders, contain many mitochondria, and have plasma membranes that are 
crammed with transporters and channels that facilitate the reabsorption and 
recovery of many small filtered molecules - this is reflected by their unique 
transcriptional profile (Brunskill et al., 2008; Thiagarajan et al., 2011).  
The proximal tubule leads on to the loop of Henle, which dips into the renal 
medulla (descending loop of Henle), and then extends back up into the cortex 
(ascending loop of Henle) where it leads on to the distal tubule. Straight 
capillaries known as vasa recta lie parallel to the loop of Henle. These vessels 
maintain counter-current exchange, which is necessary to produce 
concentrated urine. In response to hormonal regulation, the distal tubule 
recovers sodium and calcium back into the blood from the urine (reviewed by 
Subramanya and Ellison, 2014). The distal tubule, the final nephron segment, 
then drains urine into the collecting duct, an epithelial structure with distinct 
developmental origins from nephron epithelia (Saxén and Sariola, 1987; 
Kobayashi et al., 2008). In the mouse, the collecting duct tubules converge to 




Figure 1.4. Renal vasculature. (a) The vessels that transport blood into and out from 
the kidney. (b) A nephron and its vasculature. In most biological settings, blood vessels 
are organised as follows: artery  arteriole  capillary bed  venule  vein. The 
nephron vasculature is unusual in the sense that it has two capillary beds and is 
arranged as follows: artery  arteriole  capillary bed 1 [glomerular]  arteriole  




1.4. Kidney development 
1.4.1. Overview | The metanephric kidney develops from two intermediate 
mesoderm-derived cell populations, the ureteric bud and the metanephric 
mesenchyme (Grobstein, 1955; Saxén and Sariola, 1987; see section 1.4.2). 
The collecting ducts and ureter derive from the ureteric bud, whereas nephrons 
and interstitium derive from the metanephric mesenchyme (Saxén and Sariola, 
1987; Kobayashi et al., 2008).  
At approximately embryonic day (E) 10.5, the ureteric bud evaginates from a 
simple epithelial tube called the Wolffian duct in response to signals produced 
by the metanephric mesenchyme (see section 1.4.3). The ureteric bud 
invades the metanephric mesenchyme and undergoes its first of approximately 
12 rounds of branching to form the collecting duct tree (Costantini and Kopan, 
2010). Branching is usually typified by the dichotomous division of the ureteric 
bud at its tips; as a result, two new tips are generated, which elongate before 
branching again (see section 1.4.4).  
Each tip of the ureteric bud is coated by a population of nephron progenitor 
cells known as the cap mesenchyme (these cells ‘cap’ ureteric tips; Herring, 
1900). Ureteric tips induce cap mesenchyme cells to undergo mesenchymal-
to-epithelial transitions to start forming nephrons (Carroll et al., 2005); see 
section 1.4.5). Simultaneously, signals produced by the cap mesenchyme 
induce further branching of the ureteric bud in cycles (Sainio et al., 1997; 
Majumdar, 2003; Costantini and Shakya, 2006). Sections 1.4.2 - 1.4.5 
summarise how these morphogenetic events unfold.  
 
1.4.2. Metanephric development: setting the stage | Before the 
metanephros can develop, its component parts - the ureteric bud and 
metanephric mesenchyme - must emerge and meet. Although the ureteric bud 
and metanephric mesenchyme both derive from intermediate mesoderm, they 
arise from spatiotemporally distinct cell populations (Taguchi et al., 2014; Xu 
et al., 2014).  
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The ureteric bud forms as an outgrowth of the Wolffian duct, which arises at 
approximately E8 from the rostral intermediate mesoderm when odd-skipped 
related transcription factor 1- (Osr1) expressing cells undergo mesenchymal-
to-epithelial transitions and coalesce (Bouchard et al., 2002; Grote et al., 
2006). The Wolffian duct extends caudally, connecting to the cloaca at 
approximately E9.5 (Bouchard et al., 2002). Along this tube, the pronephros, 
mesonephros, and metanephros form in a rostral-to-caudal sequence.  
Based on lineage tracing of brachyury- (T) and eyes absent homolog 1- (Eya1) 
derived cells, the nephrogenic precursors of the metanephric mesenchyme are 
generated from cells in the caudal intermediate mesoderm (Taguchi et al., 
2014; Xu et al., 2014). From approximately E9.5-10.5, these intermediate 
mesoderm-derived metanephrogenic precursors accumulate at the caudal end 
of the Wolffian duct.  
Assuming these processes occur normally, the stage is now set for the 
metanephric kidney to develop (Figure 1.5a).  
 
1.4.3. Outgrowth of the ureteric bud | By E10.5, a domain of epithelial cells 
at the caudal end of the Wolffian duct (towards the cloaca) have become highly 
proliferative and pseudostratified (Chi et al., 2009). From these 
pseudostratified epithelia arises a single ureteric bud.  
Ureteric bud outgrowth partly depends on signal asymmetries along the rostro-
caudal axis of the Wolffian duct. A major instructive signal for this outgrowth is 
glial cell-line-derived neurotrophic factor (GDNF), released by 
metanephrogenic precursor cells (Sainio et al., 1997). Because GDNF-
expressing metanephrogenic cells accumulate near the caudal end of the 
Wolffian duct, the levels of GDNF are highest here (Figure 1.5b). Moreover, 
cells that highly express the GDNF receptor, Ret, predominantly localise at the 
caudal end of the Wolffian duct (Shakya et al., 2005; Costantini and Kopan, 
2010). This expression asymmetry makes the caudal Wolffian duct epithelia 
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particularly responsive to GDNF and results in ureteric bud outgrowth only at 
this site (Costantini and Shakya, 2006; Figure 1.5b).  
The high caudal GDNF expression domain is a consequence of asymmetries 
in Slit homolog 2 protein (Slit2)/roundabout homolog 2 (Robo2) expression 
(Wainwright et al., 2015). In general, Slit-secreting cells repel Robo receptor-
expressing cells (Blockus and Chédotal, 2016). At E9.5-E10.5, Slit2 is 
expressed most highly in the rostral Wolffian duct, whereas Robo2 is 
expressed most highly in the rostral nephrogenic precursors (Wainwright et al., 
2015; Figure 1.5c). Wolffian duct-secreted Slit2 signals via Robo2 to decrease 
the number of rostral GDNF-expressing metanephrogenic cells and repels 
these cells from the Wolffian duct (Figure 1.5c; Wainwright et al., 2015). In 
mutant mice that cannot produce Gdnf, Ret, GFRα1, Slit2, or Robo2 ureteric 
bud formation is faulty, illustrating the importance of these signals for its 
outgrowth (Costantini and Shakya, 2006). 
Another signal, bone morphogenetic protein 4 (BMP4), acts to inhibit ureteric 
bud outgrowth at inappropriate sites (Michos et al., 2007). BMP4 is expressed 
along the intermediate mesoderm adjacent to the Wolffian duct. Gremlin1, an 
endogenous inhibitor of BMP4, is highly expressed only at the caudal part of 
the Wolffian duct (around the site of ureteric bud outgrowth). This localised 
expression of gremlin1 supresses BMP4 activity at this site, encouraging 
ureteric epithelia to bud only at this position (Michos et al., 2007; Figure 1.5d).  
Extracellular matrix components are also essential for normal ureteric bud 
outgrowth (Müller et al., 1997; Smyth et al., 2004; Linton et al., 2007). Renal 
defects in their absence may be due to failed breakdown and remodelling of 
the ureteric bud basement membrane, or failure of extracellular matrix-
mediated signal propagation between epithelial and mesenchymal cells (Short 
and Smyth, 2016).  
Taken together, studies show that signal asymmetries along the rostro-caudal 
axis of the Wolffian duct and metanephrogenic mesenchyme are essential for 




Figure 1.5. Ureteric bud outgrowth. (a) Anatomy of the caudal-part mouse embryo 
at E10.5. The Ureteric bud is starting to branch into the metanephric mesenchyme at 
the caudal end of the Wolffian duct. (b-d) Examples of signal asymmetries that are 
important for ureteric bud outgrowth at the appropriate site. (b) GDNF/Ret pathway. 
(c) Slit2/Robo2 pathway. (d) BMP4/Gremlin pathway. The colour representing a 
proteins activity level in b-d corresponds to the colour of the cell type that produces 
it. WD, Wolffian duct; MM, metanephric mesenchyme. 
 
1.4.4. Formation of the collecting duct tree | Assuming the above processes 
have occurred normally, the ureteric bud has entered the metanephric 
mesenchyme by E11.5, and has undergone its first round of branching, 
forming a ‘T-shaped bud’ (Figure 1.6b-c). The ureteric bud, which is 
composed of tip and trunk regions, undergoes approximately 12 rounds of 
iterative branching to form an elaborated tree: this tree functions as the 
collecting duct system of the adult kidney. Within a 5-day period, approximately 
10 of these rounds of branching occur (between E11.5 and E16.5), forming 
around 1,300 tips (Figure 1.6d; Short et al., 2014).  
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To facilitate this rapid branching, tip and trunk cells must quickly proliferate. 
Indeed, pulse-chase experiments have shown that tip cell proliferation rates 
correlate closely with branching rate throughout development (Michael and 
Davies, 2004; Short et al., 2014). 
The actual process of ureteric tip cell proliferation is unusual: pre-mitotic cells 
first enter the lumen of the ureteric bud to divide, then, after dividing, one 
daughter cell reintegrates at its initial site, while the other relocates, integrating 
several cell diameters away (Packard et al., 2013); Figure 1.6e). This mitotic 
process drives epithelial cell dispersal, but the consequences of this behaviour 
are unknown.  
Ureteric trunks also undergo constant remodelling during kidney 
organogenesis. In the early developing kidney, a series of iterative ‘Y’ shaped 
ureteric bud branch points lead from the centre of the kidney to its periphery. 
In the adult kidney, however, collecting ducts are long and straight, lying 
parallel to each other and opening together into the renal pelvis. To facilitate 
this morphological change, kidney culture experiments and computer 
simulations suggest that ureteric bud branch points retract (Lindström et al., 
2015). ‘Y-shaped’ branch points become ‘V-shaped’, which modifies ureteric 
trunks from highly spread (in development) to running almost parallel to each 




Figure 1.6. Collecting duct tree formation. (a-b) The ureteric bud enters, and 
branches within, the metanephric mesenchyme by E11.5. (c) Basement membrane 
immunostaining (anti-laminin) of the ureteric bud at E11.5. Scale bar represents 50 
µm. (d) Elaboration of the ureteric/collecting tree from E12 to E16.5 (d adapted, with 
permission, from Short and Smyth, 2016). Scale value indicated. (e) Mode of 
proliferation of ureteric bud tip cells (adapted, with permission, from Davies, 2013).  
 
1.4.5. Formation of the nephron | The metanephric mesenchyme divides into 
two major cell populations with distinct genetic programmes (Brunskill et al., 
2008), the interstitium and cap mesenchyme. Cap mesenchyme cells 
condense around ureteric tips and give rise to all cell types of the nephron 
(Kobayashi et al., 2008). The cap mesenchyme is surrounded by Foxd1+ 
interstitium (or stroma), which gives rise to pericytes, fibroblasts, and other 
interstitial cell types (Kobayashi, Joshua W Mugford, et al., 2014; Sequeira-
Lopez et al., 2015). 
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As a ureteric tip branches, the overlaying cap mesenchymal population splits 
(approximately in half; Short et al., 2014), and each new ureteric tip retains a 
daughter population of nephron progenitors (Figure 1.7a). As well as the cap 
mesenchyme promoting ureteric bud growth and branching, the ureteric bud 
reciprocally regulates cap mesenchyme fate: it either promotes self-renewal or 
differentiation towards a nephron fate. These reciprocal interactions occur in 
the cortical nephrogenic zone.  
Cells within the cap mesenchyme are heterogenous in terms of the 
transcription factors they express. Self-renewing nephron progenitors localise 
at the most cortical side of the cap mesenchyme and highly express sine 
oculis-related homeobox 2 (Six2) and Cbp/p300 interacting transactivator 1 
(Cited1; Lindström et al., 2018; Figure 1.7a). In contrast, nephron progenitors 
that are primed for differentiation exhibit reduced Six2 and Cited1 expression 
(Lindström et al., 2018); these cells localise near the armpit of the ureteric tip 
(Figure 1.7a).  
Signals such as Wnt9b stimulate mesenchymal-to-epithelial transitions (MET) 
of nephron progenitor cells, as evidenced by studies showing cap cells in 
Wnt9b-deficient mice fail to undergo these transitions (Carroll et al., 2005). 
Committed nephrogenic precursors first form a pretubular aggregate at the 
armpit of the ureteric tip (Figure 1.7b). This aggregate subsequently develops 
into a polarised renal vesicle, which elongates and forms the comma-shaped 
then S-shaped body (Figure 1.7b-c). The S-shaped body is comprised of a 
proximal, medial, and distal segment. At the proximal segment of the S-shaped 
body, the renal corpuscle forms (Bowman’s capsule and glomerulus). Here, 
primitive podocytes positioned in the S-shaped cleft produce chemotactic 
signals, such as Vegf, to attract endothelial invasion (Eremina et al., 2003). 
Aberrant Vegf expression by podocytes results in defective endothelial 
migration and glomerular maturation (Eremina et al., 2003).  
The proximal tubule and loop of Henle are thought to derive from the medial 
segment of the early polarised nephron, and the distal tubule from the distal 
segment, though detailed lineage tracing is yet to be performed. The epithelia 
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of the distal segment fuse with the ureteric bud epithelia at the S-shaped body 
stage (Kao et al., 2012). The epithelial tubules continue to elongate and 
mature, eventually giving rise to a mature segmented nephron. Nephrogenesis 
ceases rather abruptly at approximately postnatal day 3, when there is a 
nephrogenic surge that leads to the exhaustion of nephron progenitor cells 
(Hartman et al., 2007).  
 
 
Figure 1.7. Nephron formation. (a) Cap mesenchyme splitting and behaviour and 
gene expression differences. (b) Initial differentiation (mesenchymal-to-epithelial) of 
cap mesenchymal cells to form the pretubular aggregate then segmented renal vesicle. 
D, distal; M, medial; P, proximal. (c) Comma- and S-shaped bodies. Note the 
endothelia that have invaded the cleft of the S-shaped body: these will eventually 


















2.1. General methods 
2.1.1. Animals 
Except the transgenic lines, embryonic tissues were obtained from pregnant 
CD-1 mice. CD-1 mice are outbred and were used as they are more genetically 
diverse, generally healthier, and produce larger litter sizes compared to inbred 
mice (Hendrich, 2012). The morning of vaginal plug discovery was considered 
as embryonic day (E) 0.5. If, for example, embryos were collected 11-days 
after plug discovery, they would be classified as E11.5. Staging would be 
confirmed based on kidney and limb bud morphology. Pregnant CD-1 mice 
were killed, and uteri removed, by qualified staff of the UK Home Office-
licenced animal house following guidelines set under Schedule 1 of the UK 
Animals (Scientific Procedures) Act 1986. All experiments were approved by 
the University of Edinburgh and performed in accordance with the institutional 
guidelines and regulations. 
 
2.1.2. Embryonic kidney dissection  
Embryonic kidneys were dissected using previously described methods 
(Davies, 2010). First, in a 150 mm Petri dish, embryos were isolated from each 
uterine horn using fine forceps and a scalpel blade. Isolated embryos were 
then killed immediately by decapitation. The caudal part of the embryo was 
divided via a sagittal cut along the spinal cord using fine hypodermic needles. 
Kidneys from each half of the embryo were identified and isolated from their 
surrounding tissue. Finally, any non-renal tissue was carefully removed from 
around the dissected kidney rudiments.  
Kidneys that were to be directly processed and imaged were fixed 
immediately. Kidneys to be cultured were isolated under sterile conditions and 
were transferred using glass Pasteur pipettes into kidney culture medium 
(KCM; Minimum Essential Medium Eagle [Sigma, M5650] supplemented with 
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1% penicillin/streptomycin [Sigma, P4333] and 10% fetal calf serum 
[Invitrogen, 10108165]). These kidneys were then transferred into organ 
culture apparatus, as described below.   
 
2.1.3. Organ culture 
Kidneys were cultured using either the Saxén-style culture system (Saxén and 
Lehtonen, 1987) or the Transwell culture system. These systems are based 
on culturing kidney rudiments at the air(gas)/medium(liquid) interface. The 
specific culture systems used for different experiments are indicated in 
relevant results sections.  
Saxén-style culture: Kidney rudiments were cultured on a polycarbonate 
membrane filter (5 µm pores; Sigma, P9699-100EA) in 2-2.5 ml of kidney 
culture medium. Filters were supported by a stainless-steel grid in 35 x 10 mm 
culture plates (Figure 2.1a; Greiner, 627-160). Kidneys were grown at 37°C in 
5% CO2 in an incubator and the KCM was refreshed every 48 hrs.  
Transwell culture: Kidneys were cultured on sterile 24 mm polyester 
membrane inserts with 0.4 µm pores (Transwells; Corning 3450) in 1.5 ml of 
KCM per well (in a 6-well plate; Figure 2.1b). KCM was changed every 48 hrs.  
 
Figure 2.1. Kidney culture systems used in this thesis. (a) The Saxén-style culture 
system. (b) The Transwell culture system.  
36 
 
2.2. Methods specific to Results chapter 1 
2.2.1. Generation of re-aggregated kidneys 
Each re-aggregated kidney was generated from 8 E11.5 kidneys that were 
dissected and pooled as previously described (Unbekandt and Davies, 2010). 
Kidney rudiments were trypsinised for 1 min at 37°C in a 5% CO2 environment. 
To gather a suspension of single cells and eliminate cell clumps, the 
trypsinised kidneys were dissociated via trituration and passed through a cell 
strainer (pore size = 40 µm; Falcon, 352340). The cell suspension was 
centrifuged for 1 min 30 secs at 800 x g to form a pellet. The pellet was then 
cultured in KCM using the Saxén-style system. The pellet was cultured with 
1.25 µM of the ROCK inhibitor, glycyl-H1152-dihydrochloride, for the initial 24 
hrs. Using a ROCK inhibitor in this system improves cell survival (Unbekandt 
and Davies, 2010). After 24 hrs, the medium was replaced with fresh KCM 
without glycyl-H1152-dihydrochloride to encourage the generation of renal 
structures. 
 
2.2.2. Whole-mount immunofluorescence  
Kidneys were fixed in pre-cooled (at -20°C) methanol (for 30 mins to 2 hrs, 
depending on sample size) and then stored at -20°C or directly processed. 
Methanol was chosen as a fixative as pre-existing antibodies in the laboratory 
were known to work well using this fixation strategy. Moreover, methanol 
fixation both fixes and permeabilises tissue, samples can be stored in 
methanol at -20°C for long periods of time, and methanol fixation avoids issues 
related to protein crosslinking. After fixation, kidneys were rinsed in 1x 
phosphate buffered saline (PBS; 3 x 30 mins) and blocked with 1x PBS with 
5% bovine serum albumin (BSA; Sigma, A9647) and 10% donkey serum 
(Sigma, D9663) for 1 hr at room temperature or overnight at 4°C. Kidneys were 
incubated with primary antibodies overnight at 4°C (for antibodies used in 
Results chapters 1 and 2, see Table 2.1). Kidneys were rinsed in 1x PBS (3 
x 1 hr) and subsequently incubated in secondary antibodies for 2-4 hrs at room 
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temperature or overnight at 4°C. After incubation with secondary antibodies, 
kidneys were washed in 1x PBS (4 x 1 hr) and mounted onto glass slides in 
mounting medium (Vectashield; Vectorlabs, H1000). Samples were covered 
by cover-slips, which were stuck in place on the slide using nail varnish. 
Secondary-only controls were often used to differentiate between background 
signal and ‘true’ signal.  
 
Table 2.1. Antibodies used in Section 1 (Results chapters 1 and 2).   
 
 
2.2.3. BABB clearing whole-mount immunofluorescence 
For deep imaging through thick samples, the whole-mount 
immunofluorescence protocol was adapted, and samples were cleared. 
Samples were first fixed in Dent’s bleach (methanol: dimethyl sulfoxide 
[DMSO]: 30% hydrogen peroxide; 4:1:1) for 2 hrs, then stored in Dent’s fixative 
Primary antibodies Working dilution Clonality Supplier (Cat. Number)
Rat anti-mouse CD31 1 in 100 Monoclonal BD Pharmingen (550274)
Rabbit anti-mouse laminin 1 in 100 Polyclonal Sigma (L9393)
Mouse anti-mouse calbindin 1 in 100 Monoclonal Abcam (ab9481)
Mouse anti-mouse pan-cytokeratin 1 in 100 Monoclonal Sigma (C2562)
Rabbit anti-mouse Six2 1 in 200 Polyclonal Proteintech (11562-1-AP)
Rabbit ant-mouse VEGFR2 1 in 100 Monoclonal Cell signalling technology (55B11)
Goat anti-human Gata3 1 in 200 Polyclonal R&Dsystems (AF2605)
Rabbit anti-mouse Lyve-1 1 in 100 Polyclonal Abcam (ab33682)
Rat anti-mouse Ly76 (TER-119) 1 in 100 Monoclonal Abcam (ab91113)
Goat anti-human collagen IV 1 in 100 Polyclonal Merckmillipore (AB769)
Goat anti-mouse SCL/Tal1 1 in 100 Polyclonal Santa cruz (ab24870)
rat-anti-EphB4 1 in 100 Monoclonal Abcam (ab73259)
rabbit-anti-LYVE1 1 in 100 Polyclonal Abcam (ab33682)
rabbit-anti-Nrp1 1 in 100 Monoclonal Abcam (ab81321)
goat-anti- Nrp2 1 in 100 Polyclonal R&D Systems (AF567)
rabbit-anti-Sema3f 1 in 100 Polyclonal Abcam (ab39956)
goat-anti-mouse-integrin alpha 8 1 in 100 Polyclonal R&D Systems (AF4076)
Conjugated primary antibodies Working dilution Clonality Supplier (Cat. Number)
FITC-conjugated mouse anti-mouse actin, α-smooth muscle 1 in 100 Monoclonal Sigma (F3777)
Conjugated secondary antibodies Working dilution Supplier (Cat. Number)
AlexaFluor 350 donkey anti-mouse 1 in 200 Life Technologies (A10035)
AlexaFluor 488 donkey anti-mouse 1 in 200 Life Technologies (A21202)
AlexaFluor 488 donkey anti-rabbit 1 in 200 Life Technologies (A21206)
AlexaFluor 647 donkey anti-rabbit 1 in 200 Life Technologies (A31573)
AlexaFluor 488 donkey anti-goat 1 in 200 Life Technologies (A11055)
AlexaFluor 647 donkey anti-goat 1 in 200 Life Technologies (A21447)
AlexaFluor 594 chicken anti-rat 1 in 200 Life Technologies (A21471)
AMCA Goat anti-rabbit 1 in 100 Abcam (ab123435)
AMCA horse anti-mouse 1 in 100 VECTOR (CI-2000)
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(methanol: DMSO; 4:1) at -20°C. They were washed with 1x PBS-Tween (3 x 
30 mins; 0.2% Tween® 20) and blocked with 1x PBS-Tween with 5% BSA, 
10% donkey serum, and 5% DMSO (AppliChem, A3672-0100) overnight. 
Samples were incubated with primary antibodies, which were diluted in the 
blocking buffer at 4°C for 1-5 days on a rocker. They were then washed in 1x 
PBS-Tween for 3 x 2 hrs. They were incubated in secondary antibodies for 24 
hrs at 4°C diluted in the blocking buffer. Subsequently, samples were washed 
for 4 x 1 hrs with 1x PBS-Tween and then dehydrated using different ratios of 
methanol: dH2O (15-mins per step; 20%, 50%, 75%, and 100% methanol). 
They were placed in a glass vial in 50% benzyl alcohol/benzyl benzoate 
(BABB) with 50% methanol and then cleared in 100% BABB until transparent. 
After clearing, samples were placed on a slide within a small drop of BABB 
and covered on the slide with a glass cover-slip prior to imaging.  
 
2.2.4. Microscopy 
The Nikon A1R confocal microscope with NIS-Elements software was used to 
generate all images in Results Chapter 1. Objectives of 4-60x were used. 
Objective lenses were oil-immersed from 40x upwards. Images were analysed 
and processed using ImageJ (FIJI) and IMARIS (version 8.3.1).  
 
2.2.5. Vascular plexus area measurements 
Using the freehand selection tool in ImageJ, the area covered by each vascular 
plexus was defined: the area of each region was traced three times 
(determined using Analyse > Measure) and the mean of the three 
measurements was taken as the area covered by that vascular plexus. The 
area of each vascular plexus at each embryonic age was pooled so that a 
mean for each age could be calculated. The trend for vascular plexus area to 
decrease over developmental time was compared to the decrease in ampulla 
size over developmental time by assessing the square root of the number of 
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cells per 3-D ampulla (using data from Short et al., 2014) and relating it to the 
vascular plexus area calculations. 
 
2.2.6. Statistical analyses and data presentation 
For the vascular plexus area analyses, D'Agostino-Pearson omnibus normality 
tests were used followed by a one-way ANOVA with the post-hoc Tukey’s 
Multiple Comparison Test. To compare the directionality of endothelial 
migration, a two-tailed Mann-Whitney test was used. A p-value under 0.05 was 
considered as statistically significant. Confidence intervals for binary (yes/no) 
percentage counts were calculated using the formula t=1.64SQRT(pq/n)+1/2n, 
where t is the 95% confidence interval, p is the proportion that were positive, 
q is 1-p, and n is the number of samples examined (Neyman, 1937). Statistical 
analyses and graph preparation were carried out using GraphPad prism 
(version 5). Figures were prepared using Adobe illustrator CC (2015) and 
movies were prepared using Adobe premiere pro CC (2015) and IMARIS 
(version 8.2.1). 
 
2.3. Methods specific to Results chapter 2 
2.3.1. Databases 
Expression of anti-angiogenic genes in the cap mesenchyme was assessed 
using the gene expression search tool on the GUDMAP website 
(http://www.gudmap.org/gudmap/pages/databasehomepage.html). 
Microarray heat map data for each gene were assessed and taken from the 
“Developing Kidney (ST1)” and “Developing Kidney (MOE430)” data sets (data 
retrieved in May 2017). The heat map data were normalised based on the 
binary logarithm (log2n) of the average expression value of a given gene 
across an entire data set. Red indicated high expression of the given gene, 
blue indicated low expression, and black indicated expression close to the 
median. Experiments had been performed in triplicate for each probe set. 
Where there were only two probe sets available for the expression of a given 
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gene, the probe set with the most consistent data between replicate samples 
was shown. Where there were more than two probe sets available for the 
expression of a given gene, the probe set with the median values was chosen 
for the analysis. The in situ hybridization images showing Sema3f RNA 
localisation in the E15.5 kidney were deposited on GUDMAP by the McMahon 
group (data retrieved in May 2017) and made available at 
http://www.gudmap.org/gudmap/pages/gene.html?geneId=MGI%3A1096347. 
The confocal z-stack of the Nrp2EGFP kidney was generated in the Potter lab 
and was deposited at-------------------------------------------------------------------------- 
http://www.gudmap.org/Resources/MouseStrains/MouseStrainsSummary.ht
ml under the heading “Mouse strains generated by external sources” (retrieved 
in May 2017). In situ hybridization data from the Allen Brain Atlas showing 
Sema3f expression at E11.5 was available at http://developingmouse.brain-
map.org/experiment/show/100093437 (section 12/20, retrieved May 2017), 
and E13.5 can be found at------------------------------------------------------------------- 
http://developingmouse.brain-map.org/experiment/show/100076578 (section 
7/16, retrieved May 2017). At the above Allen Brain Atlas links, renal Sema3f 
expression was apparent in sections 11–13 and 16–17 of the E11.5 mouse 
and in sections 6–10 and 15–16 of the E13.5 mouse.  
 
2.3.2. Animals 
As described in section 2.1.1, embryonic tissues for descriptive studies in 
Results chapter 2 were obtained from CD-1 mice killed by qualified staff of a 
UK Home Office–licensed animal house following guidelines set under 
Schedule 1 of the UK Animals (Scientific Procedures) Act 1986.  
Transgenic mice used in Results chapter 2: Caudal parts of P0 Sema3f 
knockout pups were obtained from Georgetown University, according to locally 
approved procedures. The Sema3f mutant mice were maintained in 
Georgetown University by qualified staff in accordance with the National 
Institutes of Health (NIH) Animal Care and Use Committee. The caudal 
portions of euthanized P0 Sema3f pups were sent at 4°C to the University of 
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Edinburgh, where kidneys were isolated and immunostained. This method of 
transport of embryonic tissue was described by Davies, 2006. The Sema3f 
knockout mouse line has previously been described (Walz et al., 2007). 
Sema3f mutant mice were bred for more than 9 generations into a C57BL/6 
genetic background (Charles River Laboratories, Frederick, MD). As C57BL/6 
mice are inbred, they lack genetic diversity, which is preferred for transgenic 
studies. Nrp2 mutants were kindly sent from Alex Kolodkin and Qiang Wang 
at Johns Hopkins University. Caudal parts of E18.5 Nrp2 transgenic mouse 
embryos were sent in the same manner as the Sema3f mutants. The Nrp2 
mutant mouse line has previously been described (Giger et al., 2000) and 
these mice were also bred into the C57BL/6 genetic background. Genotyping 
of the Sema3f pups was performed by Thomas Coate and genotyping of the 
Nrp2 embryos was performed by Qiang Wang.  
 
2.3.3. Whole-mount immunofluorescence 
Immunofluorescence staining for Results chapter 2 was performed as 
described in sections 2.2.2. and 2.2.3. Antibodies used in Results chapter 2 
are shown in Table 2.1. 
 
2.3.4. Microscopy 
Microscopy for Results chapter 2 was performed as described in section 
2.2.4. using the Nikon A1R and the Zeiss LSM800 confocal microscope.  
 
2.3.5. Statistics and data presentation 
95% confidence intervals were calculated as described in section 2.2.6. 
IMARIS (version 8.3.1) and Adobe Premiere Pro CC (2015) were used to 
prepare movies and Adobe illustrator CC (2015) was used to prepare figures.  
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2.4. Methods specific to Results chapter 3 
2.4.1. Animals 
As described in section 2.1.1, embryonic tissues for descriptive studies were 
obtained from CD-1 mice killed by qualified staff of a UK Home Office–licensed 
animal house following guidelines set under Schedule 1 of the UK Animals 
(Scientific Procedures) Act 1986.  
The MacGreen (Csf1rEGFP) reporter mouse line has previously been described 
(Sasmono et al., 2003). Csf1rEGFP mice were bred and maintained in-house at 
the Roslin Institute. MacGreen embryos with EGFP+ macrophages were 
genotyped using a Zeiss Axioscope A1 microscope based on obvious 
differences in fluorescence (Figure 2.2). E18.5 Six2EGFPCre mouse embryos 
were used to collect single cells for single cell analyses (performed by Yishay 
Wineberg; for details of this mouse line, see Kobayashi et al., 2008).  
 
Figure 2.2. MacGreen (Csf1rEGFP+) kidneys. E13.5 and E14.5 Csf1rEGFP+ kidneys 
(right) and Csf1rEGFP- negative control littermate kidneys (left). There was dim 
autofluorescence in negative samples and clear cell-specific staining in positive 
samples. Identical microscope settings were used. Scale bars = 100 µm.  
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2.4.2. Organ culture 
Kidneys were cultured on sterile 24 mm polyester membrane inserts with 0.4 
µm pores (Transwells; Corning 3450) in 1.5 ml of KCM per well (in 6-well 
plates; as described in Section 2.1.3; Figure 2.1b). KCM was changed every 
48 hrs, unless otherwise stated.  
 
2.4.3. Inhibition of vascular growth 
E12.5 kidneys were cultured on Transwell filters for 3 days (see section 2.1.3) 
in either 1.5 ml of KCM only (control), KCM with vascular development 
inhibitors, or KCM with DMSO (vehicle control). Inhibitor concentrations were 
calculated based on half-maximal inhibitory concentration (IC50) values 
against Vegfr2 (using values from the IUPHAR/BPS Guide to Pharmacology; 
http://www.guidetopharmacology.org/). Vatalinib had previously been used at 
a concentration of 1 µM to inhibit vascular development in cultured kidneys 
(Halt et al., 2016); therefore, I used 1 µM of vatalinib in my experiments. 1 µM 
of vatalinib is at a concentration that is 47.62 times greater than its IC50 
against Vegfr2. To calculate concentrations to use for the other inhibitors, I 
multiplied sunitinib’s and semaxanib’s IC50s against Vegfr2 by 47.62 (for 
consistency). Based on these calculations, the inhibitor concentrations used in 
the KCM were 1 µM of vatalinib, 1.076 µM of sunitinib, and 9.524 µM of 
semaxanib. As a vehicle control, DMSO was added at the same volume as the 
highest volume used for the inhibitors.  
After 3 days of culture, cultures were stopped, and kidneys were directly fixed 
in 4% paraformaldehyde (PFA) for 15 mins, washed in PBS, and then fixed in 





2.4.4. Csf1r blockade in cultured kidneys  
E12.5 kidneys were cultured on Transwell filters in 1.5 ml KCM (see section 
2.1.3) for 3 days with either 20 µg/ml anti-Csf1r mAb blocking antibody (M279) 
or 20 µg/ml anti-rat IgG (as a control). The anti-Csf1r blocking antibody was 
kindly provided by Clare Pridans (University of Edinburgh). To retain anti-Csf1r 
and anti-rat IgG (control) within the medium, KCM was not refreshed during 
the 3-day culture period. After 3 days, cultures were directly fixed in methanol 
and processed for immunofluorescence.  
 
2.4.5. Whole-mount immunofluorescence 
For details regarding the antibodies used in Results Chapter 3, see Table 
2.2. Immunofluorescence staining was performed as described in section 
2.2.2 with the following alterations. Samples were initially fixed with 4% PFA 
for 10-60 mins (depending on sample size: larger sample = longer incubation). 
After PFA fixation, samples were dehydrated in a methanol: dH2O serial 
dilution (20%, 40%, 60%, 80%, and then 100% - 15 mins per step). After 
dehydration, samples were stored at -20°C until being further processed. 
Samples were then rehydrated in a methanol: dH2O serial dilution (80%, 60%, 
40%, 20%, and then 0% - 15 mins per step) and the protocol was continued 
as described in section 2.2.2.  
 
2.4.6. BABB clearing whole-mount immunofluorescence 
The BABB clearing whole-mount immunofluorescence protocol in section 
2.2.3 was adapted, and the updated protocol used in Results Chapter 3 is 
described here. Samples were first fixed in 4% PFA for 1-2 hrs. They were 
washed in 1x PBS (2 x 1 hr) and then dehydrated in a methanol: dH2O serial 
dilution (20%, 40%, 60%, 80%, and then 100% - 15 mins per step). After a 
100% methanol wash, samples were incubated with Dent’s bleach (methanol: 
dimethyl sulfoxide [DMSO]:30% hydrogen peroxide; 4:1:1) for 2 hrs, then 
stored in methanol at -20°C. To continue the protocol, samples were 
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rehydrated in a methanol: dH2O serial dilution (80%, 60%, 40%, 20%, and then 
0% - 15 mins per step). They were washed with 1x PBS-Triton X-100 (2 x 30 
mins). They were then permeabilised using 1x PBS with 0.2% Triton X-100, 
300 mM glycine, and 20% DMSO at room temperature. Samples were then 
blocked with 1x PBS with 0.2% Triton X-100, 3% donkey serum, and 10% 
DMSO overnight at 4°C. They were then incubated with primary antibodies, 
which were diluted in the 50% blocking buffer with 50% 1x PBS at 4°C for 1-5 
days on a rocker. They were then washed in 1x PBS-Tween for 3 x 2 hrs. 
Samples were incubated in secondary antibodies for 24 hrs at 4°C diluted in 
50% blocking buffer with 50% 1x PBS. Subsequently, samples were washed 
with 1x PBS-0.2%Tween for 3 x 2 hrs during the day and then left in 1x PBS 
overnight at 4°C. They were dehydrated using different ratios of methanol: 
dH2O (15-mins per step; 20%, 50%, 75%, and 100% methanol). They were 
placed in a glass vial in 50% benzyl alcohol/benzyl benzoate (BABB) with 50% 
methanol until they sank to the bottom of the vial and were then cleared in 
100% BABB until transparent. After clearing, samples were placed on a slide 
in a drop of BABB and covered with a glass cover-slip prior to imaging.   
 
Table 2.2. Antibodies used in Section 2 (Results chapter 3).   
 
Primary antibodies Working dilution Clonality Supplier (Cat. Number)
goat anti-mouse/rat CD31 1 in 100 Polyclonal R&Dsystems (AF3628)
rabbit anti-mouse cleaved caspase 3 (D175) 1 in 100 Polyclonal Cell signaling technology (9661L)
rat anti-mouse F4/80 1 in 100 Monoclonal Abcam (ab6640)
rat anti-mouse/human Mac2 1 in 100 Monoclonal CEDARLANE (CL8942AP)
goat anti-mouse CD206 1 in 100 Polyclonal R&Dsystems (AF2535)
goat anti-mouse Gata3 1 in 200 Polyclonal R&Dsystems (AF2605)
rabbit anti-mouse CD31 1 in 100 Polyclonal abcam (ab124432)
rabbit anti-mouse collagen IV 1 in 100 Polyclonal abcam (ab6586)
goat anti-human collagen IV 1 in 100 Polyclonal Merckmillipore (AB769)
rabbit anti-mouse laminin 1 in 100 Polyclonal Sigma (L9393)
rabbit anti-GFP - ChiP Grade 1 in 500 Polyclonal abcam (ab290)
rabbit anti-mouse Six2 1 in 200 Polyclonal Proteintech (11562-1-AP)
mouse anti-mouse Meis1/2/3 1 in 100 Monoclonal Active Motif (39795)
Cell stains Working dilution Supplier (Cat. Number)
TO-PRO™-3 Iodide (642/661) 1 in 5000 Invitrogen (T3605)
Conjugated secondary antibodies Working dilution Supplier (Cat. Number)
AlexaFluor 488 donkey anti-mouse 1 in 200 Life Technologies (A21202)
AlexaFluor 488 donkey anti-rabbit 1 in 200 Life Technologies (A21206)
AlexaFluor 594 donkey anti-rabbit 1 in 200 Life Technologies (A21207)
AlexaFluor 647 donkey anti-rabbit 1 in 200 Life Technologies (A31573)
AlexaFluor 488 donkey anti-goat 1 in 200 Life Technologies (A11055)
AlexaFluor 594 donkey anti-goat 1 in 200 Life Technologies (A21203)
AlexaFluor 647 donkey anti-goat 1 in 200 Life Technologies (A21447)
AlexaFluor 594 chicken anti-rat 1 in 200 Life Technologies (A21471)
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2.4.7. Microscopy  
Microscopy for Results chapter 3 was performed as described in section 
2.2.4. using the Zeiss LSM800 confocal microscope.  
 
2.4.8. Sphericity measurements  
Sphericity measures how spherical an object is. The sphericity of Mac2+ and 
CD206+ cells in the E14.5 kidney was measured using IMARIS (version 8.3.1). 
Cells were surface-rendered and non-cellular rendered objects were manually 
removed. IMARIS automatically calculated the sphericity of each rendered cell 
based on Wadell’s 1935 equation, as shown below:  
  




2.4.9.1. E9.5/E10.5 macrophage density localisation 
Numbers of F4/80+ macrophages were manually counted using plugin  
analyse  cell counter in ImageJ in 10 individual z-planes through cleared 
caudal regions of mouse embryos (at E9.5 and E10.5). To calculate 
macrophage density in the caudal region of embryos, regions that were devoid 
of tissue and regions that included nephrogenic cells were traced using the 
Freehand selections tool on ImageJ and were subtracted from the overall area 
per field of view. Macrophage density (F4/80 cells per mm2) was calculated by 
dividing macrophage numbers by the calculated area of the caudal region in 
each field of view. Macrophage density within the Six2+ nephrogenic 
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populations were scored in a similar way, with the area covered by Six2+ cells 
on each field of view being calculated using the Freehand selections tool.  
 
2.4.9.2. Macrophage density along the rostro-caudal axis of the E10.5 
metanephric mesenchyme 
To calculate macrophage density along the rostro-caudal axis of the 
metanephric mesenchyme at E10.5, I used the Straight line tool on ImageJ to 
draw a line along the length of the main population of Six2+ cells and measured 
the length of this line. I divided the length of this line by four to define each 
quarter of the population along its rostro-caudal axis and counted macrophage 
numbers per quarter. I then related macrophage numbers (calculated using 
plugin  analyse  cell counter in ImageJ) to the area of each quarter to 
calculate macrophage density (F4/80 cells per mm2). I also quantified 
macrophage density within isolated rostral populations of Six2+ cells at E10.5. 
Macrophage density was represented on a linear 3-colour scale, with blue 
indicating the lowest levels, black indicating values in the middle, and red 
indicating the highest values. 
 
2.4.9.3. Macrophage density at E11.5 
Macrophage density was calculated in the E11.5 peri-Wolffian mesenchyme 
and metanephric mesenchyme as described in section 2.4.8.1. The 
metanephric mesenchyme was defined and drawn by a kidney development 
researcher who was blinded to the experimental purpose. To eliminate 
potential bias based on macrophage or vasculature localisation, only the 
Gata3 channel (showing ureteric bud) was shown to the blinded researcher. 
Peri-Wolffian mesenchyme and metanephric mesenchyme areas were 
quantified and macrophage numbers counted (using plugin  analyse  cell 





2.4.9.4. Vascular depletion experiments  
Macrophage density: Firstly, kidney areas were measured using the Freehand 
selections tool in ImageJ. Macrophages and blood vessels were only counted 
if they fell within the boundary of the kidney (using plugin  analyse  cell 
counter in ImageJ). To validate the counting method, a second, blinded 
counter was given coded samples and asked to count macrophage numbers 
using the same method (n = 3 per group). 
Vascular density: The CD31 channel was separated from other channels in 
ImageJ. For each sample, the Despeckle and Subtract Background (rolling ball 
radius = 50) tools were used and the image contrast was enhanced; these 
steps were performed to increase the accuracy of thresholding based on CD31 
signal. Files were converted into RGB and thresholded using the Huang 
method. The kidney area was drawn using the Freehand selections tool in 
ImageJ, and the percentage area covered by CD31+ structures was taken as 
the vascular density (% CD31+ area per field).  
Macrophage localisation: To count whether macrophages localised within the 
interstitium or cap mesenchyme, I stained kidneys with the cap mesenchyme 
marker Six2. Any macrophages that did not localise within the Six2+ cap 
mesenchyme were classed as interstitial and the percentages of macrophages 
in/out of the caps were plotted.  
Ureteric bud branching generations: I counted the number of ureteric bud 
bifurcations from the primary bifurcation site (at the upper ureter) to the final 
bifurcation site (at the kidney’s periphery) in each kidney.  
 
2.4.9.5. Csf1r F4/80 co-staining 
Csf1rEGFP+ kidneys were fixed, immunostained, and cleared (using protocol in 
section 2.4.6). An anti-GFP antibody was used to label Csf1rEGFP+ cells and 
the co-localisation of GFP+ and F4/80+ cells was quantified using plugin  
analyse  cell counter in ImageJ. Quantification was based on assessments 
of 8 z-planes from an E14.5 Csf1rEGFP+ kidney.  
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2.4.8.6. Macrophage nephrogenic zone localisation 
Macrophage localisation was quantified in the E17.5 nephrogenic zone by co-
staining for F4/80, collagen IV, and Six2. Collagen IV marks blood vessel 
basement membranes in the developing kidney and Six2 marks nephron 
progenitor populations (see Results Chapter 1). To quantify macrophage 
localisation, I analysed macrophage location in 3D by scrolling through z-
planes. Quantifying macrophage localisation in 3D was necessary for various 
reasons. For example, macrophages sitting above the cap mesenchyme in 3D 
may appear within the cap mesenchyme in 2D images - the same was true for 
macrophage localisation around blood vessels. Therefore, careful analyses of 
individual z-planes were required to assess the depth of macrophages relative 
to structures of interest.  
 
2.4.8.7. F4/80 CD206 co-staining  
Quantification was performed at different ages using antibodies against F4/80 
and CD206 as described in section 2.4.9.5. Quantifications at E14.5 and 
E17.5 were made based on macrophages in the cortical nephrogenic zone. 
 
2.4.8.8. Mac2 CD206 co-staining  
Quantification was performed at different ages using antibodies against Mac2 
and CD206 as described in section 2.4.9.5. Quantification at E14.5 and E17.5 
were made based on macrophages in the cortical nephrogenic zone. 
 
2.4.8.9. F4/80 cell and Mac2 cell localisation comparisons 
Quantification was performed in the E17.5 nephrogenic zone using antibodies 
against Mac2 or F4/80. Quantifications were performed as described in 
section 2.4.9.6, but anti-CD31 and anti-collagen IV were used to show blood 
vessels rather than only anti-collagen IV, and anti-Six2 was not used.  
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2.4.8.10. Macrophage blockade quantification 
Macrophage numbers were quantified using the add spots tool on the F4/80 
channel in IMARIS (version 8.3.1). Spot number per kidney was defined as 
total macrophage number per kidney. To calculate kidney area, kidneys were 
drawn using the Freehand selections tool in ImageJ and the area covered by 
each kidney was measured. To calculate the CD31+ area per field (%), the 
CD31 channel was prepared for thresholding using process  filters  
median [radius = 2 pixels] then image brightness/contrast was adjusted in 
ImageJ. Images were thresholded using image  adjust  threshold (default 
thresholding). After thresholding, the percentage of the thresholded area per 
field of view was measured and defined as the vascular density (% CD31+ area 
per field). The numbers of isolated CD31+ structures per field were then 
quantified using plugin  analyse  cell counter in ImageJ. The number of 
CD31+ structures per field was divided by the total CD31+ area per field to give 
the average % of the field covered by each CD31+ structure. 
 
2.4.9. Single cell RNA sequencing data analysis 
Single cell RNA sequencing experiments were performed by Yishay Wineberg 
(Bar-Ilan University, Ramat Gan, Israel) following the smart-seq2 protocol 
(Picelli et al., 2014). MATLAB and GraphPad were used to prepare single cell 
heatmap clustering graphs (using the Bioinformatics Toolbox in MATLAB; 
analyses performed by Yishay Wineberg) and principle component analyses 
(PCA) graphs (using the Statistics and Machine Learning Toolbox in MATLAB; 
analyses performed by Yishay Wineberg).  
PCA graphs were prepared based on the expression of 48 genes chosen 
based on relevant literature (by Tomer Kalisky and Yishay Wineberg). To 
standardise the expression values for each gene, values were first log-
transformed. Next, the log gene expression value for each cell was subtracted 
from the mean log gene expression value of all cells analysed. This value was 
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then divided by the standard deviation, and truncated into the range of -1,1 to 
eliminate outliers.  
Gene signature analyses: The gene signatures for mature macrophages and 
erythro-myeloid progenitor cells were based on signatures generated by Mass 
et al (2016; available at----------------------------------------------------------------------- 
www.sciencemag.org/content/353/6304/aaf4238/suppl/DC1). The gene 
signature for monocytes was based on genes expressed highly by monocytes 
but not by mature macrophages (based on microarray data), and was adapted 
from Hoeffel et al (2015); Figure S3A - https://ars.els-
cdn.com/content/image/1-s2.0-S1074761315001259-mmc1.pdf). Values 
used for gene signature analyses in Figure 4.2.19 were based on averaged 
gene expression values of the different identified cell subtypes (n = 6 
F4/80+CD206+ cells, n = 3 Mac2+ cells, and n = 1 Six2+ nephron progenitor 
cell). 
Gene set enrichment analyses - Biological processes and Cellular Component: 
The Panther Gene Overrepresentation Test was used to assess whether the 
top 1% of expressed genes (234 genes) by Mac2+ and F4/80+CD206+ cells 
were enriched for certain biological processes or cellular components (Mi et 
al., 2013; http://pantherdb.org/tools/compareToRefList.jsp). The gene 
ontology consortium defines a biological process as ‘pathways and larger 
processes made up of the activities of multiple gene products.’ Cellular 
component refers to ‘where gene products are active’. The reference dataset 
used for this analysis was based on the entire gene list used in the single cell 
analyses (rather than using the reference list for the mouse genome). False 
discovery rate corrected p-values were calculated using Fisher's Exact with 
FDR multiple test correction. For more details about this tool, see Mi et al., 





2.4.10. Statistics and data presentation 
Data were shown as mean ± standard error of the mean. Gaussian distribution 
tests were performed using the Kolmogorov-Smirnov test and D’Agostino and 
Pearson omnibus normality test. Data that passed normality testing were 
analysed using parametric tests, whereas data that did not pass normality tests 
were analysed using non-parametric tests (the specific tests used were 
indicated in relevant results sections). When more than two groups were 
compared, post-hoc tests were used to compare differences between each 
individual column. All p-values were based on two-tailed comparisons. 
GraphPad (version 5) was used for statistical tests and graph preparation. 
IMARIS (version 8.3.1) and Adobe Premiere Pro CC (2015) were used to 

















3. Section 1 | Development of the Renal Vasculature 
 
3.1. Introduction 
3.1.1. Overview | The development of the renal vasculature is incompletely 
understood. This introduction for Section 1 describes the mechanisms of 
blood vessel formation and reviews current concepts relating to how the kidney 
becomes vascularised. For a description of renal vascular anatomy in the 
adult, see Chapter 1 of this thesis; in this chapter, I focus on renal vascular 
development.  
 
3.1.2. Angiogenesis and vasculogenesis | In general, there are two modes 
of blood vessel formation: vasculogenesis and angiogenesis. Although the 
prefixes used to describe these processes have the same literal meaning 
(angio- and vasculo- both refer to blood vessels), they are mechanistically 
distinct. Vasculogenesis is de novo blood vessel formation via differentiation 
and coalescence of mesoderm-derived endothelial precursors (often termed 
angioblasts; His, 1900; Risau and Flamme, 1995), whereas angiogenesis is 
new blood vessel development from pre-existing vessels (Rabl, 1887; Patel-
Hett and D'Amore, 2011).  
By necessity, the first embryonic blood vessels are generated by 
vasculogenesis (Drake and Fleming, 2000). This process generates an early 
vascular network before the circulation is established (Risau and Flamme, 
1995; Jin and Patterson, 2009). In vasculogenesis, undifferentiated 
mesodermal cells differentiate into angioblasts, which subsequently migrate, 
aggregate, form capillary-like cords, and finally generate functional endothelial 
vessels (Drake, 2003; Figure 3.1). The signals that induce mesoderm-to-
endothelial transitions are poorly defined, but fibroblast growth factors, 
vascular endothelial growth factors/receptors, and angiopoietins/Tie receptors 
are significant (Cox and Poole, 2000; Jin and Patterson, 2009). Though 
originally thought to take place only during the formation of the first embryonic 
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vessels, studies have demonstrated that vasculogenesis can also occur in 
developing organs and in the adult (Pardanaud et al., 1989; Gebb and 
Shannon, 2000; Murohara et al., 2000; Drake, 2003).  
 
 
Figure 3.1. Steps involved in vasculogenesis and evidence for vasculogenesis in 
vitro and in vivo. (a) Steps involved in vasculogenesis. (b) Vasculogenesis in vitro 
(adapted from Ambrosi et al., 2005). (c) Vasculogenesis in vivo in the early chick 
embryo (adapted from Drake, 2003). Upper panel: Angioblasts are shown in green. 
At step 1, angioblasts aggregate. At step 2, angioblasts elongate and form cords. At 
step 3, vessels mature and lumenise. Lower panel: Shows stages 1-3 occurring in vivo. 
White arrowheads = isolated angioblasts (SCL/Tal1+QH1- cells). Full white arrows = 
endothelial cells that are generating capillary-like-structures (SCL/Tal1+QH1+ cells).  
Scale bar = 50 µm.  
 
Angiogenesis, in contrast, is where endothelial cells sprout or split from pre-
existing vessels to form new vessels or remodel old ones (Figure 3.2). Though 
angiogenesis by vessel splitting (intussusceptive angiogenesis) contributes to 
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vascular remodelling, most blood vessels in development and adulthood are 
generated and modified by sprouting angiogenesis (Herbert and Stainier, 
2011). 
In the absence of angiogenic factors, endothelia line the luminal side of stable 
pre-existing blood vessels and remain in a quiescent state that is maintained 
by the transcription factor, Erg (Dryden et al., 2012). This quiescence is 
interrupted when endothelia are exposed to pro-angiogenic signals, such as 
angiopoietin-2, which activate endothelial tip cells and initiate sprouting 
angiogenesis (Scharpfenecker et al., 2005).  
Pro-angiogenic factors induce fundamental changes in endothelial cells and 
the local environment. For example, endothelial cell-cell junctions are 
loosened, basement membrane-degrading proteases are activated, and 
endothelial tip cells generate numerous filopodial extensions (which survey the 
environment for further guidance signals; Herbert and Stainier, 2011). 
Furthermore, glycolytic flux is enhanced in activated tip cells, which facilitates 
increased endothelial motility (De Bock et al., 2013).  
Trailing the endothelial tip cell are endothelial stalk cells, which support vessel 
elongation, form vascular lumens, and maintain the connection between the 
sprouting endothelia and the parental vessel. Stalk cells are highly proliferative 
and dynamically compete for tip cell position in sprouting vessels (Jakobsson 
et al., 2010). When a tip cell meets a nearby vessel, it can connect (vessel 
anastomosis), forming a new channel for blood. Our knowledge of the 
mechanisms controlling anastomosis are limited, but other cell types, such as 
macrophages, can facilitate this process by acting as cellular chaperones to 
promote endothelial connections (Fantin et al., 2010; see Introduction to 
Section 2). 
Following anastomosis, vascular accessory cells, such as pericytes and 
smooth muscle cells (mural cells), are recruited to stabilise vessel walls. Newly 
formed vessels are specified into arteries, veins, or capillaries in response to 
a combination of genetic factors and haemodynamic forces (Rocha and 
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Adams, 2009). Subsequent cell-cell junction stabilisation and basement 
membrane re-assembly result in endothelia re-establishing their quiescent 
state. For detailed reviews of the steps and molecules involved in 
angiogenesis, see Herbert and Stainier, 2011 and Potente et al., 2011.  
 
 
Figure 3.2. Mechanisms of angiogenesis. (a) Sprouting angiogenesis involves the 
activation of an endothelial tip cell, which sprouts away from a pre-existing vessel to 
form a new channel. (b) Intussusception is the creation of a new vessel due to the 
splitting of a pre-existing vessel in two.  
 
3.1.3. Mechanisms of kidney vascularisation: angiogenesis-only, 
vasculogenesis-only, or both?  The relative contribution of each blood 
vessel-generating mechanism during kidney vascularisation is widely debated. 
In principle, the renal vasculature may assemble through vasculogenesis-only 
(improbable and not supported), angiogenesis-only (conceivable but 
overlooked), or a combination of both processes (the favoured option). Though 
the combination option is supported – almost all pertinent reviews since 1995 
58 
 
suggest both processes occur (Table 3.1) – opinions are often ambiguous and 
inconsistent regarding the relative contribution of each mechanism. 
According to the combination theory, endogenous endothelial progenitors 
generate blood vessels in situ via vasculogenesis at the periphery of the 
kidney, while, simultaneously, the endothelia of the major vessels and the 
medulla form via angiogenesis, by branching from extrinsic sources 
(Abrahamson, 2009; Bates et al., 2014; Hum et al., 2014; Stolz and Sims-
Lucas, 2014; Tufro and Gulati, 2015). Eventually, these angiogenic vessels 
are thought to communicate and connect with the vasculogenic vessels 
(Figure 3.2a).  
Early support for this model came from Colberg (1863), who provided evidence 
for the existence of glomeruli not connected to the circulation, and Herring 
(1900), who proposed that blood vessels can develop endogenously in the 
kidney. More recently, this concept has been substantiated by studies that 
have identified endogenous endothelial and mural cell progenitors within the 
metanephric mesenchyme (Loughna et al., 1997; Sims-Lucas et al., 2013; 
Sequeira-Lopez et al., 2015; Halt et al., 2016; Hu et al., 2016): this implies that 
the kidney has the potential to form blood vessels intrinsically. But this model 












Table 3.1. Reviews favour the concept that both vasculogenesis and angiogenesis 
occur in the development of the renal vasculature.  
 
 
3.1.4. The first renal blood vessels | In the mouse, metanephric kidney 
development initiates at embryonic day 10.5 (E10.5) when a region of the 
Wolffian duct swells and protrudes to form the ureteric bud (reviewed by 
Costantini and Kopan, 2010). At this initial stage of kidney organogenesis, no 
vessels are discernible within the metanephric mesenchyme; however, based 
on 2D sections, sporadic Flk1+ endothelial cells are dispersed around its 
perimeter (Hyink et al., 1996; Robert et al., 1998).  
By E11, just before the first branch of the ureteric bud, erythrocyte-carrying 
capillaries are present in the loose mesenchyme between the Wolffian duct 
and the metanephric mesenchyme (Hyink et al., 1996; Loughna et al., 1996) 
and intermittent endothelia remain at the perimeter of the metanephric 
mesenchyme (Hyink et al., 1996; Robert et al., 1998). It is approximately at 
Title of review Authors Journal Year Pro-vasculogenesis?
Pro-
angiogenesis?
Vascular ontogeny within selected 
thoracoabdominal organs and the limbs. DeSesso JM. Reproductive Toxicology 2017 Yes Not mentioned
Unwrapping the origins and roles of the renal 
endothelium. Stolz DB, Sims-Lucas S. Pediatric Nephrology 2015 Yes Yes
Development of Glomerular Circulation and 
Function Tufro A, Gulati A Pediatric Nephrology 2015 Yes Yes
Patterning the renal vascular bed Herzlinger D, Hurtado R. Seminars in Cell & Developmental Biology 2015 They are unsure Yes
Developmental Origins and Functions of 
Stromal Cells in the Normal and Diseased 
Mammalian Kidney
Li W, Hartwig S, Rosenblum 
ND. Developmental Dynamics 2014 Yes Yes
Embryonic Development of the Kidney Bates C, Ho J, Sims-Lucas S Pediatric Nephrology 2014 Yes Yes
Vascular Heterogeneity in the Kidney Molema G, Aird WC. Seminars in Nephrology 2012 Yes Not mentioned
Development of the Renal Arterioles Sequeira Lopez ML, Gomez RA.
Journal of the American 
Society of Nephrology 2011 Yes Yes
Development of kidney glomerular 
endothelial cells and their role in basement 
membrane assembly.
Abrahamson, DR. Organogenesis 2009
Yes (for glomerular 
capillaries and under 
experimental conditions)
Yes
Glomerular endothelial cell differentiation Ballermann BJ. Kidney International 2005 Yes Yes (minor contribution)
Kidney vasculogenesis and angiogenesis:
role of Vascular Endothelial Growth Factor
Del Porto F, Mariotti A, Ilardi M, 
Messina FR, Afeltra A, 
Amoroso A.




Origins and formation of microvasculature in 
the developing kidney
Abrahamson DR, Robert B, 
Hyink DP, St John PL, Daniel 
TO.
Kidney International 1998 Yes (not committed) Yes (not committed)
Origin of glomerular capillaries: is the verdict 
in? Woolf AS, Loughna S. Experimental Nephrology 1998 Yes Yes
Renal microvascular assembly and repair: 
power and promise of molecular definition.
Takahashi T, Huynh-Do U, 
Daniel TO. Kidney International 1998 Yes Yes
Role of angiotensin in renal vascular 
development Gomez RA Kidney International 1998 Yes Yes
Development and differentiation of 
endothelium Risau W. Kidney International 1998 Weakly Yes
Development of the kidney vasculature Gomez RA, Norwood VF, Tufro-McReddie A.
Microscopy Research and 
Technique 1997 Yes Yes
Origin of the glomerular vasculature in the 
developing kidney. Hyink DP, Abrahamson DR. Seminars in Nephrology 1995 Weakly Yes
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this stage, between E11 and E11.5, that the first blood vessels enter the 
metanephric mesenchyme. These vessels enter at the ventral aspect of the 
kidney, lying parallel to the early ureteric bud (Hyink et al., 1996; Robert et al., 
1998). There are conflicting views on the origin of these initial blood vessels. 
Although numerous reviews assume that the first renal blood vessels originate 
as direct outgrowths from the embryonic aorta (Gómez and Sequeira López, 
2002; Bates et al., 2014; Herzlinger and Hurtado, 2014; Stolz and Sims-Lucas, 
2014), evidence suggests otherwise.  
Hyink et al (1996) performed binding studies with Bandeiraea simplicifolia 
isolectin B4 (BSLB4; a lectin that marks endothelia) and determined that the 
first vessels enter the kidney from sites neighbouring the stem of the ureteric 
bud at ~E11. Similarly, Roberts et al (1998) used beta-galactosidase 
histochemistry and determined that the first vessels of the kidney do not 
originate via a branch from the dorsal aorta. Rather, 2D sections suggested 
that the initial vessels were generated from the sporadic Flk1+ endothelia 
surrounding the metanephric mesenchyme (also at ~E11); it was suggested 
that these endothelia merge to form a vessel that projects into the kidney 
alongside the invading ureteric bud (Roberts et al., 1998). Regardless of their 
origin, the first renal blood vessels have formed by the first branch of the 
ureteric bud (at E11.5), entering the kidney at the hilum (Robert et al., 1998; 
Hyink et al., 1996; Loughna et al., 1996). A limitation of many of these early 
studies was that 2D sections were used to make assumptions about 3D 
structures (i.e. blood vessels).  
 
3.1.5. Development of the renal microvasculature | At the periphery of the 
developing kidney, in the cortical nephrogenic zone, many new vessels form 
around ureteric bud tips and emerging nephrons (Kloth et al., 1994; Sabine 
Kloth et al., 1997) Even at the earliest stage of nephron development, the renal 
vesicle stage, blood vessels surround developing nephron epithelia (Kloth et 
al., 1994). By the S-shaped body stage, blood vessels continue to enclose 
nephron epithelia and begin forming within the S-shaped cleft to initiate 
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glomerular capillary development (Kloth et al., 1994). These vessels stem from 
pre-existing vessels of the renal vasculature (Kazimierczak, 1980; Kloth et al., 
1994; Naruse et al., 2000). 
Microinjections of FITC-tagged tomato lectin into the embryonic heart (to mark 
systemically connected vessels) show that some peripheral vessels within the 
nephrogenic zone were not stained by the lectin; this observation was used to 
argue that these vessels were not systemically connected and that they may 
form via vasculogenesis from local endothelial progenitor pools (Rymer et al., 
2014; Figure 3.2b-c); however, a possible limitation of this technique is that 
the embryonic heart may not be strong enough to generate the pressure 
required to pump the lectin into these peripheral vessels. Regardless of how 
they are generated, the patterning of these nephrogenic endothelia, and how 
they organise in relation to the other cell types in the nephrogenic zone is 









Figure 3.3. | The combination theory of kidney vascularisation. (a) Concept 
overview: At E11, scattered angioblasts are present within the metanephric 
mesenchyme. These angioblasts generate early renal blood vessels via vasculogenesis. 
Simultaneously, blood vessels stemming from the aorta branch through the medullary 
portion of the kidney via angiogenesis. The angiogenic vessels then meet and connect 
with the vasculogenic vessels to establish blood flow throughout the kidney. UB = 
ureteric bud; MM = metanephric mesenchyme. The UB is omitted from E12.5 onwards 
for illustrative purposes. (b-c) In agreement with the combination theory, Rymer et al 
(2014) suggest that some peripheral vessels in the kidney are not perfused and that 
they are therefore likely to have formed via vasculogenesis (vessels considered non-
perfused are shown as blue and vessels considered perfused are green). Perfusion is 
based on the injection of tomato lectin into the embryonic heart: this lectin is then 
transported through the embryonic vasculature and binds to the endothelia of the 
vessels that it reaches. 
 
3.1.6. Development of the definitive renal artery and vein | There are also 
conflicting views about the development of the renal artery and vein. One 
classical theory of renal artery development is the ‘ladder’ theory of Felix 
(1912). Felix suggested that, in humans, the arteries supplying the 
63 
 
mesonephros (the mesonephric arteries) persist after mesonephric 
degeneration. The theory states that because they persist, they can be re-
assigned as the definitive adrenal, phrenic, gonadal, and renal arteries. The 
term ‘ladder’ refers to the fact that the mesonephric arteries are present in a 
segmental arrangement and the theory proposes that as the kidney ascends 
(from a pelvic to lumbar region during its development) it climbs up a ‘ladder’ 
of successive mesonephric arteries to its final position (Figure 3.3). As it 
provides a convenient explanation for developmental variation in renal artery 
anatomy, Felix’s ladder theory was widely accepted. Indeed, relatively recent 
reports have used this theory to explain anatomical abnormalities of the renal 
artery (Narita et al., 2012); however, this theory has now been contested in 
both rats and humans (Isogai et al., 2010; Hinata et al., 2015).  
In contradiction to Felix’s theory, Isogai et al (2010) used micro-injections of 
resin and dye to demonstrate that the mesonephric arteries have degenerated 
prior to the ascent of the metanephros in rat embryos. The group went on to 
demonstrate that primary renal arteries branch from the common iliac artery in 
the pelvic region of the rat embryo (at E14; equivalent to E12.5 for the mouse), 
entering the kidney at its dorso-caudal aspect. It was shown that as the kidney 
ascends, these primary renal arteries elongate, with their aortic root shifting 
towards the site of aortic bifurcation before it degenerates. Before these 
primary renal arteries degenerate, the definitive renal artery has formed as a 
branch of the abdominal aorta and has connected to the metanephros at its 
rostro-ventral aspect (Isogai et al., 2010); as a result, there is no interruption 
of blood flow when switching from one artery to the other. In cases where 
primary renal arteries fail to degenerate, an accessory renal artery may remain 
attached at the inferior pole of the kidney (Isogai et al., 2010). This is a 
common, normally benign, anatomical variation present in 25-40% of humans 
(He and Hamdorf, 2013).  
For the renal vein, the primary connection is at the level of the posterior 
cardinal vein; whereas, the definitive renal vein originates from the inferior 
vena cava (Isogai et al., 2010). In adults, the renal artery, vein and ureter enter 




Figure 3.3. | Felix’s ladder theory of renal artery development. (a) The 
mesonephric arteries initially supply the mesonephros. Before the mesonephros 
degenerates the metanephros begins developing. (b) The ladder theory posits that as 
the metanephric kidney ascends it climbs up successive mesonephric arteries (which 
no longer function as mesonephric arteries) as if they were rungs of a ladder. The 
ladder theory also states that other organs, such as the gonad, receive arterial blood 
through re-purposed mesonephric arteries.  
 
3.1.7. Endothelial markers | Being able to effectively label and track 
endothelial cells and vascular components in the developing kidney is 
important to further understand relevant developmental processes. In a review 
by Woolf and Loughna (1998), a sequence of gene activation was predicted 
for endogenous endothelial cells in the kidney (from undifferentiated 
mesenchymal cells, to endothelial cells, to mature capillaries). They suggested 
that a first marker indicating that a cell is of an endothelial lineage is VEGFR-
2 (Flk-1). Subsequently, as endothelial progenitors proliferate and begin to 
migrate they express VEGFR-1 and Tie-2 in addition to VEGFR-2. Next, during 
capillary morphogenesis, endothelial cells start expressing Tie-1 and CD31 
(PECAM), and Banderia simplicifolia B4 lectin binds to the cells. Finally, 
mature capillaries are positive for von Willebrand factor (vWF) and will 
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abundantly endocytose acetylated-low-density lipoprotein (Woolf & Loughna, 
1998). More recent studies, however, have illustrated that renal endothelia are 
highly heterogenous, and that there are likely numerous programmes of 
endothelial differentiation (Brunskill and Potter, 2010; Halt et al., 2016; Daniel 
et al., 2018; Yoder, 2018). For example, studies suggest that stem cell 
leukemia/T-cell acute lymphocytic leukemia protein 1+ (SCL/Tal1+; Hu et al., 
2016), melanoma cell adhesion molecule+ (CD146+; Halt et al., 2016), and 
forkhead box D1+ (Foxd1+; Sims-Lucas et al., 2013) cells can all act as 
endothelial precursors in the kidney. Overall, a combination of markers is 
required to depict endothelia of different types and at different stages of 
maturation. Here, we mostly use the pan-endothelial marker CD31, as it is 
expressed throughout all renal endothelial beds (Daniel et al., 2018) and is 
also expressed early in the endothelial differentiation programme (Yoder, 
2018).  
 
3.1.8. Aims of Results Chapters 1 and 2 | In Results Chapter 1, I describe 
renal vascularisation from the initiation of organogenesis to birth. Due to the 
inherent limitations of analysing 2D sections to make conclusions about blood 
vessels, which are 3D structures, many assumptions of early works are 
contentious. Here I imaged entire whole mount kidneys and caudal parts of 
mouse embryos in 3D. Results chapter 1 focuses primarily on the first renal 
vessels and on endothelialisation within the cortical nephrogenic zone. In 
Results Chapter 2, I explored the gene expression patterns and functional 
requirement of semaphorin-3f and neuropilin-2 in the development of the renal 
vasculature.  
The hypotheses were (1) that renal vascular patterning corresponds with the 
patterning of other renal structures and (2) that the renal vasculature 
predominantly develops via angiogenesis. To examine these hypotheses, the 




(1) To describe the origins and spatiotemporal organisation of the first renal 
blood vessels. 
(2) To characterise how blood vessels pattern within the cortical 
nephrogenic zone throughout renal development, and to relate 
endothelial patterning to the arrangement of other cellular structures in 
this tissue region. 
(3) To analyse the expression patterns of semaphorin-3f and neuropilin-2 
and to examine whether these proteins are functionally required for 
normal blood vessel patterning in the cortical nephrogenic zone.  
Collectively, the data presented here enhance our understanding of vascular 
development in the kidney across time and space and provide a valuable 
framework to compare normal versus experimentally perturbed endothelial 

















These data have contributed to the following publication:  
Munro DAD, Hohenstein P, Davies JA. 2017. Cycles of vascular plexus 







3.2. Results chapter 1: Vascularisation of the developing mouse kidney 
3.2.1. Results 
3.2.1.1. The first renal blood vessels stem from the peri-Wolffian 
mesenchyme 
The origins and patterning of the first renal blood vessels in the embryonic 
mouse remain obscure (see Section 3.1). To map the formation of the first 
renal vessels in mouse embryos, I immunostained early metanephric kidneys 
with antibodies against CD31 (endothelial marker) and laminin (ureteric bud 
basement membrane marker).  
The ureteric bud branches from the Wolffian duct at approximately E10.5 
(Saxén, 1987). Confocal z-projections of an E10.5 kidney stained for CD31 
and laminin demonstrated that capillaries are present adjacent to the ureteric 
bud even at this initial stage of kidney organogenesis (Figure 3.2.1a). By 
E11.25, the ureteric bud has extended and bifurcated (forming a T-shaped 
bud; Figure 3.2.1b-c). Confocal z-projections of an E11.25 kidney show that 
CD31+ endothelia are present along the stalk of the ureteric bud and have 
formed a vascular ring around the ‘armpits’ of the T-shaped bud (Figure 
3.2.1b-c). Most of the metanephric mesenchyme is avascular at E11.25, but 
CD31+ endothelial projections protrude into the mesenchyme from the 
vascular ring (Figure 3.2.1b).  
By E11.5, CD31+ endothelia were present as a ring around the ureteric bud 
stalk and were in connection with vessels from a highly vascularised tissue 
region lying between the metanephric mesenchyme and Wolffian duct, the 
peri-Wolffian mesenchyme (Mills et al., 2017; Figure 3.2.1d-f).  
Between E11.5-E11.75, the cross stroke of the ureteric ‘T’ elongates before 
further bifurcations take place. Many blood vessels have formed within the 
metanephric mesenchyme during this short elongation phase (Figure 3.2.2a-
e). 3D rendering of confocal z-projections illustrates that these vessels remain 
connected to the peri-Wolffian mesenchyme vasculature by E11.75 (in 8/8 
kidneys analysed; Figure 3.2.2f-f’). These vessels radiate from the vascular 
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ring around the top of the ureteric bud stalk (Movie 3.1). By E12.5, the 
metanephric mesenchyme is largely vascularised (Figure 3.2.2g).  
Together, these data illustrate that the early kidney becomes vascularised by 
blood vessels stemming from the peri-Wolffian mesenchyme (see 3.2.2. 
Discussion). These vessels form as a vascular ring around the ureteric bud 
by E11.25 and spread throughout the kidney by E12.5 (Figure 3.2.3a).   
 
 
Figure 3.2.1. Kidney vascularisation from E10.5 to E11.5. 
(a) CD31+ vessels (white arrowheads) are present adjacent to the ureteric bud from 
the initiation of its development at E10.5.  
(b) The first renal vessels have formed alongside the ureteric bud stalk by E11.25. 
These vessels ring around the top of the ureteric stalk. White arrowhead shows 
endothelial cells projecting into the metanephric mesenchyme. 
(c) 3D reconstruction of the image in b, showing the close association between the 
blood vessels and the ureteric bud stalk.  
(d) Cartoon portraying the different tissue regions discussed. At E11.5, the peri-
Wolffian mesenchyme is highly vascularised, whereas the metanephric mesenchyme 
is predominantly avascular. 
(e) Six2+ nephron progenitor cells demarcate the metanephric mesenchyme at E11.5. 
TOPRO shows all cell nuclei. This image shows that the peri-Wolffian mesenchyme 
and metanephric mesenchyme contain distinct cell populations.  
(f) At E11.5, blood vessels connected to the peri-Wolffian mesenchyme vasculature 
form around the top of the ureteric bud stalk.  
Abbreviations: UB, ureteric bud; WD, Wolffian duct; PMW, peri-Wolffian 






Figure 3.2.2. Kidney vascularisation from E11.5 to E12.5 
(a-e) Representative images of E11.5-E11.75 kidneys. 
(f-f’) 3D rendering shows that peri-Wolffian mesenchyme blood vessels connect 
with the renal blood vessels at E11.75 (n = 8). 
(g) By E12.5, the majority of the metanephric mesenchyme is vascularised.  
Abbreviations: UB, ureteric bud; WD, Wolffian duct; PMW, peri-Wolffian 





Figure 3.2.3. The first renal blood vessels 
(a) Cartoons depicting the arrangement and origins of the first renal blood vessels. UB, 





3.2.1.2. The first renal blood vessels connect with the embryonic 
circulation 
It is unknown whether the first renal blood vessels connect with the embryonic 
circulation and whether they are perfused with blood. I hypothesised that the 
early renal blood vessels would (1) connect with larger blood vessels outside 
of the kidney and (2) that they would contain erythrocytes because of their 
connection with the circulation. To begin testing these hypotheses, I 
immunostained caudal regions of mouse embryos at E11 and E11.5 with 
antibodies against CD31 (endothelial marker), Gata3 (ureteric bud marker), 
and Six2 (cap mesenchyme marker). These antibodies were used to assess 
the position of extra- and intra-renal blood vessels relative to the early 
structures of the metanephric mesenchyme. To image deeply within the tissue, 
I performed tissue clearing with benzyl alcohol/benzyl benzoate (BABB).  
At E11, confocal z-stacks show that the kidney lies caudally to the common 
iliac artery and ventrolaterally to the caudal artery (Figure 3.2.4a-b; Movie 
3.2). Scrolling through confocal z-planes of the E11 caudal part embryo 
illustrated that the blood vessels in the kidney could be traced to either the 
caudal or common iliac arteries and were therefore connected to the 
embryonic circulation (Movie 3.3).  
By E11.5, the kidney had migrated cranially, and was positioned ventrally to 
the common iliac artery (Figure 3.2.4c-d; Movie 3.4). Again, scrolling through 
confocal z-planes demonstrated that the renal blood vessels could be traced 
to either the caudal or common iliac arteries (Figure 3.2.5a-c; Movie 3.5).  
The haem in erythroid cells is not degraded by BABB (Yokomizo et al., 2012). 
As haem acts as a major chromophore under visible light, erythroid cells 
fluoresce without the requirement for antibody staining (Horecker, 1943; 
Tainaka et al., 2016). I performed a co-localisation experiment with anti-Ter119 
(an erythroid cell marker) and confirmed that the autofluorescing cells 




At both E11 and E11.5, autofluorescing erythroid cells were present within the 
major arteries and the first renal blood vessels (Figure 3.2.7a; Movie 3.2-3.5). 
I confirmed this finding by immunostaining whole-mount kidneys with anti-
Ter119 (erythroid marker; Figure 3.2.7b-c).  
In the embryonic mouse, primitive erythrocytes are gradually enucleated 
between E12.5-E16.5 (Kingsley et al., 2004; McGrath et al., 2008). In 
agreement, all Ter119+ erythroid cells within E11.5 and E12.5 kidneys were 
nucleated primitive erythroblasts (100% at E11.5 [n = 100 cells counted] and 
E12.5 [n = 100 cells counted], ± 0.5% 95%C.I.; Figure 3.2.7b-c; Movie 3.6).  
Collectively, these results show that the blood vessels in the E11 and E11.5 
kidneys were connected to the embryonic circulation via the caudal and 




Figure 3.2.4. Position of major blood vessels relative to the E11 and E11.5 kidneys 
(a-a’’) At E11, the cranial pole of the kidney lies ventrally to the common iliac artery 
and the dorsal aspect of the kidney lies ventrolaterally to the caudal artery.   
(b) Cartoon portraying the location of the E11 kidney relative to major arteries.  
(c-c’’) At E11.5, the kidney had started migrating cranially, and now sits ventrally to 
the common iliac artery. 
(d) Cartoon portraying the location of the E11.5 kidney relative to major arteries. 







Figure 3.2.5. The early renal blood vessels are connected to the caudal artery and 
common iliac artery. 
(a) Location of E11.5 kidneys in the caudal-part mouse embryo.   
(b-b’’) Z-projection of the right side of an E11.5 caudal-part mouse embryo 
(individual z-stacks shown in c.  
(c) The E11.5 blood vessels around the ureteric stalk connect to the caudal artery and 
common iliac artery. Yellow arrows show the dorsalmost and ventralmost aspect of 
the kidney. Yellow arrowheads show the first renal blood vessels around the ureteric 
bud stalk. Note that the Six2+ kidney mesenchyme is avascular, whereas the 
surrounding tissue is highly vascularised.  










Figure 3.2.6. Erythroid cells autofluoresce in BABB cleared kidneys. 
(a) Anti-Ter119 (erythroid cell marker) stained E16.5 kidneys. 
(b) Secondary only control (no anti-Ter119 incubation). Identical microscope settings 
were used for a and b.  
(c) Haem autofluorescence in blue and red channels, and anti-Ter119 staining in the 
far-red channel.  
(d) Grey values for blue, red, and far-red channels. The gray value profile for the far-
red channel shows the highest values at either side of the plot (representing anti-Ter119 
binding at each side of the plasma membrane). In contrast, for the blue and red 
channels, the signal is strongest intracellularly (where the haem resides).  






Figure 3.2.7. The first renal blood vessels carry erythroid cells. 
(a) At E11, autofluorescing erythroid cells are observed in the first blood vessels.   
(b) At E11.5, Ter119+ erythrocytes are present around the top of the ureteric stalk.   
(c) At E12.5, many Ter119+ erythrocytes are present within the kidney. 
Abbreviations: UB, ureteric bud; WD, Wolffian duct; PMW, peri-Wolffian 
mesenchyme; MM, metanephric mesenchyme. Scale bars: 100 µm. 
 
3.2.1.3. Endothelial plexus formation in the nephrogenic zone of the 
kidney 
After E12.5, a nephrogenic zone forms in the periphery of the kidney: it 
consists of ureteric bud tips, cap mesenchyme, early nephron structures, and 
interstitium (Herring, 1900; Short et al., 2014). Within this region, ureteric tips 
branch, cap mesenchymal populations split, and nephrogenesis is initiated: 
these processes occur in cycles throughout most of kidney development.  
Immunostaining for CD31 and laminin shows that endothelia arranged around 
the branching ureteric bud in polygonal networks (endothelial plexuses) from 
E13.5 and throughout embryonic development (Figure 3.2.8a-e). The average 
cross-sectional area covered by these endothelial plexuses decreased with 
embryonic age (based on area coverage quantifications and statistical testing; 
p < 0.001; Figure 3.2.8f). The average decrease was 0.0011 mm2 per every 2 
days from E13.5 to P0 (using linear regression analyses, (slope = −0.0011 
mm2 day-1; −0.0013 to −0.00076mm2 day-1 95%C.I.; r2=0.99). Average 
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endothelial plexus size was inversely correlated with embryonic age (r = -
0.996; p < 0.01).  
To examine whether endothelial plexus formation and ureteric tip branching 
may be developmentally linked, we compared the rate in which these 
structures decreased in size throughout kidney organogenesis. The reduction 
in endothelial plexus cross-sectional area did not differ from the decrease in 
the square root of cell number per ureteric ampulla throughout development 
(cell number per ampulla based on data from Short et al., 2014; p = 0.266; 
Figure 3.2.8g).  
 
Figure 3.2.8. Endothelial plexuses form around ureteric tips (ampullae) from 
E13.5 onwards.  
(a-d) Endothelial plexuses arrange around ureteric bud tips in (a) E13.5, (b) E15.5, (c) 
E17.5, and (d) E19.5 (P0) mouse kidney.  
(e) Blend projection (created using IMARIS) showing the organisation of endothelia 
around ureteric tips/ampullae (A = ampulla).  
(f) The avascular area enclosed by the plexus decreases with embryonic age (n = 30-
51 plexus areas from n = 1 kidney counted per group; D’Agostino-Pearson omnibus 
normality tests were used followed by a one-way ANOVA with the post-hoc Tukey’s 
Multiple Comparison Test; p < 0.001). 
(g) The rate of decrease of endothelial plexus area and the square root of cell numbers 
per ampulla across embryogenesis (the slopes are not significantly different; p = 
0.266). 




3.2.1.4. Endothelial plexuses assemble around the cap mesenchyme  
Ureteric bud tips are coated by cap mesenchymal cells (Herring, 1900). When 
ureteric tips bifurcate, the cap mesenchymal cell populations split (Short et al., 
2014). This allows each newly formed ureteric bud tip to inherit a population of 
overlying cap mesenchymal cells.  
Confocal z-projections show that endothelia localised around the boundaries 
of cap mesenchymal populations (Figure 3.2.9a). Furthermore, endothelia 
always crossed the bifurcation site of the ureteric bud (which is newly 
accessible, due to the splitting of the cap mesenchyme; Figure 3.2.9a). 3D 
reconstructions show that the endothelia across the bifurcation site contacted 
and appear to distort the basement membrane of the ureteric bud along its 
path (Figure 3.2.9b).  
I wanted to understand how new endothelial plexuses form, and how this 
relates to the spatiotemporal organisation of ureteric bud tips and the cap 
mesenchyme. I asked the question: are new endothelial plexuses formed 
when endothelia migrate away from or towards the ureteric bud bifurcation 
site? To examine this, I quantified endothelial orientation in E17.5 kidneys. 
94.44% of endothelia projected away from the bifurcation site (Figure 3.2.10a-
d). Endothelial projections across the bifurcation site could be observed at 
every progressive step, from starting to project to meeting and connecting with 
the endothelia on the other side (Figure 3.2.10e-h). These endothelial 
projections coincided with cap mesenchymal splitting.  
From this, I developed a model showing that when cap mesenchymal cells 
vacate newly forming bifurcation sites, endothelia migrate across the newly 
emptied region to form new plexuses (Figure 3.2.10e-i). Endothelia project in 
this orientation at other ages tested (E14.5 is shown as another example in 
Figure 3.2.11a-c), supporting the concept that this patterning is cyclical and 







Figure 3.2.9. Endothelia surround the cap mesenchyme and cross the bifurcation 
site of the ureteric bud. 
(a) Endothelial plexuses arrange around Six2+ cap mesenchyme populations. White 
arrowheads show blood vessels across the bifurcation site of the ureteric bud.  
(b-b’’’) Endothelia cross the bifurcation site of the ureteric bud. (b’-b’’’) 3D 
reconstructions of the ureteric bud and endothelia show that the crossing endothelia 
contact and distort the basement membrane of the ureteric bud along its path.  






Figure 3.2.10. New endothelial plexuses form as endothelia migrate from the 
bifurcation site as the cap mesenchyme splits in cycles.  
(a) Whole-mount E17.5 kidney stained with antibodies against CD31 and Six2.  
(b) To form new endothelial plexuses, endothelia most often project away from the 
bifurcation site (p = 0.0112; two-tailed Mann-Whitney test; n = 5 fields of view from 
5 kidneys). BP, bifurcation point. 
(c-d) Cartoons portraying the two possible orientations for endothelia to project: (1) 
from the bifurcation point and (2) towards the bifurcation point.  
(e-i) Cyclical model of endothelial plexus formation. CM, cap mesenchyme; UB, 
ureteric bud. 






Figure 3.2.11. Endothelial plexus formation in the E14.5 kidney 
(a-c) Endothelia project away from the cap mesenchyme at E14.5. Individual z-planes 
are shown in c to show that green and blue cells are not overlapping (mesenchymal 
cells [green] are above the ureteric bud cells [blue]).  
Scale bars: a, c = 100 µm; b = 20 µm. 
 
 
3.2.1.5. Endothelial plexuses develop around the ureteric bud and cap 
mesenchyme in kidney culture models 
I next tested whether endothelia arranged in similar patterns around the 
ureteric tips and cap mesenchyme populations in culture models. This was to 
assess whether the patterning ‘rules’ we have shown in vivo are also obeyed 
in vitro. First, I dissected and cultured E12.5 kidneys for 2 and 4 days. In these 
cultured kidneys, endothelial plexuses formed around ureteric tips in a similar 
manner to that observed in vivo (Figure 3.2.12a-b). Endothelial plexuses did 
not form around the epithelia of nephrons (Figure 3.2.12c-c’). Moreover, they 
arranged around, but not through, cap mesenchymal populations (Figure 
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3.2.12d). Some of the endothelial vessels were enclosed by a collagen IV 
basement membrane and carried Ter119+ erythroid cells (Figure 3.2.12e).  
I then produced suspensions of renogenic stem cells (using previously 
described methods; (Unbekandt and Davies, 2010) and re-aggregated these 
cells and cultured them as a pellet. Cap mesenchymal niches formed in this 
culture system, and endothelia formed around these Six2+ cap mesenchymal 
populations (Figure 3.2.12f).  
Together, these data illustrate that endothelia pattern around cap 
mesenchymal and ureteric bud cells in various culture systems, obeying the 








Figure 3.2.12. Endothelial formation in kidney culture models.  
(a-b) Endothelia arrange as plexuses around ureteric bud tips in culture after 2 and 4 
days.  
(c-c’) In culture, endothelial plexus formation occurs specifically around ureteric bud 
epithelia, not nephron epithelia. The kidney in c is the same as shown in b, but with 
the laminin channel also displayed. The image shown in c’ is the area within the dashed 
white box in c. 
(d) Endothelial plexuses arrange around cap mesenchymal populations in culture.  
(e) Some endothelial vessels in culture are enclosed by a collagen IV+ basement 
membrane and carry Ter119+ erythroid cells.  
(f) Endothelia arrange around cap mesenchymal populations in the ‘re-aggregated 
kidney’.  




3.2.1.6. Characterisation of plexus endothelia  
CD31 does not always discriminate between vascular and lymphatic 
endothelia (Podgrabinska et al., 2002). Therefore, I analysed whether the 
endothelial plexuses were vascular by performing a co-staining experiment to 
assess whether the CD31+ cells co-expressed the lymphatic marker, lymphatic 
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vessel endothelial hyaluronan receptor 1 (Lyve1) or a typically vascular 
marker, vascular endothelial growth factor receptor 2 (Vegfr2). The plexus 
endothelia were Vegfr2+, but Lyve1- (Figure 3.2.13a-d).  
Previous work suggested that stem cell leukemia/ T-cell acute lymphocytic 
leukemia protein 1+ (SCL/Tal1+) cells are haemovasculogenic progenitor cells 
in the developing kidney (Hu et al., 2016). I assessed whether SCL/Tal1+ cells 
were located around the nephrogenic zone that might act as endothelial 
progenitors. SCL/Tal1+ is nuclear, and positive staining was observed in the 
nephrogenic zone; these positive nuclei were always nuclei of the CD31+ 
endothelia of the vascular plexuses (Figure 3.2.13e-f; Figure 3.2.14a-c). This 
shows that SCL/Tal1+ marked only mature endothelia in the nephrogenic zone. 
Together, these data show that plexus endothelia were vascular CD31+Lyve-
1−Vegfr2+SCL/Tal1+ cells. 
Vascular plexuses also carried erythroid cells, further indicating that these 
endothelia were vascular (Figure 3.2.15a-c). This was unexpected since 
previous studies suggested that, in later development, peripheral vessels in 
the nephrogenic zone are vasculogenic, do not contain a lumen, and do not 
carry blood (Rymer et al., 2014). At E16.5, the erythroid cells were 
predominantly enucleated (94% were enucleated [n = 100 cells]; the 95% 
confidence interval is ± 4.39%). This corroborates with previous findings that 
most erythroid cells are fully mature by this stage of embryonic development 
in the mouse (Kingsley et al., 2004; McGrath et al., 2008).  
Should the vascular plexuses be fully mature, a basement membrane would 
enclose them. I determined that the endothelial vessels were enclosed by a 
collagen IVhigh lamininlow basement membrane (Figure 3.2.16a-c’’). 
I next hypothesised that if these vessels were forming via angiogenesis that 
they would always be in connection with pre-existing vessels. At all ages 
examined, even the most peripheral endothelia in the kidney could be traced 
all the way back to the renal arteries (n = 50 traced vessels from between 
E13.5-E17.5; Movie 3.7).  
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Collectively, these data show that the vascular plexuses contained mature 
erythrocytes, were enclosed by a basement membrane, and were always 
connected to pre-existing renal blood vessels.  
 
 
Figure 3.2.13. Plexus endothelia are vascular 
(a-b) Plexus endothelia are Lyve1- (E11.5 yolk sac used as positive control for Lyve1 
antibody).  
(c-d) Plexus endothelia are Vegfr2+. 
(e-f) Plexus endothelia are SCL/Tal1+. 







Figure 3.2.14. Nuclei of plexus endothelia are SCL/Tal1+. 
(a) SCL/Tal1 stains endothelial nuclei. White box shows zoomed version of a 
SCL/Tal1+ CD31+ cell. Dashed white lines outline the cell nuclei.  
(b) Anti-SCL/Tal1 primary antibody and secondary antibody. 
(c) Secondary only negative control (image taken using identical microscope settings 
as b). 





Figure 3.2.15. Plexus endothelia carry erythrocytes 
(a-a’’’) Plexus endothelia carry erythrocytes at E14.5. 
(b-c) Plexus endothelia carry erythrocytes at E16.5.  




Figure 3.2.16. Vascular plexuses are enclosed by a basement membrane. 
(a-a’’’) Vascular plexuses are enclosed by collagen IVhigh lamininlow basement 
membrane.  
(b-b’’) Confirmation that the basement membranes of the vascular plexuses contain 
relatively low levels of laminin (relative to blood vessels in the ureter) at E15.5 (yellow 
arrowheads show lamininhigh blood vessels).  
(c-c’’) Confirmation that the basement membranes of the vascular plexuses contain 
relatively low levels of laminin (relative to blood vessels in the ureter) at E17.5 (yellow 
arrowheads show lamininhigh blood vessels). 





In Results Chapter 1, I imaged whole-mount metanephric kidney rudiments 
that had developed normally in vivo in CD-1 mouse embryos. From this, I have 
described renal vascular patterning from the initiation of kidney development 
(~E10.5) to birth (~E19.5/P0). These results improve our understanding of the 
initial steps of renal vascularisation and provide a new conceptual model to 
explain how endothelia pattern cyclically within the cortical nephrogenic zone 
(Figure 3.2.17a-b).  
The vascular plexuses within the nephrogenic zone will probably be required 
for the proper assembly and function of the adult kidney’s vasculature. For 
example, these vessels arrive before peripheral nephrons begin forming and 
may act as vessel sources for the generation of the nephron microvasculature 
(Figure 3.2.17b). As well as a possible architectural role, these blood vessels 
may promote the formation of renal structures such as nephrons and collecting 
duct tubules. Oxygen promotes nephrogenesis (Rymer, Paredes, Halt, 
Schaefer, Wiersch, Zhang, D. a Potoka, et al., 2014; Schley et al., 2015), and 
erythrocytes carried within the plexus blood vessels may supply oxygen to 
drive nephrogenesis; unfortunately, due to a lack of specific tools, I was unable 
to investigate the consequences of disrupting vascular plexus formation on 
adult kidney function. 
My model of vascular plexus formation from pre-existing blood vessels (via 
angiogenesis) is based on multiple findings. In three-dimensional 
reconstructions of the renal vasculature, I did not observe any endothelia that 
were not connected with the pre-existing vasculature. Instead, I show that even 
the most peripheral CD31+ endothelia can be tracked all the way back to the 
renal artery. If the vascular plexuses formed via vasculogenesis, I would have 
expected to observe isolated angioblasts/endothelia within this region (Drake 
et al., 1997); however, even when staining for SCL/Tal1 (an earliest marker of 
the endothelial lineage; Drake et al., 1997), positive cells were always also 
CD31+ and in connection with the pre-existing vasculature. Furthermore, the 
observation that the peripheral vascular plexuses were basement membrane-
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enclosed and carried erythrocytes is more consistent with angiogenesis than 
with vasculogenesis. Nevertheless, the erythrocytes within the plexus blood 
vessels could arise in part, or entirely, via haemovasculogenesis (Sequeira 
Lopez et al., 2003; Hu et al., 2016), rather than being transported there via the 
embryonic circulation.  
 
Figure 3.2.17. Model for cyclical vascular plexus formation.  
(a) Cartoon illustrating the arrangement of the ureteric bud, cap mesenchyme, and 
vascular plexuses in the nephrogenic zone (side-view). Labels summarise the 
characteristics of the plexus vessels.  
(b) As a ureteric tip branches and the cap mesenchyme splits, a blood vessel forms 
across the bifurcation site to form a new vascular plexus. These vessels may act as 
sources for the generation of the microvasculature of early nephron structures.  
 
A major result of this chapter is that endothelia never enter the Six2+ nephron 
progenitor/cap mesenchyme populations, and instead arrange around them 
(Figure 3.2.17a-b). Even prior to E11.5, when the majority of the metanephric 
mesenchyme consists of Six2+ cells, endothelia arrange around, but not 
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through, this cell population; this avoidance may explain why the 
metanephrogenic mesenchyme is avascular at its earliest stages, despite it 
being surrounded by systemically-connected vessels. This patterning may be 
a result of the Six2+ cells releasing an anti-angiogenic signal, or signals, which 
inhibit(s) endothelial migration into the cap. Alternatively, it may simply be that 
the nephrogenic interstitium is a more permissive environment for these 
vessels to form. Uncovering the mechanisms that control this vascular 
patterning will greatly enhance our understanding of how the complex vascular 
architecture of the kidney is formed.  
The avoidance of the cap mesenchyme by blood vessels raises the possibility 
of hypoxia-regulated control of nephron progenitor cell behaviour. Whether a 
nephron progenitor cell differentiates or self-renews is partly dictated by its 
metabolism: glycolytic nephron progenitors are more likely to self-renew, and 
oxidative ones are more likely to differentiate (Liu et al., 2017). Nephron 
progenitors become more oxidative later in development, corresponding with 
their en masse differentiation and exit from the progenitor niche (Liu et al., 
2017). I have shown that the avascularity of the cap mesenchyme decreases 
over developmental time, as the average area covered by vascular plexuses 
decreases. This decreased avascularity later in development may lead to 
increased oxygen provision to nephron progenitor cells, which may contribute 
to their shift towards oxidative metabolism and differentiation.  
Another interesting observation is that endothelia form across the branching 
site of the ureteric bud (when the Six2+ cap populations split, and the ureteric 
bud bifurcates). In many branching organs, cell types that cross the bifurcation 
site control branching stereotypy via mechanical forces or short-distance 
signalling (Fukuda et al., 1988; Lazarus et al., 2011; Kim et al., 2015). It is 
possible that blood vessels crossing the ureteric bud branching site may play 
similar roles in regulating renal branching morphogenesis.  
As explained in the beginning of this chapter, a long-standing question 
concerning kidney vascularisation is, do blood vessels form through 
angiogenesis-only mechanisms, vasculogenesis-only mechanisms, or a 
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combination of both? In support of kidney vascularisation by angiogenesis, 
cross-transplantation experiments have consistently indicated that the kidney 
can attract the invasion of exogenous blood vessels (Ekblom et al., 1982; 
Sariola et al., 1983; Abrahamson et al., 1998). However, these studies did not 
examine whether renal vessels were also developing de novo from 
endogenous precursors, so were weighed against revealing vasculogenesis. 
Other cross-transplantation studies specifically focused on assessing the 
kidney’s ability to generate blood vessels intrinsically by probing for genetic 
markers of endogenous endothelia (Abrahamson et al., 1998; Hu et al., 2016). 
In these studies, transplant-derived vessels often developed, and were 
assumed to form via vasculogenesis, as the transplanted kidney rudiments 
were claimed to be avascular at the time of grafting (for example, E12 kidneys; 
Hyink et al., 1996; Robert et al., 1998; Abrahamson et al 1998., Sequeira-
Lopez et al., 2001, and E12.5 kidneys; Hu et al., 2015). Based on my results, 
however, these transplanted kidneys would be highly vascularised prior to their 
transplantation. In fact, it would be technically challenging to transplant an 
embryonic kidney rudiment at any age (with the ureteric bud and metanephric 
mesenchyme) without also transplanting contaminating donor-derived blood 
vessels, as noted by Loughna et al., 1997. These donor-derived blood vessels 
could persist and contribute to vascular formation via angiogenic mechanisms, 
rather than vasculogenic. This may explain why chimeric endothelial vessels, 
with host- and transplant-derived endothelia, are often observed in cross-
transplanted kidneys (Hyink et al., 1996; Robert et al., 1998; Abrahamson, 
2009; Sequeira Lopez and Gomez, 2011) 
In kidney culture experiments, the potential for extrinsic blood vessels to 
invade the kidney is eliminated, as exogenous vessels are removed during 
dissection. Also, factors that drive angiogenesis, such as blood flow (Gebala 
et al., 2016), can no longer influence endothelial organisation (perhaps 
explaining why glomerular capillaries do not mature in culture; Bernstein, 1981; 
Serluca et al., 2002). Thus, kidney culture may not offer a suitable 
environmental milieu to make conclusions about in vivo vascular formation, as 
angiogenesis would seemingly be thwarted. However, I and others have 
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shown that endothelia from the early embryonic kidney can persist in culture 
(Gao et al., 2005; Halt et al., 2016), and live tracing experiments of cultured 
kidneys from endothelial cell-specific Tie1Cre:R26RYFP reporter mice illustrated 
that vessels develop from the pre-existing endothelia via mechanisms that are 
consistent with sprouting angiogenesis (Halt et al., 2016).  
Regardless of the mechanism of blood vessel formation, there is evidence that 
endogenous endothelial cells exist within the kidney (Sims-Lucas et al., 2013; 
Hu et al., 2016; Halt et al., 2016) and my results do not eliminate the possibility 
that vasculogenesis may contribute to the renal vasculature in some 
undetermined way. An example of an endogenous metanephric cell type that 
can differentiate into endothelial-marker expressing cells are the interstitial 
Foxd1+ cells (Sims-Lucas et al., 2013; Halt et al., 2016; Mukherjee et al., 2017). 
Within the cortical nephrogenic zone, vascular plexus formation occurs within 
the interstitial Foxd1+ populations of cells (Sims-Lucas et al., 2013). Perhaps 
the Foxd1+ cells that express endothelial-markers are induced to differentiate 
and are recruited into the developing vascular plexuses via a mechanism that 
combines vasculogenic (differentiation, migration, and coalescence of 
endogenous endothelia) and angiogenic principles (vessels forming from pre-
existing vessels). The precise mechanisms by which these cells contribute to 
renal vascularisation should be explored in the future.  
In this results chapter, I demonstrated that the first renal blood vessels stem 
from pre-existing capillaries situated within a peri-Wolffian mesenchymal 
region. I propose that, as the nephron progenitor population splits, these first 
vessels migrate via angiogenesis through the newly forming renal interstitium 
towards the periphery of the kidney. When at the renal periphery, vessels begin 
patterning as polygonal-shaped vascular plexuses around the cap 
mesenchyme/ureteric bud as the nephrogenic zone forms. As rounds of 
branching morphogenesis occur, new plexuses then form in cycles throughout 
the remainder of embryogenesis. Based on these results, I suggest that in vivo 













Refuting the hypothesis that semaphorin-
3f/neuropilin-2 exclude blood vessels from the cap 
mesenchyme in the developing kidney 
 
 
These data have contributed to the following publication:  
Munro DAD, Hohenstein P, Coate TM, and Davies JA. 2017. Refuting the 
hypothesis that semaphorin-3f/neuropilin-2 exclude blood vessels from the 







 “The great tragedy of science — the slaying of 
a beautiful hypothesis by an ugly fact.” 
T H Huxley (1870) 
 
3.3. Results chapter 2: Refuting the hypothesis that semaphorin-
3f/neuropilin-2 exclude blood vessels from the cap mesenchyme in the 
developing kidney 
3.3.1. Brief introduction 
In the previous chapter, I described how blood vessels pattern cyclically 
around the splitting cap mesenchyme and branching ureteric bud. In this 
chapter, I tested the hypothesis that part of this patterning (the avoidance of 
the cap mesenchyme by the blood vessels) arises through the cap 
mesenchyme expressing a specific candidate anti-angiogenic signalling 
molecule.  
Semaphorins, such as semaphorin-3f (Sema3f), can act as anti-angiogenic 
signalling molecules (Bielenberg et al., 2004; Guttmann-Raviv et al., 2007; 
Parker et al., 2010; Buehler et al., 2013; Guo et al., 2013). Sema3f is typically 
thought of as an axonal guidance molecule but is also highly expressed in 
various non-neuronal developing organs, such as the skin, lung, and kidney 
(Giger et al., 1998); its roles in these organs are poorly understood.  
In vascular development, Sema3f inhibits angiogenesis by interacting with its 
receptors on the endothelial cell membrane: neuropilin-1 (Nrp1), its low-affinity 
receptor, and neuropilin-2 (Nrp2), its high-affinity receptor (Sakurai et al., 2012; 
Guo et al., 2013). Sema3f/Nrp signalling results in the suppression of 
endothelial cell migration, proliferation, and survival (Guttmann-Raviv et al., 
2007; Procaccia et al., 2014; Nakayama et al., 2015; Figure 3.3.1a).  
Mechanistically, binding of Sema3f to its high-affinity receptor, Nrp2, leads to 
plexin-A1 recruitment and the formation of a Nrp2/Plexin-A1 complex (Figure 
3.3.1b). This complex attracts the tyrosine kinase, ABL2, and the GTPase 
activating protein, p190RhoGAP (Shimizu et al., 2008). When recruited, ABL2 
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phosphorylates and activates p190RhoGAP (Figure 3.3.1b). A small GTPase, 
RhoA, is then inactivated (GTP to GDP) by active p190RhoGAP. GTPases, 
such as RhoA, act as molecular switches that propagate signals from the 
plasma membrane to the cytoskeleton (Etienne-Manneville and Hall, 2002). 
When RhoA is inactive, it cannot trigger downstream signalling to inactivate 
the effector molecule, cofilin, which is an actin depolymerising factor 
(Andrianantoandro and Pollard, 2006). Thus, Sema3f/Nrp2 signalling 
facilitates the disassembly of F-actin chains by active cofilin, resulting in 
cytoskeletal collapse and diminished cell migration (Shimizu et al., 2008; 
Nakayama et al., 2015; Figure 3.3.1b). 
 
3.3.2. Aims of this chapter  
To test the hypothesis that vascular repulsion from the cap mesenchyme is 
dependent on cap mesenchyme-expressed anti-angiogenic signals, the aims 
of Results Chapter 2 are as follows: 
(1) To identify a cap mesenchyme-expressed anti-angiogenic candidate 
gene. 
(2) To characterise the expression patterns of the identified gene (Sema3f) 
and its receptors (Nrp1 and Nrp2) in the developing kidney and adjacent 
tissue. 
(3) To test the hypothesis that signalling through the identified pathway (the 
Sema3f/Nrp signalling pathway) in the cortical nephrogenic zone is 






Figure 3.3.1. Sema3f/Nrp signalling. (a) Sema3f is secreted by its producing cell. If 
neighbouring cells express Nrp1 and/or Nrp2, Sema3f can bind, initiating downstream 
signalling. Sema3f/Nrp signalling results in reduced cell survival, proliferation, and 
migration. (b) The Sema3f/Nrp2 signalling pathway and its consequences on F-actin 










3.3.3.1. Selection of a cap mesenchyme-expressed anti-angiogenic 
candidate gene 
Endothelia pattern in cycles around cap mesenchymal populations in the 
nephrogenic zone of the developing kidney (Figure 3.3.2a). I sought to identify 
candidate genes that might guide this endothelial patterning around the cap 
mesenchyme.  
I hypothesised that this patterning was controlled by a cap mesenchyme-
expressed anti-angiogenic signal. To test this hypothesis, I used PubMed to 
identify pertinent literature and prepared a non-exhaustive list of 39 candidate 
genes whose proteins can function as anti-angiogenic molecules (based on 
relevant reviews). The PubMed search terms to find relevant reviews were: 
((anti-angiogenic[Title]) AND "review"[Publication Type]) AND ("2000"[Date - 
Publication] : "2018"[Date - Publication]). I then created a list of criteria to be 
met by these genes for them to be considered as a candidate (Figure 3.3.2b).  
The first criterion to be met was that the gene had to be highly expressed in 
the cap mesenchyme both embryonically (E15.5) and early postnatally 
(between P0-P4). At these time-points, vascular plexus formation is underway 
and microarray heatmap data are available in the GenitoUrinary Development 
Molecular Anatomy Project (GUDMAP) database (Brunskill et al., 2008; 
Harding et al., 2011). The GUDMAP database contains microarray gene 
expression data for multiple cell types in the developing and early postnatal 
kidney. Based on GUDMAP data, three genes met this initial selection 
criterion: isthmin-1 (Ism1), semaphorin-3f (Sema3f), and suppressor of 
cytokine signalling-3 (Socs3). These anti-angiogenic candidate genes are 
highly expressed at E15.5 and at least at one age between P0 and P4 in the 
cap mesenchyme (Figure 3.3.2c, Figure 3.3.3). This first selection criterion 
reduced our candidate gene list from 39 to 3. 
The next criterion was that the relative expression of the candidate gene had 
to be lower in the nephrogenic interstitium (which is where vascular plexuses 
97 
 
form) than the cap mesenchyme (which the vascular plexuses avoid). The 3 
remaining candidate genes met this condition, as their relative expression was 
low/moderate in the nephrogenic interstitium (Figure 3.3.2d).  
Next, the anti-angiogenic function of the protein had to be mediated through 
endothelial cell non-autonomous signalling. This was true for Ism1 and 
Sema3f, but not Socs3. The anti-angiogenic function of Socs3 is endothelial 
cell autonomous (Stahl et al., 2012; Rao et al., 2015). Thus, Socs3 was 
discounted as a candidate gene, and only 2 candidate genes remained.   
Ism1 and Sema3f are secreted proteins, which exert their anti-angiogenic 
effects by binding to their receptors on endothelial plasma membranes 
(Guttmann-Raviv et al., 2007; Xiang et al., 2011; Rao et al., 2015). Receptor-
ligand binding results in downstream signalling that prevents endothelial 
survival and proliferation. As a result, our next criterion was that the Ism1 and 
Sema3f receptors must be expressed by the plexus endothelia for their signal 
to be transduced. Ism1 receptors are integrin alpha-5 (Itga5; Zhang et al., 
2011) and 78 kDa glucose-regulated protein homolog (Grp78; Chen et al., 
2014): based on GUDMAP microarray data, these receptors were expressed 
weakly in renal endothelia (Figure 3.3.2e). The Sema3f receptors are 
neuropilin-1 (Nrp1) and neuropilin-2 (Nrp2): based on GUDMAP microarray 
data, these receptors were expressed highly in renal endothelia (Figure 
3.3.2e). Thus, Sema3f fulfilled all the criteria and was chosen as a candidate 
gene that may guide vascular plexus patterning around the cap mesenchyme 
in the developing kidney. Since the receptors of the other candidate genes 
were expressed at low levels by renal endothelia, it is possible that they play 








Figure 3.3.2. Selection of a cap mesenchyme expressed anti-angiogenic 
candidate gene.  
(a) Cartoons depicting the relevant cell populations in the nephrogenic zone of the 
developing kidney (images showing cap mesenchyme, ureteric bud tips, and 
nephrogenic interstitium were adapted from GUDMAP).  
(b) Selection criteria.  
(c) Genes with anti-angiogenic potential that were expressed highly in the cap 
mesenchyme (Ism1, Sema3f, and Socs3).  
(d) Expression of Ism1, Sema3f, and Socs3 in the nephrogenic interstitium.  
(e) Expression of the receptors for Ism1 (Grp78 and Itgav) and Sema3f (Nrp1 and 
Nrp2) in renal endothelia.  
Expression data were reproduced, with permission, under the terms of the GUDMAP 




Figure 3.3.3. Expression of genes with anti-angiogenic potential in the cap 
mesenchyme of the developing kidney (microarray heat map data). This list is not 
exhaustive. These data have been reproduced under the terms of the GUDMAP licence 
for re-use.   
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3.3.3.2. Sema3f and Nrp2 are expressed in a complementary pattern in 
the developing kidney 
Sema3f expression in the cap mesenchyme of the developing kidney has been 
validated at the RNA level by in situ hybridisation of whole-mount E15.5 
kidneys (data made available on GUDMAP by the McMahon lab; Figure 
3.3.4a). Additionally, in situ hybridisation data from the Allan Brain Atlas shows 
that Sema3f is highly expressed in the early kidney (E11.5 and E13.5; Figure 
3.3.4b-c’).  
I next investigated the localisation of the Sema3f protein. This was achieved 
by staining whole-mount E12.5 and E15.5 kidneys with anti-Sema3f and 
clearing the tissue prior to imaging (with benzyl alcohol/benzyl benzoate 
[BABB]). At E12.5, Sema3f staining was present both in the tubular epithelia 
and the presumptive cap mesenchyme (Figure 3.3.4d). At E15.5, Sema3f 
staining co-localised with the cap mesenchyme marker integrin alpha-8 (Itga8; 
Müller et al., 1997; Figure 3.3.4d). Furthermore, Sema3f staining was present 
in tubular epithelia and the nephrogenic interstitium: this was unsurprising as 
Sema3f is secreted and not restricted to the cell type that manufactures the 
protein. Indeed, Sema3f would be required to exit the cap to bind to its 
receptors on the endothelial membrane.  
Endothelia in the nephrogenic interstitium had to express either Nrp1, Nrp2, or 
both, to respond to Sema3f. Confocal z-stacks of an E15.5 Nrp2EGFP 
transgenic mouse kidney, collected by the Potter lab (Cincinnati Children's 
Hospital Medical Centre), show Nrp2 expression by proximal tubules and an 
unknown cell type within the nephrogenic interstitium (Movie 3.8; adapted with 
permission from the Potter lab). I determined that the Nrp2+ cells within the 
nephrogenic interstitium were endothelial as they co-expressed the endothelial 
marker CD31. Nrp2+ endothelia consistently crossed the bifurcation site of the 
ureteric bud (42/42,100%, 95%CI ± 1.19%; n = 42 bifurcation sites analysed 
in 1 kidney; Figure 3.3.5a-c). Endothelia migrate across the bifurcation site to 
form new vascular plexuses, and the Nrp2+ endothelia were positioned in the 




Figure 3.3.4. Sema3f expression in the cap mesenchyme of the developing 
kidney 
(a) In situ hybridisation of E15.5 kidneys (from GUDMAP; submitted by the 
McMahon lab). Shows that Sema3f expression is localised to the cap mesenchyme.  
(b-b’) In situ hybridisation of E11.5 kidney (image credit: Allan Institute). Shows 
that Sema3f is expressed in the mesenchyme of the early kidney. 
(c-c’) In situ hybridisation of E13.5 kidney (image credit: Allan Institute). Shows 
that Sema3f is expressed in the mesenchyme of the early kidney. 
(d) Anti-Sema3f and anti-Gata3 antibody staining at E12.5.   
(e) Anti-Sema3f and anti-Itgav8 antibody staining at E15.5. Secondary only for 
Sema3f channel was used as negative control (image taken using identical 
microscope settings).  








Figure 3.3.5. Nrp2 expressing endothelia are present in the nephrogenic 
interstitium surrounding the cap mesenchyme 
(a) Nrp2+ cells in nephrogenic interstitium are endothelial.  
(b) Nrp2+ endothelia cross the bifurcation site of the ureteric bud as the cap 
mesenchyme splits. White arrowhead shows an example of an Nrp2+ endothelial cell 
crossing the bifurcation site to form a new vascular plexus.  
(c) Nrp2+ endothelia positioned around the borders of cap mesenchymal populations. 
(d) Cartoon depicting the cell types of interest. Green Nrp2+ endothelial cells migrate 
across the bifurcation site as the cap mesenchyme splits.  




3.3.3.3. Expression of Nrp1 and Nrp2 in the developing kidney and ureter 
Endothelia differentially express Nrp1 and Nrp2 (Herzog et al., 2001).  Nrp1 is 
preferentially expressed by arteries, whereas Nrp2 is preferentially expressed 
by lymphatic and venous endothelia (Herzog et al., 2001). I verified these 
findings in the developing ureter by co-staining Nrp1+/Nrp2+ endothelia with 
venous and lymphatic markers (Figure 3.3.6a-d). 
Nrp2 was strongly expressed by lymphatic vessels in the ureter, and I next 
examined whether any Nrp2+ lymphatic vessels had formed within the kidney. 
To examine this, I used BABB to clear E15.5 whole-mount kidneys. In doing 
so, I demonstrated that Nrp2+ lymphatic endothelia had formed around the 
ureter and that these vessels connected to lymphatic vessels within the renal 
pelvis (Figure 2.3.7a-c). This Nrp2+ network of lymphatics also supplied the 
developing adrenal gland, gonad, kidney, mesonephros and ureter (Figure 
3.3.7a; Movie 3.9).   
In the early kidney (E11.5 and E12.5), most renal blood vessels expressed 
Nrp2, but few expressed Nrp1 (Figure 3.3.8a-d). In the E13.5 kidney, Nrp1 
expression was observed in renal/segmental arteries (Figure 3.3.8c). The 
vascular plexuses in the E13.5 kidney contained many Nrp2+ cells, but few 
Nrp1+ cells (Figure 3.3.8e). In contrast, the E18.5 vascular plexuses 










Figure 3.3.6. Nrp1 and Nrp2 expression in the developing ureter. 
(a) Based on vessel morphology, CD31+Nrp2+ endothelia are venous (V; loosely 
packed endothelia with larger-diameter vessel) and CD31+Nrp2- endothelia are 
arterial (A; tightly packed endothelia with smaller-diameter vessel).  
(b) Based on co-staining experiments, Nrp2 is expressed by lymphatic vessels in the 
ureter (Nrp2+Lyve-1+CD31+ co-stained vessels).  
(c-c’) Based on co-staining experiments, Nrp2 is expressed by veins in the ureter 
(Nrp2+EphB4+Nrp1- co-stained vessels). Nrp1 is expressed by arteries in the ureter, 
but not lymphatic or venous endothelia (all Nrp1+ vessels were Nrp2-EphB4-). 

















Figure 3.3.7. Nrp2 expression by renal endothelia. 
(a) Nrp2 is expressed by a network of lymphatic vessels that supply the developing 
kidney, gonad, ureter, and adrenal gland.  
(b) Nrp2+ lymphatic vessels are connected to the lymphatic vessels that wrap around 
the ureter (representative image of n = 5 confocal z-stacks). 
(c) Nrp2+ lymphatic vessels form alongside renal segmental arteries. The magenta 
cells are erythrocytes, which autofluoresce in BABB cleared tissue due to heme 
acting as a major chromophore under visible light. Red traced lines show the 
positions of segmental arteries relative to the Nrp2+ lymphatic vessels.  







Figure 3.3.8. Nrp1 and Nrp2 expression in the developing metanephric kidney. 
(a) Nrp2 is, and Nrp1 is not, expressed by renal blood vessels at E11.5. 
(b) Nrp2 is, and Nrp1 is not, expressed by renal blood vessels at E12.5. 
(c) Nrp2 is expressed by most renal vessels at E13.5, apart from renal arteries, which 
express Nrp1.  
(d) Cartoons portraying the endothelial expression of Nrp1 and Nrp2 in the early 
kidney relative to the cap mesenchyme.  
(e-f) Nrp2 is expressed by vascular plexus endothelia in the nephrogenic zone 
throughout kidney development, whereas Nrp1 is only expressed by vascular plexus 
endothelia at later stages of kidney development.  







3.3.3.4. Sema3f and Nrp2 are not required for endothelial exclusion from 
the cap mesenchyme 
Based on their expression patterns, I maintained my hypothesis that 
Sema3f/Nrp2 are involved in vascular exclusion for the cap mesenchyme. I 
tested this hypothesis by staining plexus endothelia and cap mesenchyme 
populations in kidneys from embryos/pups that had specific genetic ablation of 
Sema3f and of Nrp2.  
Plexus endothelia patterned normally around the cap mesenchyme in kidneys 
of Sema3f+/- and Sema3f-/- postnatal day 0 (P0) pups, as shown by 
immunofluorescence for anti-Six2, anti-collagen IV, and anti-CD31 (Figure 
3.3.9a-b). Plexus endothelia also patterned normally around the cap 
mesenchyme in kidneys of Nrp2+/- and Nrp2-/- E18.5 embryos, as shown by 
immunofluorescence for anti-Six2 and anti-CD31 (Figure 3.3.10a-b).  
Based on these data, I rejected the hypothesis that Sema3f/Nrp2 signalling is 







Figure 3.3.9. Endothelial patterning is normal in Sema3f-/- pups 
(a) No differences in endothelial patterning around the cap mesenchyme in P0 
Sema3f+/+, Sema3f+/-, and Sema3f-/- pups (images are representative of n = 2-3 P0 
pups, 4-6 kidneys, and 9-12 total fields of staining per genotype). 
(b) Genotyping confirmation (genotyping performed by Thomas Coate, Georgetown 
University). Asterisks in genotyping gel indicate the pups whose kidneys are shown 
as representative images.  








Figure 3.3.10. Endothelial patterning is normal in Nrp2-/- embryos 
(a) No differences in endothelial patterning around the cap mesenchyme in E18.5 
Nrp2+/+, Nrp2+/-, and Nrp2-/- embryos. 
(b) Genotyping confirmation (genotyping performed by Qiang Wang, Johns Hopkins 
University). Asterisks in genotyping gel indicate the embryos whose kidneys are 
shown as representative images. 






In Results Chapter 2, I identified a candidate pathway to explain vascular 
patterning in the nephrogenic zone, I characterised the expression patterns of 
Sema3f, Nrp1, and Nrp2, and demonstrated that, despite their complementary 
gene expression patterns, Sema3f and Nrp2 are not required for the exclusion 
of endothelia from the cap mesenchyme.   
For the expression of anti-angiogenic candidate genes in the cap 
mesenchyme, E15.5 is the only embryonic time-point available in GUDMAP. 
Blood vessel patterning around the cap mesenchyme is cyclical and repetitive; 
a mechanism responsible for excluding endothelia from the cap mesenchyme 
would be present at all stages of development when the cycles are taking 
place. Thus, E15.5 is a useful time-point, as the cycles of vascular plexus 
formation are underway. As this candidate selection process was not a 
comprehensive survey of all potential anti-angiogenic genes, it is possible that 
some cap mesenchyme-expressed anti-angiogenic genes, which may have 
also been strong candidates, were overlooked. Furthermore, the first selection 
criterion may have been too stringent as the number of genes was reduced 
from 39 to 3 after this step, meaning potentially important candidates may have 
been discounted without enough consideration. Nevertheless, as the purpose 
was to identify only a single candidate, this selection process was useful. 
I investigated only the effects of Sema3f and of Nrp2 deletion on the patterning 
of endothelia around the cap mesenchyme. The interactions between these 
proteins may be important for many other aspects of renal development that I 
did not explore. For example, I demonstrated that Nrp2 is also highly 
expressed by the developing renal lymphatic endothelia, but I did not assess 
lymphatic patterning in the absence of Sema3f/Nrp2. Moreover, Sema3f is also 
expressed by developing renal tubular cells (Villegas and Tufro, 2003), which 
may mediate the guidance of endothelia around the developing nephrons and 
collecting ducts.  
Nrp2 is a receptor for both Sema3f and Vegf (Favier et al., 2006). Thus, 
signalling through Nrp2 can be pro- or anti- angiogenic. As genetic deletion of 
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Sema3f did not result in a vascular patterning defect, any defect due to Nrp2 
ablation would presumably be a consequence of interfering with the Vegf-Nrp2 
pathway. However, endothelial patterning was also normal in Nrp2 null 
kidneys, indicating that its role as a receptor for Sema3f and Vegf is not 
required for normal vascular plexus patterning in the nephrogenic zone. 
Nrp2 is highly enriched in endothelial tip cells (Siemerink et al., 2012). Based 
on the location of the Nrp2+ plexus endothelia at the vascular front (the site of 
new blood vessel formation), I speculate that these Nrp2+ cells are the 
endothelial tip cells in the kidney; however, there are no known endothelial tip 
cell-restricted markers to verify this hypothesis.  
Even though vascular plexus formation was normal in Nrp2 and Sema3f 
mutant embryos/pups, this pathway may still be involved in this patterning. 
Rather than being controlled by one signalling pathway, the patterning of 
endothelia in the nephrogenic zone may be dictated by the overall ratio of pro-
to-anti-angiogenic signals; in this case, even if the Sema3f/Nrp2 pathway was 
involved, eliminating these specific signalling components alone may not be 
enough to alter the vascular phenotype. Furthermore, in the absence of 
Sema3f/Nrp2, other proteins may be upregulated to compensate for their loss 
to maintain normal endothelial patterning. For example, there is redundancy 
between different semaphorins in certain developmental settings, such as 
epithelial morphogenesis in the kidney (Xia et al., 2015). Comparing class-3 
semaphorin gene/protein expression levels in cap mesenchyme cells from wild 
type and mutant kidneys may be a valuable method to identify potential 
compensatory molecules.  
Other than cap mesenchyme expressed anti-angiogenic molecules, there are 
other potential explanations for endothelial avoidance from the cap 
mesenchyme. One possibility is that the interstitium may simply offer a 
permissive environment for the endothelia to develop, whereas the condensed 
nature of the cap mesenchyme may inhibit the entrance of other cell types. 
Alternatively, there could be cell types located within the nephrogenic 
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interstitium but not the cap mesenchyme (e.g. macrophages, smooth muscle 
cells, mural cells) that specifically facilitate interstitial neovascularisation. 
These data should inform future studies investigating the biological 
significance of Sema3f/Nrp in kidney organogenesis.  
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4. Section 2 | Macrophages in the developing kidney 
For a review about kidney macrophages in development, see: 
Munro DAD, Hughes J. 2017. The Origins and Functions of Tissue-Resident 




Macrophages are large phagocytic cells that were first observed and described 
by Ilya Metchnikoff, who demonstrated their capacity to engulf microbial and 
host cells (Metchnikoff, 1905; Gordon, 2008). Though classically thought of as 
innate immune cells, macrophages also facilitate wide-ranging morphogenetic 
processes such as stripe formation in zebrafish (Eom and Parichy, 2017) and 
synaptic pruning in the mouse embryonic brain (Paolicelli et al., 2011; Zhan et 
al., 2014).  
All solid adult organs contain macrophages, and for a long time most or all of 
these macrophages were thought to derive from bone marrow-derived 
precursor cells (van Furth et al., 1972; Yona and Gordon, 2015); however, 
studies have challenged this concept and it is now clear that most adult 
macrophages derive from sequential waves of macrophage precursors that 
colonise organs during embryogenesis before the bone marrow has even 
formed (Schulz et al., 2012; Hashimoto et al., 2013; Epelman et al., 2014; 
Hoeffel et al., 2015; Sheng et al., 2015) 
Once macrophages arrive in a given embryonic organ, they can promote its 
development. One way in which macrophages may enhance organogenesis is 
by facilitating vascular development, as has been demonstrated in the 
developing testis and brain (Fantin et al., 2010; DeFalco et al., 2014). Indeed, 
an emerging function of macrophages is to promote angiogenesis by 
mediating cross-connections between sprouting endothelial vessels (Fantin et 
al., 2010; Liu et al., 2016).  
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In Section 2 of this thesis, I investigated the arrival, localisation, heterogeneity, 
and functions of kidney macrophages during development. A specific focus 
was to explore the relationship between the developing renal vasculature and 
kidney macrophages.  
 
4.1.2. Origins of tissue-resident macrophages 
Macrophages colonise the embryo in overlapping waves (Schulz et al., 2012; 
Hoeffel et al., 2015; Sheng et al., 2015). The first wave of macrophages comes 
from the yolk sac. Macrophage precursor cells, called erythro-myeloid 
progenitors (EMPs), emerge in the yolk sac from blood islands and hemogenic 
endothelia at approximately E7 (Moore and Metcalf, 1970; Palis et al., 1999; 
McGrath et al., 2003; Kasaai et al., 2017). As the embryonic circulation is 
established at approximately E8.5, these ‘early’ EMPs migrate into and 
throughout the embryo, entering newly forming organs such as the brain and 
liver (Kierdorf et al., 2013; Gomez Perdiguero et al., 2015). Early EMPs arise 
independently from the transcriptional regulator of hematopoiesis, c-Myb 
(Sumner et al., 2000; Sandberg et al., 2005; Perdiguero and Geissmann, 
2013). These cells are not thought to pass through a monocytic phase as they 
differentiate into pre- then mature macrophages (Takahashi et al., 1989; 
Schulz et al., 2012; Mass et al., 2016). This first wave is known as the 
‘primitive’ wave (Hoeffel and Ginhoux, 2018). 
The second wave of macrophages derive from c-Myb-dependent ‘late’ EMPs. 
These late EMPs also originate from the yolk sac (Hoeffel et al., 2015). Upon 
entering the embryo via the vasculature, many of these cells enter the liver and 
rapidly expand in numbers (Gomez Perdiguero et al., 2015; McGrath et al., 
2015; Rantakari et al., 2016). Unlike the early c-Myb-independent EMPs, many 
late c-Myb-dependent EMPs pass through a monocytic intermediate phase 
before becoming mature macrophages (Hoeffel et al., 2015). To exit the fetal 
liver and colonise other developing organs, these cells must depart via 
diaphragms in the fenestrae of liver sinusoidal endothelium in a PVLAP-
dependent manner (Rantakari et al., 2016). These cells travel to all embryonic 
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tissues apart from the brain, which has become inaccessible due to formation 
of the blood-brain barrier (Alliot et al., 1999). This second wave is known as 
the ‘transient definitive’ wave (Hoeffel and Ginhoux, 2018). 
From the third wave, macrophage precursor cells are generated from 
intraembryonic hemogenic endothelium in the aorta-gonad-mesonephros 
region (Medvinsky and Dzierzak, 1996; Yokomizo and Dzierzak, 2010). In this 
case, the macrophage precursor cells are generated from hematopoietic stem 
cells (HSCs). Like the late EMPs, HSCs enter the fetal liver, where they 
increase in numbers (Sheng et al., 2015). HSCs differentiate into monocytic 
cells and then colonise organs and mature into monocyte-derived 
macrophages (Kumaravelu et al., 2002; Kieusseian et al., 2012; Sheng et al., 
2015). This third wave is known as the ‘definitive’ wave (Hoeffel and Ginhoux, 
2018). 
During development, many HSCs also enter the spleen and bone marrow 
where they are maintained into adulthood and can differentiate into circulating 
monocytes. These circulating monocytes contribute greatly to some mature 
macrophage pools, such as in the adult intestine and heart (Bain et al., 2014; 
Epelman et al., 2014). In cases of inflammation/injury/infection, circulating 
monocytes are recruited in higher numbers to an organ, where they may limit, 
or in many cases worsen, the damage inflicted (Tsou et al., 2007; Shi and 
Pamer, 2011; Seok et al., 2013).  
Together, studies show that macrophages of most adult organs derive 
predominantly from waves of embryo-generated macrophages, which have an 
exceptional capacity to self-maintain in situ (Figure 4.1.1; (Merad et al., 2002; 
Ajami et al., 2007; Hashimoto et al., 2013; Sieweke and Allen, 2013; Hoeffel 






Figure 4.1.1. Macrophage precursors colonise the embryo in waves. Wave 1 
(primitive wave): early erythro-myeloid progenitors (EMPs) from the yolk sac migrate 
throughout the embryo and differentiate into pre-macrophages (pMacs) and then 
mature macrophages. Wave 2 (transient definitive wave): Late EMPs from the yolk 
sac enter the fetal liver, where they expand and differentiate into pMacs and/or 
monocytes. Late EMPs then exit the fetal liver and travel throughout the embryo. 
Wave 3 (definitive wave): Haematopoietic stem cells (HSCs) emerge from hemogenic 
endothelia in the aorta-gonad-mesonephros region. HSCs enter the fetal liver, expand 
and differentiate into monocytes, and then travel throughout the embryo and contribute 
to various macrophage populations. HSCs also enter the spleen and bone marrow, 
where they are maintained as precursors in adulthood. A newly defined population of 
pre/pro-B cells are also produced and released from the adult bone marrow and can 
contribute to some macrophage populations (Audzevich et al., 2017). Upon engrafting 
in an organ, the genetic programme of a macrophage becomes defined in a tissue-
specific manner. EMP, erythro-myeloid progenitor; HSC, haematopoietic stem cell; 
pMac, pre-macrophage; permission was obtained to adapt the camera lucida drawings 
by Perry (Gordon et al., 1988). 
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4.1.3. Kidney macrophage origins  
Macrophages from each precursor wave enter the kidney at different stages 
during its lifespan (the primitive, transient definitive, definitive, and circulating 
monocyte waves; (Schulz et al., 2012; Jang et al., 2013; De Cortie et al., 2014; 
Epelman et al., 2014; Hoeffel and Ginhoux, 2015; Hoeffel et al., 2015; Sheng 
et al., 2015).  
At the earliest stages of kidney development (E10.5-E12), there are no data 
about the origin(s) of macrophages. At E12.5, flow cytometry experiments 
show that kidney macrophages are phenotypically yolk sac-derived 
(CD45+CD11blowF4/80highLy6C− cells) and are not derived from monocytic cells 
(CD45+CD11bhighF4/80lowLy6C+ cells; Hoeffel et al., 2015).  
Fate mapping experiments, using the tamoxifen-inducible Runx1Cre/EYFP and 
Csf1rCre/EYFP mice, have demonstrated that the percentage of yolk sac-derived 
macrophages within the kidney dramatically decreases from E13.5 to 
adulthood (Hoeffel et al., 2015; Epelman et al., 2014a; for details about these 
mouse models, see Hoeffel and Ginhoux, 2015). Since yolk sac-derived 
macrophages have low apoptosis rates and high proliferation rates (Hoeffel et 
al., 2015), it is assumed that the reduced proportion of yolk sac-derived kidney 
macrophages is a consequence of their dilution by the later arriving monocyte-
derived macrophages (Hoeffel et al., 2015; Figure 4.1.2). As a result, yolk sac-
derived macrophages contribute minimally to the adult kidney macrophage 
population. 
Monocyte-derived macrophages colonise the murine kidney in high numbers 
from E13.5 (Epelman et al., 2014a; Hoeffel et al., 2015). Consequently, studies 
suggest that resident macrophages in the adult kidney are almost all 
monocyte-derived (Epelman et al., 2014a; Hoeffel et al., 2015; Sheng et al., 
2015). Yet, it is unclear whether these monocytes derive from late EMPs 





Figure 4.1.2. The relative proportions of yolk sac- and monocyte-derived 
macrophages in the embryonic/postnatal kidney. Based on fate-mapping 
experiments by Hoeffel et al., 2015. Microglia (brain macrophages), in contrast to 
kidney macrophages, are all yolk sac-derived. Figures were prepared, with permission, 
based on data from Hoeffel et al (2015). 
 
Evidence for adult kidney macrophages being HSC-derived came from Sheng 
et al (2015), who produced tamoxifen-inducible c-KitCre/EYFP mice to fate-map 
HSC progeny. Since all HSCs express c-Kit, tamoxifen induces EYFP-labelling 
of these cells (for details, see Sheng et al., 2015); Sheng et al labelled cells at 
numerous time-points and concluded that adult kidney macrophages were 
largely HSC-derived, rather than EMP-derived. However, c-Kit is expressed by 
EMPs as well as HSCs (Gomez Perdiguero et al., 2015) and it is not clear 
whether this model dependably distinguishes between EMP-progenitors and 
HSC-progenitors (Hoeffel and Ginhoux, 2015). In contrast, Epelman et al 
(2014) used the Flt3Cre/GFP fate-mapping model and demonstrated that adult 
kidney macrophages derive from both HSC-dependent and HSC-
independent/EMP-derived monocytes. All HSCs transiently express Flt3 
(Boyer et al., 2011); therefore, any labelled GFP+ cells using this model were 
classed as HSC-derived, whereas GFP- cells were classed as HSC-
independent. Epelman et al (2014) demonstrated that ~50% of adult kidney 
macrophages were GFP+, and therefore HSC-derived (Epelman et al., 2014). 
Another study tackled this question using the Runx1Cre/EYFP fate-mapping 
model and instead determined that adult kidney macrophages predominantly 
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arise from late EMP-derived fetal monocytes (Hoeffel et al., 2015). Labelled 
EMPs reached the fetal liver and converted into the monocytes and 
macrophages that eventually colonised developing organs such as the kidney 
(Hoeffel et al., 2015). Collectively, it is likely that both EMP- and HSC-derived 
monocytes generate most mature macrophages in the adult kidney. Though, 
which of these cell types is the predominating source remains unsettled and 
further analyses of the specific limitations of the different fate-mapping models 
are required (as reviewed by Hoeffel and Ginhoux, 2015). 
In the healthy adult, circulating monocytes from the bone marrow also colonise 
the kidney at low levels (Sheng et al., 2015). In cases of 
injury/inflammation/infection, circulating monocytes are recruited in higher 
numbers, as evidenced by studies examining the engraftment of bone marrow-
derived cells in irradiated mice (Jang et al., 2013; De Cortie et al., 2014; Hoeffel 
et al., 2015). 
Recently, Guilliams and Scott (2017) proposed a niche competition hypothesis 
to explain differences in macrophage origins between organs. Based on this 
model, whether a macrophage precursor occupies an organ (or niche) is 
primarily dependent on it being both accessible and available (Figure 4.1.3). 
Since macrophages can enter the kidney via the circulation throughout much 
of development and adulthood, the kidney is almost always accessible for the 
different macrophage progenitor waves. Since the capacity to house 
macrophages increases as the kidney enlarges developmentally, the kidney is 
available to be colonised by macrophages from the different progenitor waves 
during the pre- and neo-natal periods. As renal growth ends, macrophage 
niches become full and, consequently, the kidney niche becomes unavailable 
(Figure 4.1.3). This hypothesis may explain why adult kidney macrophages 
are predominantly embryonically/neonatally-derived (Epelman et al., 2014; 
Hoeffel et al., 2015; Sheng et al., 2015). 
To summarise, kidney macrophages have diverse origins. Initially, yolk sac-
derived macrophages colonise the early kidney (primitive wave), but these 
cells are gradually replaced later in development by late EMP- and/or HSC-
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derived monocytic cells (transient definitive and definitive waves; Figure 
4.1.2). Macrophages that arrive in the kidney during development self-renew 
in situ throughout adulthood and are only partially replaced by circulating 
monocytes from the bone marrow in adulthood.  
 
 
Figure 4.1.3. Kidney macrophages derive from multiple sources. Based on the 
niche competition hypothesis of macrophage origins (Guilliams and Scott, 2017), the 
mixed ontogeny of renal macrophages may be the consequence of kidney niches being 
both accessible and available throughout organogenesis and phases of adulthood. The 
“?” in circulating bone marrow-derived monocytes illustrates that it is unknown 
whether these cells persist in the kidney when inflammation/disease is resolved. Cup 





4.1.4. Developmental functions of kidney resident macrophages 
In developing organs, macrophages can drive processes such as the 
clearance of cellular debris, branching morphogenesis, and 
neovascularisation (Gouon-Evans et al., 2000; Kawane et al., 2003; Pollard, 
2009; DeFalco et al., 2014; Sathi et al., 2017). Few studies, however, have 
investigated the specific functions of macrophages in the developing kidney.  
 
4.1.4.1. Clearance of apoptotic cells | Macrophages clear cellular debris 
released from dying cells through a process named efferocytosis (meaning ‘to 
bury’ or ‘to take to the grave’). Impaired efferocytosis results in the 
accumulation of uncleared cellular debris, which can cause inflammation via 
activation of the innate immune system (Green et al., 2016). Kawane et al. 
(2003) demonstrated that defective efferocytosis in the developing thymus 
results in impaired thymic development, characterised by reduced thymus size 
and thymocyte number. In the developing mouse and human kidney, 
efferocytosis is thought to be carried out by macrophages (Camp and Martin, 
1996; Erdösová et al., 2002; Figure 4.1.4), but the consequences of defective 
efferocytosis during renal development are unknown.  
 
4.1.4.2. Branching morphogenesis and nephrogenesis | There is also 
some evidence that macrophages promote branching morphogenesis and 
nephrogenesis during kidney development (Rae, Woods, Sasmono, 
Campanale, Taylor, Dmitry A. Ovchinnikov, et al., 2007; Muthukrishnan et al., 
2017); Figure 4.1.4). For example, Rae et al (2007) added colony stimulating 
factor-1 (Csf-1), a macrophage mitogen, to kidney cultures and compared 
branching morphogenesis and nephrogenesis rates. Csf-1 treatment 
enhanced macrophage numbers in the culture system and there was a 
corresponding increase in ureteric bud branching and nephron formation; 
however, it was not shown whether these effects were due to the increased 
numbers of macrophages, macrophage activation status alterations, the 
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addition of Csf-1 per se, or a combination thereof. Nevertheless, these findings 
are supported by in vivo studies of kidney development in Csf-1 treated mice 
and in cases where the Csf-1 receptor was ablated or blocked (Alikhan et al., 
2011). Treatment of neonatal mice with Csf-1 enhanced kidney growth, 
resulting in larger heavier kidneys, which was associated with increased 
kidney macrophage numbers (Alikhan et al., 2011). Furthermore, mice lacking 
the Csf1 receptor have lighter kidneys relative to wild type mice (Alikhan et al., 
2011) and, correspondingly, in vivo blockade of this receptor with an anti-Csf1r 
blocking antibody lead to reduced kidney: body weight ratios relative to control 
treated mice (Sauter et al., 2014).  
 
4.1.4.3. Blood vessel development | In many developmental organs, such 
as the brain and testes, macrophages can facilitate vascular development 
(Fantin et al., 2010; Rymo et al., 2011; DeFalco et al., 2014); however, the 
cellular relationship between macrophages and endothelia in the developing 
kidney remains unexplored.  
Blood vessels are often generated through sprouting of endothelial cells and 
their subsequent cross-connections (anastomoses) with other vessels. In 
developing organs, and in response to blood vessel ruptures, these cross-
connections can be facilitated by macrophages, which adhere to endothelia 
and generate mechanical traction forces to pull vessels together (Fantin et al., 
2010; Liu et al., 2016).  
Hypoxia can also stimulate a pro-angiogenic response in macrophages (Cattin 
et al., 2015). Macrophages highly express the p110γ isoform of 
phosphoinositide 3-kinase (PI3K), which stabilises the hypoxia-inducible 
transcription factors, HIF1α and HIF2α, in response to hypoxia (Joshi et al., 
2014). As a result, hypoxia-responsive elements stimulate the production of 
pro-angiogenic genes in macrophages (Joshi et al., 2014). Indeed, 
macrophage-produced VEGF-A has been shown to stimulate endothelial 
proliferation and angiogenesis in hypoxic environments (Cattin et al., 2015). 
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Yet, no studies have investigated the roles of macrophages in the 
vascularisation of the developing kidney.  
 
Figure 4.1.4. Strength of evidence for roles of macrophages in processes relating 
to kidney development. Stars are used to indicate the strength of evidence for a role 
of macrophages in various organogenetic processes in the kidney (0 stars, no direct 
evidence  5 stars, strong evidence). 
 
4.1.5. Section 2 aims 
In Section 1, I characterised the patterning of the renal vasculature throughout 
embryonic development. Various cell types are involved in the assembly and 
remodelling of vascular beds in the embryo and adult (Herbert and Stainier, 
2011). Here I explored the arrival, localisation, heterogeneity, and functions of 
macrophages in the developing kidney. A major aim was to understand the 
relationship between the renal vasculature and kidney macrophages.  
The specific aims of Results chapter 3 were:  
(1) To characterise when macrophages arrive in the developing kidney and 
where they localise in relation to other renal cell types.  
(2) To assess macrophage heterogeneity in the developing kidney and 
compare the associations between different macrophage sub-types and 
the renal vasculature. 
(3) To determine whether macrophages are required for normal vascular 
development in the kidney.  
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4.2. Results chapter 3: Macrophages in the developing kidney 
4.2.1. Results 
4.2.1.1 Macrophages arrive in the caudal part of the embryo before the 
metanephric mesenchyme is invaded by the ureteric bud 
To characterise macrophage distribution in the embryo as the metanephric 
kidney’s component parts emerged and developed, I immunostained and 
optically cleared caudal-parts of E9.5-10.5 mouse embryos. At these stages, 
macrophages are yolk sac-derived and highly express colony-stimulating 
factor 1 receptor (Csf1r), fractalkine receptor (Cx3cr1), and F4/80 (Schulz et 
al., 2012; Mass et al., 2016). Csf1r and Cx3cr1 mark both precursor and mature 
macrophages, whereas F4/80 marks only mature macrophages (Frame et al., 
2016; Mass et al., 2016).  
At E9.5, bilateral Six2+ nephrogenic cell populations arranged as cords that lay 
medial to Wolffian ducts and lateral to the dorsal aorta (Figure 4.2.1a-d; Movie 
4.1). There were no F4/80+ macrophages near to the Six2+ nephrogenic cells 
at this stage (Figure 4.2.1e-f; Movie 4.2). This finding agrees with previous 
studies using Cx3cr1GFP/+ embryos, in which GFP expressing yolk sac-derived 
macrophages arrived only from E9.5 onwards (Schulz et al., 2012; Perdiguero 
and Geissmann, 2013; Mass et al., 2016; Stremmel et al., 2018). The absence 
of F4/80+ macrophages at E9.5 indicated that they are unlikely to facilitate the 
earliest development of metanephric precursor populations. 
By E10.5, as ureteric bud outgrowth started, Six2+ metanephrogenic cells had 
accumulated at the caudal end of the Wolffian duct (Figure 4.2.2a; as 
described by (Wainwright et al., 2015). Immunostaining for a pan-endothelial 
marker, CD31, demonstrated that the metanephrogenic cell populations were 
avascular at this stage (Figure 4.2.2b; Movie 4.2).  F4/80+ macrophages were 
now present in high numbers in the caudal part of the embryo but largely 
avoided the E10.5 metanephrogenic mesenchyme (Figure 4.2.2b-c; Movie 
4.2); however, macrophage density was high in isolated clusters of Six2+ cells 




Figure 4.2.1. Macrophage arrival in the caudal part of early mouse embryo. (a) 
E9.5 mouse embryo. White dashed box indicates the position of the nephrogenic cord. 
(b-c) Z-projections of Wolffian ducts (Gata3), nephrogenic precursors (Six2), and 
nuclei (TOPRO; in b) at E9.5. (d) 3D rendering of Wolffian ducts (Gata3), 
nephrogenic precursors (Six2), and dorsal aorta (pseudo-rendered based on CD31 
staining) arrangement at E9.5. (e) Location of nephrogenic cords relative to dorsal 
aorta. (f-g’) Absence of F4/80+ macrophages in the caudal part of the E9.5 embryo. 
White arrowhead in f shows a single macrophage present adjacent to a somite. Scale 
bars = 100 µm (excepting f, where the scale bar = 200 µm). 
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Figure 4.2.2. Macrophages initially avoid Six2+ metanephrogenic populations. (a) 
3D rendering of Wolffian ducts (Gata3) and metanephrogenic precursor population 
(Six2) arrangement at E10.5. White arrowheads show isolated clusters of nephrogenic 
cells. (b) F4/80+ macrophage localisation around the E10.5 metanephrogenic 
progenitors (Six2). (c) Macrophage density at E9.5 and E10.5 in the caudal part of the 
embryo and within the metanephric Six2+ populations (n = 20 fields of view from 2 
cleared E9.5 embryos and 20 fields from 2 cleared E10.5 embryo). (d) Quantification 
of macrophage density (per mm2) along the rostro-caudal axis of the E10.5 
metanephrogenic mesenchyme and within isolated groups of rostral nephron 
progenitor cells (n = 4 metanephroi from 2 E10.5 embryos). Scale bars = 100 µm. 
 
4.2.1.2. Macrophages enter the metanephric interstitium when the 
nephron progenitor population splits 
The ureteric bud had invaded the metanephrogenic mesenchyme by E11 and 
bifurcated by E11.5 (Figure 4.2.3a, c). At E11 and E11.5, numerous F4/80+ 
macrophages and blood vessels were present in the peri-Wolffian 
mesenchyme (situated between the metanephrogenic mesenchyme and 
Wolffian duct), but relatively few were present within the metanephrogenic 
mesenchyme itself (Figure 4.2.3a-c; 2.71-fold higher macrophage density in 
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E11.5 peri-Wolffian mesenchyme than metanephrogenic mesenchyme). The 
few F4/80+ macrophages within the metanephrogenic mesenchyme were most 
often at its border nearest the peri-Wolffian mesenchyme (Figure 4.2.3a, c), 
in agreement with macrophage localisation in Csf1rEGFP kidneys (Figure 
4.2.3d; Rae et al., 2007). Blood vessels also enter the kidney from this side 
(Munro et al., 2017).  
At E11.5, Six2+ cells were present as a single population scattered throughout 
the metanephrogenic mesenchyme (Figure 4.2.4a). By E12.5, the Six2+ 
population had split (Figure 4.2.4b), resulting in the ‘capping’ of each ureteric 
bud tip (Short et al., 2014). The interstitium that forms between cap 
mesenchyme populations was occupied by blood vessels (Airik et al., 2006; 
Munro et al., 2017). By E12.5, F4/80+ macrophages were dispersed 
throughout the vascularised kidney interstitium and commonly wrapped 
around the blood vessels (Figure 4.2.4c). Studies have shown that these 
kidney macrophages are yolk sac-derived (CD45+CD11bloF4/80hiLy6C−) and 
that few monocytes (CD45+CD11bhiF4/80loLy6C+) are present at this stage 
(Hoeffel et al., 2015). Up until E12.5, no intravascular F4/80+ macrophages 
were observed (i.e. being carried within the vasculature). Together, these data 
show that the early kidney is simultaneously colonised (in time and space) by 





Figure 4.2.3. Higher macrophage density in the vascularised peri-Wolffian 
mesenchyme region in comparison to the avascular metanephric mesenchyme. 
(a) E11 kidney, macrophages (F4/80), ureteric bud (Gata3), erythrocytes (heme 
autofluorescence), and vasculature (CD31). (b) Macrophage localisation is higher in 
the peri-Wolffian mesenchyme than the metanephric mesenchyme (macrophage 
density in peri-Wolffian mesenchyme = 260.20 ± 20.08 per mm2 [mean ± SEM]; 
macrophage density in metanephric mesenchyme = 95.86 ± 12.29 per mm2 [mean ± 
SEM]; p < 0.0001; two-tailed paired t-test [testing whether densities were the same]; 
n = 10). (c) E11.5 kidney, macrophages (F4/80), ureteric bud (Gata3), erythrocytes 
(heme autofluorescence), and vasculature (CD31). (d) Similar arrangement of 








Figure 4.2.4. Macrophages enter the kidney when the nephron progenitor 
population splits and the renal interstitium forms. (a) At E11.5, nephron 
progenitors (Six2) gather as a single population, which is predominantly devoid of 
macrophages (F4/80) and red blood cells (RBCs; heme autofluorescence). (b) By 
E12.5, nephron progenitor cell populations have split, creating fissures in the 
mesenchyme that are occupied by macrophages and erythrocytes. In the ‘F4/80 and 
RBC’ panels in a and b, the dashed green lines represent the boundaries of Six2+ 
nephron progenitor populations. Images in a and b are z-projections; consequently, 
macrophages and RBCs that appear within Six2+ populations may be localised above 
these cell populations in 3D. (c) At E12.5, macrophages primarily localise around the 





4.2.1.3. Macrophages localise in the renal interstitium independently 
from the interstitial vasculature  
As many interstitial macrophages in the early kidney were perivascular, I next 
examined whether macrophage localisation within the interstitium depended 
on the presence of blood vessels. To test this, I inhibited vascular development 
in E12.5 kidneys cultured for 72 hrs and compared macrophage localisation 
(inhibitors: sunitinib, vatalanib, and semaxanib). Macrophage localisation did 
not differ between groups (p = 0.7142; one-way ANOVA; n = 4-9 kidneys per 
group; Figure 4.2.5a-c), suggesting that interstitial macrophage localisation 
did not depend on endothelia-derived signals. Macrophage density was, 
however, deceased in vascular-depleted kidneys, and correlated with vascular 
density, suggesting that endothelia may instead promote macrophage survival 
and/or proliferation (Figure 4.2.5d-e). Relative to the vehicle control (DMSO), 
vascular depletion did not alter other aspects of kidney development (Figure 
4.2.6a-c) and a second, blinded counter corroborated the differences in 
macrophage density between groups (Figure 4.2.6d). These data suggest that 
macrophages localise in the interstitium independently from endothelia-





Figure 4.2.5. Macrophage localisation does not depend on the vasculature in 
culture. (a) Representative images of macrophages (F4/80) and cap mesenchyme 
populations (Six2) in control and treated kidneys. (b) Endothelia are depleted in 
sunitinib, vatalinib, and semaxanib treated kidneys (representative images; stitched 
confocal z-stacks, 3x3 tiles). (c) Vascular density is decreased in treated kidneys (p for 
overall ANOVA < 0.0001; n = 5-8 per group). (d) Macrophage localisation is unaltered 
between groups (p for overall ANOVA = 0.71; n = 4-9 kidneys per group). (e) 
Macrophage density is decreased in treated kidneys (p for overall ANOVA < 0.0001; 
n = 10-15 kidneys per group). (f-g) Macrophage density positively correlated with 
vascular density in all groups (f: r = 0.71, 0.48-0.85 95%CI; p < 0.0001; n = 32 
kidneys) and in control groups only (g: r = 0.74, 0.33-0.92 95%CI; p = 0.0035; n = 13 
kidneys). Data are from 2 identical experiments (different antibodies were used for 
sample staining after fixation). Vascular density data used in c, f, and g were obtained 
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from the second experimental run. Macrophage localisation data in d were determined 
from the first experimental run. Macrophage density data in e includes data from both 
experimental runs. In f-g, the colour of the data point represents its group (e.g. green 
dots represent kidneys treated with sunitinib). Scale bars = 100 µm.  
 
 
Figure 4.2.6. Vascular inhibition does not influence other aspects of kidney 
development. (a) Representative images of developing collecting duct tree (Gata3) in 
control and treated kidneys (stitched confocal z-stacks, 3x3 tiles). (b) Kidney area 
differed between groups (p for overall one-way ANOVA = 0.0003; n = 10-15 per 
group). Post testing using Dunnett's Multiple Comparison Test determined that only 
vehicle control and control groups significantly differed (when individually comparing 
each group to vehicle controls, and with significance set at < 0.05). (c) No difference 
in ureteric bud branching generations between groups (p for overall ANOVA = 0.205; 
n = 5-8 per group).  (d) Agreeing macrophage density counts of counter 1 and a second 
blinded counter (counter 2; n = 3 per group; p = 0.84; counter accounted for <0.1% of 
total variance). Scale bars = 100 µm.
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4.2.1.4. Most mature macrophages in the developing kidney are 
interstitial perivascular cells 
I next investigated whether the close spatiotemporal association between 
macrophages and endothelia continued throughout later kidney development. 
First, I confirmed that F4/80 is a specific macrophage marker in the developing 
kidney by co-staining an E14.5 Csf1rEGFP kidney with anti-GFP and anti-F4/80. 
All F4/80+ cells co-expressed Csf1r (100% ± 0% [mean ± SEM]; n = 730 cells 
counted from 8 z-slices; Figure 4.2.7; Movie 4.3).  
I then immunostained and optically cleared E13.5, E15.5, and E18.5 kidneys 
to explore organ-wide macrophage localisation. F4/80, CD31, and Gata3 co-
staining demonstrated that macrophages were present throughout the 
medullary and cortical portions of developing kidneys and localised highly 
around the renal vasculature (Figure 4.2.8a-e; Movie 4.4). Macrophages 
arranged parallel to major renal blood vessels, such as segmental arteries, but 
rarely interacted with their endothelia (Figure 4.2.8a-b, d-e). In contrast, 
macrophages did interact with the endothelia of small calibre vessels, such as 






Figure 4.2.7. F4/80 is a macrophage-specific marker in the kidney. (a) Percentage 
of cells singly or doubly positive for Csf1r (anti-GFP) and/or F4/80 in the developing 
kidney (n = 730 cells from 8 z-slices of a cleared E14.5 ‘MacGreen’ kidney). (b) 
Example of a z-stack image used for the quantification in a. (c) Example of a 
Csf1r+F4/80+ macrophage in the developing kidney. Csf1r (GFP) is cytoplasmic. 














Figure 4.2.8. Macrophage localisation relative to the vasculature in later kidney 
development. (a-b) Macrophages arranged parallel to major vessels in the E15.5 
kidney, but rarely contacted the endothelia (b: red macrophages = arranged parallel to 
segmental arteries; white macrophages = other macrophages; image prepared in Adobe 
Photoshop). (c-c’’) Macrophages spatially interacted with newly forming vessels in 
the E15.5 cortical nephrogenic zone. (d-e) Macrophages also arranged parallel to 
segmental arteries in E13.5 (d) and E18.5 (e) kidneys. Scale bars = 100 µm. 
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From approximately E13.5 onwards, important organogenetic processes occur 
in cycles within the cortical nephrogenic zone of the developing kidney: ureteric 
bud tips branch, cap mesenchyme populations split, nephrogenesis initiates, 
and interstitial vascular plexuses form (Herring, 1900; Short et al., 2014; Munro 
et al., 2017). Due to the significance of this zone in renal organogenesis, I next 
focused on macrophages within this region. Using the E17.5 nephrogenic zone 
as a representative example, I determined that 89.6% ± 1.45% (mean ± SEM) 
of macrophages localised within the interstitium, whereas only 10.4% ± 1.45% 
(mean ± SEM) localised within the cap mesenchyme (n = 10; Figure 4.2.9a, 
c, d).  
Of the interstitial macrophages in the E17.5 nephrogenic zone, 78.5% ± 2.1% 
(mean ± SEM) were wrapped around the nephrogenic zone blood vessels 
(Figure 4.2.9b, e-f). This localisation was qualitatively consistent throughout 
prenatal kidney development (Figure 4.2.10). Though most macrophages 
localised within the interstitium, they never expressed the nephrogenic 
interstitial marker, Meis2, consistent with their reputed exogenous origins 
(Kobayashi et al., 2014; Figure 4.2.11). 
These nephrogenic zone blood vessels are at a vascular front in the 
developing kidney (i.e. a site of neovascularisation; Munro et al., 2017). In this 
region, the extent of macrophage contact with the vasculature and vascular 
basement membrane varied: a single macrophage may have peri- (around), 
extra- (outside), and intra- (within) vascular regions (Figure 4.2.12a-b). I did 
not detect any entirely intravascular F4/80hi kidney macrophages at any 
developmental stage, indicating that these cells either arrived via extravascular 
routes, that precursor cells gained F4/80hi status only after exiting the 
vasculature, or combinations thereof.  
Within the cortical nephrogenic zone, F4/80+ macrophages typically co-stained 
for the mannose receptor, CD206, a marker associated with 
perivascular/mature macrophage status (discernible co-staining at E14.5, 
94.1% ± 1.0% of cells; at E17.5, 96.5% ± 1.0% of cells [mean ± SEM]; Figure 
4.2.13a-c). Even at E11.5, before the nephrogenic zone formed, F4/80+ 
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macrophages typically co-expressed CD206 (98.8% ± 0.71% [mean ± SEM]; 
Figure 4.2.13a). Immunostaining confirmed that CD206+ macrophages were 
largely perivascular (4.2.13d-e) and demonstrated that CD206 predominantly 
localised in intracellular vesicle membranes, while F4/80 localised in the 
plasma membrane (most highly at sites of lamellipodia and filopodia; Figure 
4.2.13g-g’).  
These data show that most F4/80+CD206+ kidney macrophages in the 
nephrogenic zone localised around, but not within, the interstitial blood vessels 
throughout the embryonic period of renal organogenesis. 
 
 
Figure 4.2.9.  Most kidney macrophages in the nephrogenic zone are interstitial 
perivascular cells. (a) Kidney macrophage localisation in the E17.5 nephrogenic 
zone. The red bar shows the percentage of interstitial macrophages that are 
perivascular. CM, cap mesenchyme. (b) Macrophages localised around vascular 
plexus endothelia in the E18.5 nephrogenic zone. (c) Kidney macrophage localisation 
around cap mesenchymal populations in the E17.5 nephrogenic zone. (d) Example of 
an intra-cap mesenchymal macrophage. (e) Example of a perivascular macrophage. (f) 
Schematic depicting macrophage localisation alongside the different cell types within 
the nephrogenic zone (ureteric tips are not shown for illustrative purposes). Scale bars 





Figure 4.2.10. Macrophage localisation in the nephrogenic zone throughout 
embryonic kidney development. (a-d) Macrophages localise around and contact the 
endothelia of the nephrogenic vascular plexuses from E13.5 and throughout the 
remainder of prenatal kidney development (a = E13.5; b = E14.5; c = E15.5; d = 








Figure 4.2.11. Macrophages do not express the interstitial cell marker, Meis1. (a-
a’’) Macrophages (F4/80+ white cell) in the nephrogenic interstitium do not express 
nuclear Meis1 (magenta), an interstitial marker. Scale bar = 10 µm.  
 
 
Figure 4.2.12. Perivascular macrophage. (a-b) Example of a perivascular 
macrophage in the nephrogenic zone, with intra-, peri-, and extra-vascular regions. 





Figure 4.2.13. F4/80+ macrophages co-express CD206. (a) Percentage of cells singly 
or doubly positive for CD206 and F4/80 in the E11.5 kidney and the cortical 
nephrogenic zone of E14.5 and E17.5 kidneys. (b-c) Representative images of double 
positive cells. CD206 and F4/80 channels were 3D rendered. (d-e) CD206+ 
macrophages localise around the interstitial vasculature. (f) Macrophages with 
irregular morphologies express higher levels of F4/80 than small, spherical 
macrophages. (g) Example F4/80+CD206+ macrophage illustrating the distinct 
localisation of the two proteins. Scale bars: b-c, f = 50 µm; d-e = 100 µm; g = 10 µm. 
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4.2.1.5. Late-arriving Mac2hi cells travel within the renal vasculature and 
intermingle with mature macrophages in the nephrogenic zone 
In the developing lung, a subpopulation of galectin3+ (Mac2+) macrophages 
are dispersed alongside yolk sac-derived F4/80hi macrophages. Mac2+ 
macrophages colonised the lung from E12.5 onwards and were speculated to 
be fetal liver-/monocyte-derived (Tan and Krasnow, 2016), though this was not 
confirmed experimentally.  
Here I stained Csf1rEGFP embryos with anti-Mac2 and demonstrated that the 
developing kidney also contained Mac2+Csf1rEGFP+ cells (Figure 4.2.14a-b). 
Mac2+ cells intermingled alongside interstitial F4/80+CD206+ macrophages 
throughout development (Figure 4.2.15a-e). Mac2+ cells were present as early 
as E11.5 within the peri-Wolffian mesenchyme, but in very low numbers 
(Figure 4.2.15a). The proportion of kidney myeloid cells that were Mac2+ 
dramatically increased later in development, while the proportion of CD206+ 
cells correspondingly decreased (Figure 4.2.15g). In later kidney 
development, tubular lumens also strongly stained for Mac2 (Figure 4.2.15d 
and f), in agreement with previous descriptions of its expression pattern in the 
developing human kidney (Winyard et al., 1997). At any given time, 14.4% ± 
2.2% (mean ± SEM) of Mac2+ cells in the cortical nephrogenic zone were being 
carried within blood vessels (at the point of fixation; Figure 4.2.16a-c), 
indicating that either the vasculature is their mode of arrival into the kidney, 
that some of these cells are constitutively intravascular, or combinations 
thereof.  
F4/80lowCD11bhi monocytes arrive in the developing kidney and differentiate in 
high numbers from approximately E13.5, leading to the dilution of 
F4/80hiCD11blow yolk sac-derived macrophages in later development (Hoeffel 
et al., 2015). The similar arrival kinetics of Mac2+ cells shown here (Figure 
4.2.15g) led us to hypothesise that these cells represented the wave of 
monocyte-derived macrophages. Consistent with monocyte status, Mac2+ 
cells were morphologically spherical in comparison to the irregular morphology 
of the CD206+ mature macrophages (Figure 4.2.16d; Evrard et al., 2015).  
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Figure 4.2.14. Mac2+ cells co-express Csf1r. (a-b) Mac2 is expressed by a subset of 
Csf1rEGFP+ cells. (b) Example of an individual Csf1rEGFP+Mac2+ cell. Scale bars: a = 




Figure 4.2.15. The proportion of Mac2+ cells increases later in kidney 
development. (a) At E11.5, there were 6.4 ± 0.7 Mac2+ cells per E11.5 kidney/peri-
Wolffian mesenchyme region; n = 7). (b-c) Mac2+ and CD206+ cells in the E14.5 
kidney. c shows examples of individual cells from b. (d-e) Mac2+ and CD206+ cells 
in the E17.5 kidney. e shows Mac2+ and CD206+ cells in the E17.5 nephrogenic zone. 
(f) Mac2+ expression in apical domain of ureteric epithelial tubules. (g) The percentage 
of Mac2+ myeloid cells increases over developmental time, while the percentage of 





Figure 4.2.16. Mac2+ cells localisation and morphology. (a) Quantification of 
Mac2+ and F4/80+ macrophage localisation in E17.5 nephrogenic zone (n = 14 fields 
of view for F4/80 localisation and n = 15 fields of view for Mac2 localisation). The 
only intravascular cells were Mac2+. (b) Example of an intravascular Mac2+ cell at 
E17.5. (c) 3D rendering of the intravascular Mac2+ cell from b. (d) Mac2+ cells are 
more spherical than CD206+ cells (p < 0.0001; unpaired two-tailed t-test; n = 290 
CD206+ cells;  n = 51 Mac2+ cells from E14.5 nephrogenic zone). Scale bars: b = 5 







I received and analysed single cell RNA-sequencing data for 14 cells identified 
as macrophages from 576 cells from the E18.5 kidney (using the Smart-seq2 
protocol; Wineberg et al., in preparation). Principle component analyses (PCA) 
identified these cells as macrophages based on their mRNA expression levels 
of 48 genes (genes chosen by Tomer Kalisky and Yishay Wineberg based on 
relevant literature). I hypothesised that by performing PCA specifically on 
these macrophages that both the Mac2hi and F4/80hiCD206hi cells could be 
identified and that they would cluster separately. Indeed, distinct macrophage 
clusters were identified using PCA specifically on these macrophages (Figure 
4.2.17a-d; PCA performed by Yishay Wineberg). One cluster contained 6 
F4/80hiCD206hiMac2- cells, while the other cluster contained 3 Mac2hiF4/80-
CD206- cells, substantiating my immunofluorescence observations that there 
are distinct macrophage populations in the developing kidney. 
To explore the characteristics of these cell types, I analysed whether their 
mRNA signatures were consistent with erythro-myeloid progenitor-, monocyte- 
and/or mature macrophage- status (signatures based on Hoeffel et al., 2015 
and Mass et al., 2016). As expected, mRNA signatures of the 
F4/80hiCD206hiMac2- cells were consistent with their being mature 
macrophages (Figures 4.2.18 - 4.2.19a-d). In contrast, Mac2hiF4/80-CD206- 
cells expressed higher levels of monocyte-associated mRNA than 
F4/80hiCD206hiMac2- cells, possibly signifying their derivation from monocytes 
(Figures 4.2.18 - 4.2.19a-d); however, expression of monocyte-associated 
mRNA by individual Mac2hi cells was extremely variable (Figure 4.2.18c). 
Mac2hi cells also highly expressed the monocyte marker, CD11b (Itgam; 
Schulz et al., 2012), supporting my hypothesis that these cells are monocytic 
or monocyte-derived (Figure 4.2.19e). Moreover, Mac2hi cells expressed 
CD18 and CD11a (Figure 4.2.19e). CD11b/CD18 form the Mac-1 adhesion 
complex and CD11a/CD18 form the LFA-1 adhesion complex; these 
complexes are critical for intravascular crawling and extravasation of 
monocytes (Schenkel et al., 2004) 
Although Mac2hi cells had a monocyte-like mRNA phenotype, they also highly 
expressed some genes associated with mature macrophages. Indeed, gene 
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set enrichment analyses, using the PANTHER over-representation test 
(http://www.pantherdb.org/), demonstrated that the top 1% of genes expressed 
by Mac2hi cells were significantly over-represented in biological processes 
such as leukocyte degranulation (false discovery rate [FDR] corrected p = 
0.0013), immune response (FDR corrected p = 0.00012), actin filament 
organisation (FDR corrected p = 0.00019), regulated exocytosis (FDR 
corrected p = 0.021), and hydrogen peroxide metabolism (FDR corrected p = 
0.028). These data are consistent with Mac2hi cells having wide-ranging 
functional repertoires as developmental effector cells. 
Predictably, the top 1% of genes expressed by F4/80hiCD206hi cells were over-
represented in macrophage-associated biological processes such as 
pinocytosis (FDR corrected p = 0.0038), endocytosis (FDR corrected p = 
0.000000016), immune system processes (FDR corrected p = 0.031), 
endosomal transport (FDR corrected p = 0.0021), and phagocytosis (FDR 
corrected p = 0.015). Notably, biological processes relating to vascularisation 
were also over-represented in the top 1% of genes expressed by 
F4/80hiCD206hi macrophages, such as blood vessel morphogenesis (FDR 
corrected p = 0.039), vasculature development (FDR corrected p = 0.027), and 
endothelial tube morphogenesis (FDR corrected p = 0.048; Figure 4.2.19f). 
Together, these data suggest that monocytic Mac2hi cells travel into the kidney 
via the vasculature, arriving in high numbers later in development and 
intermingling alongside the mature F4/80hiCD206hi macrophages. Both Mac2hi 
and F4/80hiCD206hi cells were enriched for mRNA associated with immune 
defence, but only F4/80hiCD206hi cells were enriched for mRNA involved in 







Figure 4.2.17. Single cell RNA-sequencing of kidney macrophages. (a-c) Principle 
component analyses (PCA) indicated that (a-b) F4/80hiCD206hi cells cluster together 
on the bottom right side of the graph and that (c) Mac2hi cells cluster at the top left of 
the graph. Red = high expression; Blue = low expression. (d) I speculated that the 
Mac2hi cells represented monocytes or monocyte-derived cells (highlighted in pink), 
whereas the F4/80hiCd206hi cells (highlighted in green) represented mature 
macrophages. A Six2hi nephron progenitor cell is shown as a negative control (bottom 







Figure 4.2.18. Single cell gene expression signature comparisons. (a-c) Comparing 
single cell RNA sequencing data for individual cells. (a) Mature macrophage 
signature. Hierarchical clustering separated the F4/80hiCD206hi cells from the Mac2hi 
cells (lines above heatmap graph). (b) Erythro-myeloid progenitor signature. 
Signatures in a-b are based on Mass et al., 2016. (c) Genes highly expressed by 
monocytes but not macrophages (signature in c is based on Hoeffel et al., 2015). Black 
rows in b and c represent genes that were not expressed by any of the cells analysed. 




Figure 4.2.19. Mac2+ cells are monocyte-like and F4/80+CD206+ cells are 
macrophages that express genes associated with vascular development. (a-c) 
Average mRNA transcript levels for the different cell types and different genes 
associated with erythro-myeloid progenitors, monocytes, and mature macrophages (n 
= 6 F4/80hiCD206hi cells; n = 3 Mac2hi cells; n = 1 Six2hi nephron progenitor cell 
[NPC]). (d) Mac2hi cells are enriched for monocyte-associated mRNA, whereas 
F4/80hiCD206hi cells are enriched with mature macrophage-associated mRNA. Each 
data point in d represents the average expression of a single relevant gene. Differences 
between groups in d were tested using non-parametric Kruskal-Wallis tests with post-
hoc Dunn’s multiple comparison tests. (e) Mac2hi cells express the subunits of the 
macrophage-to-endothelial adhesion complexes, Mac-1 and Lfa-1. (f) Genes 
associated with vascular development are significantly over-represented in the top 1% 
of F4/80hiCD206hi macrophage expressed genes, but not in the top 1% of the Mac2hi 





4.2.1.6. Macrophages have functions associated with renal 
vascularisation 
Based on kidney macrophage localisation (Figure 4.2.9), their gene 
expression profiles (Figure 4.2.19f), and their known capabilities of regulating 
vascular formation (Fantin et al., 2010; Rymo et al., 2011; DeFalco et al., 
2014), I hypothesised that macrophages are involved in renal vascularisation.  
Renal macrophages engulf cells in the developing mouse and human kidney 
(Camp and Martin, 1996; Erdösová et al., 2002); however, the identities of the 
phagocytosed cells are unknown. I observed F4/80+ renal macrophages 
engulfing erythrocytes and dying endothelia (Figure 4.2.20a-e), demonstrating 
that, as well as spatially associating with the vasculature, kidney macrophages 
directly interact with blood and vascular components during development. As 
far as I can determine, erythrocyte phagocytosis by macrophages in vivo has 
hitherto only been described in the spleen, bone marrow, and liver and has not 
been described in the kidney.  
To elucidate the roles of macrophages in renal vascular development, I 
attempted to use genetic, pharmacological, clodronate liposome-based, and 
blocking antibody-based approaches to deplete kidney macrophages. The 
genetic, pharmacological, and clodronate liposome-based approaches were 
unsuccessful. Using the blocking antibody-based approach, however, I 
efficiently depleted F4/80+ macrophages using an anti-Csf1r mAb blocking 
antibody (M279) in a kidney culture model (Figure 4.2.21a-e). Csf1r is 
essential for macrophage proliferation, migration, and survival (Dai et al., 2002; 
Mouchemore and Pixley, 2012). 
E12.5 kidneys were treated for 72 hrs with either 20 µg/ml of anti-Csf1r or 
normal anti-rat IgG as a control. Consistent with previous studies, anti-Csf1r 
treated kidneys were smaller than controls (p = 0.0046; Figure 4.2.21f; Rae 
et al., 2007; Alikhan et al., 2011; Sauter et al., 2014). The area covered by 
CD31+ endothelia did not significantly differ between groups (p = 0.077); 
however, macrophage-depleted kidneys had more disconnected endothelial 
structures per field of view (p = 0.031) and the average size of the CD31+ 
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structures were reduced relative to controls (p = 0.029; Figure 4.2.21g-i). 
These data are consistent with the hypothesis that macrophages facilitate 
endothelial anastomoses in the developing kidney.  
 
 
Figure 4.2.20. Kidney macrophages phagocytose dying endothelia and 
erythrocytes. (a-b’’’) Apoptotic endothelial cell (cleaved caspase 3+CD31+) in the 
cortical nephrogenic zone being phagocytosed by an F4/80+ kidney macrophage. 
Yellow arrowheads in b’’ show endothelial CD31+ cell debris within the macrophage 
body. (c-e) F4/80+ kidney macrophage phagocytosing an erythrocyte (RBC; heme 
autofluorescence) in the E13.5 kidney. Yellow box in c indicates the macrophage of 
interest. d-d’’ shows 3d rendering of this macrophage and the phagocytosed RBC. 




Figure 4.2.21. Kidney macrophages promote endothelial anastomoses. (a-d) 
Representative images of anti-rat IgG (control; a-b) and anti-Csf1r (blocking antibody; 
c-d) treated kidney explants. (e-i) Anti-Csf1r treated kidneys had (e) fewer 
macrophages (p < 0.0001), (f) reduced area (p = 0.0046), (h) more disconnected 
endothelial structures (p = 0.031), and (i) smaller endothelial structures (p = 0.029) 
relative to control treated kidneys (n = 5 fields of view; 1 field of view per biological 
replicate/kidney explant). (g) Vascular density (CD31+ area per field) did not 
significantly differ between groups (p = 0.077). All data were normally distributed 
(based on Kolmogorov-Smirnov normality testing). Groups were compared using two-





In Results Chapter 3, I investigated macrophages in the developing kidney. 
While previous studies have focused on tracing macrophage lineages in the 
developing and adult kidney, I explored differences in the arrival, localisation, 
heterogeneity, and functions of these cells during organogenesis. My results 
are consistent with previous lineage tracing studies and provide new links 
between macrophage origins/subtypes and their specific localisation/ 
functions. 
Yolk sac-derived macrophage precursors are trafficked via the vasculature into 
embryonic tissue where they begin differentiating into mature macrophages 
from E9.5 without passing through a monocytic intermediate phase (Takahashi 
et al., 1989; Schulz et al., 2012; Mass et al., 2016; Stremmel et al., 2018). 
Here, I demonstrate that mature F4/80hi macrophages arrive adjacent to the 
emerging metanephric mesenchyme in high numbers between E9.5 and 
E10.5. Initially, macrophages avoid the metanephric mesenchyme; however, 
when the Six2+ nephron progenitor population splits, and the renal interstitium 
forms (at approximately E12), F4/80hi macrophages enter the kidney in high 
numbers. 
Early kidney macrophages are yolk sac-derived F4/80hi cells (Hoeffel et al., 
2015). These F4/80hi kidney macrophages are never intravascular, and I 
hypothesise that they begin entering the kidney via extravascular migration 
from the peri-Wolffian mesenchyme as the renal interstitium first forms. This 
could be tested, in part, by culturing Csf1rEGFP kidneys and using time-lapse 
imaging to assess macrophage migration in the absence of a functional 
circulation. This experiment would not eliminate the possibility that yolk sac-
derived macrophage precursors can enter the kidney via intravascular 
transport in vivo, but it would test whether macrophages are capable and 
inclined to migrate via extravascular routes into the kidney as the interstitium 
forms.  
Though few monocyte-derived cells are present in the early kidney, fetal 
monocytes arrive in high numbers from the fetal liver between E13.5 and E17.5 
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and can differentiate into mature macrophages, which persist and self-renew 
in situ in the adult kidney (Hoeffel et al., 2015). Based on my data, I suggest 
that these fetal monocytes and/or fetal monocyte-derived cells can be marked 
during development based on their high expression of Mac2, a member of the 
lectin family with wide-ranging functions (Rotshenker, 2009; de Oliveira et al., 
2015; Yang et al., 2017).  
Considering the overrepresented biological processes and cellular 
components in Mac2+ cells (based on the top 1% of expressed genes), it is 
likely that these are functional effector cells in the developing kidney. For 
example, genes associated with oxidative stress and bacterial response are 
overrepresented in Mac2+ cells. Since the embryo has long been believed to 
be sterile (Tissier, 1900), it is unclear why these cells would require anti-
bacterial gene expression. Perhaps these cells are priming themselves for 
postnatal life, or perhaps the embryonic environment is not as sterile as once 
thought, as is now being questioned (Wassenaar and Panigrahi, 2014; Perez-
Muñoz et al., 2017). 
Currently, there is little information regarding the roles of monocytes during 
development. Monocyte numbers dramatically increase later in kidney 
development and it is likely that their developmental functions will be 
particularly important later in organogenesis. Since fetal monocytes are 
present in high numbers in developing organs, and as they are distinct from 
macrophages (at least transiently), future studies should assess their roles in 
organogenesis. 
Notably, a subset of Mac2+ cells co-expressed CD206, a mature macrophage 
marker, at all ages examined; these cells may be converting from monocytes 
to macrophages. Indeed, Hoeffel et al (2015) demonstrated that fetal 
monocytes generate most macrophages in various organs, including the 
kidney.  
A limitation of the investigations of the Mac2+ and F4/80+CD206+ cells by single 
cell RNA sequencing was the low number of analysed cells. Nevertheless, it is 
likely that these data provide accurate depictions of true differences between 
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these cell subpopulations. To substantiate gene expression differences on a 
larger scale, and at the protein level, the levels of certain proteins of interest 
could be compared between the Mac2+ and F4/80+CD206+ cell populations 
using alternative methods, such as multi-colour flow-cytometry. 
In terms of macrophage functions in the kidney, it is unlikely that they facilitate 
the emergence of the earliest nephron progenitors or the Wolffian duct, as 
macrophages do not arrive until these cell populations are already present. 
Based on macrophage location at E10.5, however, they may clear rostral 
nephrogenic cells, so that only a single population of nephron precursors 
gather at the caudal-most end of the Wolffian duct. Rostral nephrogenic cells 
at E10.5 are highly apoptotic (personal communication with Andreas Schedl) 
and macrophages localise alongside these cells. Testing whether nephron 
progenitor condensation occurs normally in the absence of macrophages may 
illustrate whether macrophages are required for this process.   
An important finding of this chapter was that loss of macrophages results in 
abnormal kidney vascularisation in culture. While control-treated cultured 
kidneys had characteristic net-like vascular plexuses, the macrophage-
depleted kidneys formed relatively discontinuous endothelial structures. These 
data are consistent with findings that macrophages can facilitate vascular 
anastomoses in different biological settings (Fantin et al., 2010; Liu et al., 
2016). In the kidney, previous studies have shown that loss of Csf1r-
dependent macrophages results in decreased kidney growth (Sauter et al., 
2014), whereas gain in Csf1r-dependent macrophages enhances kidney 
growth (Alikhan et al., 2011). There is evidence that macrophages enhance 
renal branching morphogenesis and nephrogenesis in culture, which may 
explain macrophage-linked kidney growth in vivo (Rae et al., 2007; 
Muthukrishnan et al., 2017). Our studies add to these findings by 
demonstrating that macrophages also facilitate endothelial anastomoses in the 
cultured kidney.  
If the kidney is insufficiently vascularised in the absence of macrophages, this 
could lead to reduced oxygen and nutrient provision to the organ, restricting 
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renal growth. Although my data suggest that macrophage loss in culture leads 
to abnormal renal vascularisation, future studies should examine the 
consequences of kidney macrophage loss in vivo, where vascular 
development is also influenced by blood flow (Gebala et al., 2016). Moreover, 
the specific mechanisms of macrophage-mediated vascularisation should be 
explored. 
Based on the localisation and gene expression of kidney macrophages shown 
here, I speculate that, rather than secreting pro-angiogenic factors such as 
VEGF, macrophages may promote vascular cross-connections by remodelling 
the vascular basement membrane and extracellular matrix (based on high 
expression of genes such as the metalloproteinase, Adam15) and by acting as 
cellular chaperones and generating mechanical forces to pull endothelia 
together (as illustrated by Fantin et al., 2010; Liu et al., 2015). Future studies 
could begin investigating this by crossing endothelial and macrophage reporter 
mice and performing time-lapse imaging on cultured kidneys.  
Aside from promoting renal vascularisation, kidney macrophages can engulf 
erythrocytes during development, an activity that has not previously been 
associated with kidney macrophages. In the adult kidney, macrophages 
interact with blood vessels and survey vascular transport for small immune 
complexes (Stamatiades et al., 2016). During development, there are likely to 
be fewer immune complexes transported via the vasculature (as the embryo 
is thought to be relatively sterile; Tissier, 1900), but resident macrophages may 
nevertheless survey blood flow for various factors, such as maternal-derived 
antibodies that cross the placenta and damaged cells (e.g. erythrocytes). The 
observation that kidney macrophages engulf erythrocytes suggests that this is 
a more general capability of macrophages than previously recognised.  
I also demonstrated that macrophage density is reduced upon vascular 
depletion. Reduced macrophage density may due to loss of pro-proliferation 
and/or anti-survival signals in the absence of renal endothelia; however, this 
observation may be due to the use of pharmacological inhibitors at high 
concentrations, which may have off-target effects on other tyrosine kinase 
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receptors, such as Csf1r. Alternatively, this effect may be due to inhibition of 
Vegf signalling in fetal kidney macrophages. My single cell RNA-sequencing 
data suggest that macrophages in the E18.5 kidney do not express Vegf 
receptors, but I have not eliminated the possibility that Vegf receptors are 
expressed by macrophages at earlier developmental stages.  
My data also suggest that macrophage localisation in the renal interstitium is 
independent from endothelia, since macrophages remained interstitial in the 
absence of endothelia; however, macrophages may have remained in the 
interstitium due to attraction to signals derived from apoptotic endothelia. 
Future studies should use methods that do not rely on pharmacological 
inhibitors to explore the co-dependence of renal macrophages and endothelia 
during development. 
Collectively, these experiments detail the arrival and localisation of 
macrophages in the embryonic kidney and demonstrate the close relationship 
between macrophages and endothelia throughout renal organogenesis. 
Furthermore, these results demonstrate co-dependence between 
macrophages and endothelia, as loss of one cell type influences the 





Figure 4.2.22. Kidney F4/80hiCD206hi cells and Mac2hi cells. (a) Previous lineage 
tracing experiments revealed the origins of kidney macrophages. The results shown 
here provide new information regarding the arrival, localisation, heterogeneity, and 
functions of cells that engraft in the kidney from the different macrophage precursor 
waves. (b) Expanding diversity of cell types found within the cortical nephrogenic 
zone. The existence of macrophages and monocytes within the nephrogenic zone has 
not previously been established in detail. These cells may be implicated in 
nephrogenesis, interstitial development, branching morphogenesis, and 





5. Conclusion chapter 
5.1. Summary  
The initial aim of this thesis was to describe the patterning of blood vessels in 
the embryonic kidney. While most pertinent reviews agree that both blood 
vessel-generating mechanisms - angiogenesis and vasculogenesis - occur 
during kidney vascularisation, opinions are often inconsistent regarding the 
relative contribution of each mechanism. Thus, a major goal was to describe 
renal vascularisation in 3D throughout renal organogenesis and to evaluate 
evidence for each mechanism occurring. Unexpectedly, I found no evidence 
for vasculogenesis. Instead, my data were consistent with angiogenesis 
predominating throughout the fetal period of kidney organogenesis. From my 
studies of the renal vasculature, I propose a new model to explain blood vessel 
formation in the developing kidney (Section 5.2; also see Munro et al., 2017).  
My initial studies led me to investigate macrophages in the developing kidney. 
Macrophages have been associated with vascular development (Fantin et al., 
2010) and I wanted to explore whether they were required for kidney 
vascularisation. As little is known about macrophages in the developing 
kidney, I also examined their arrival, localisation, and heterogeneity. From this 
work, I described the arrival kinetics and tissue localisation of both mature 
macrophages and monocytic cells in the developing kidney. I also explored 
how macrophages and endothelia influenced each other in kidney culture. My 
results suggest co-dependence between these cells types: when 
macrophages were lost, there were fewer endothelial cross-connections; when 
endothelia were lost, macrophage numbers were reduced.  
Endothelia, monocytes, and macrophages are thought to arrive from extra-
renal sources during development (Kobayashi et al., 2014; Hoeffel et al., 2015; 
Section 5.4). Since blood vessels and phagocytic cells are important for renal 
organogenesis (Rae, Woods, Sasmono, Campanale, Taylor, Dmitry A 
Ovchinnikov, et al., 2007; Alikhan et al., 2011), my results may have significant 
implications for the generation of renal organoids (Takasato et al., 2015; 
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Iakobachvili and Peters, 2017), where the addition of cell types from extra-
renal sources is seldom considered (Section 5.5).   
5.2. A new model of kidney vascularisation 
From my investigations, I propose that the kidney becomes vascularised as 
outlined below: 
(1) Vessels in the peri-Wolffian mesenchyme, which connect to the 
circulation, form a ring around the ureteric stalk by E11 via 
angiogenesis, avoiding the Six2+ metanephric mesenchyme.  
(2) When the population of Six2+ nephron progenitors in the metanephric 
mesenchyme splits, and the renal interstitium forms (at approximately 
E12), the vessels ringing the ureteric stalk enter the kidney via 
angiogenic invasion of the interstitium.  
(3) By the time the nephrogenic zone forms, these interstitial vessels have 
reached the periphery of the kidney, where they begin forming 
polygonal plexuses (via angiogenesis) around the nephron progenitors 
in cycles throughout the remainder of kidney development (Figure 5.1).  
At all stages, these renal blood vessels are systemically connected and carry 
blood throughout the developing kidney tissue (except for newly forming 
angiogenic sprouts, which are systemically connected but not instantly blood 
carrying; Potente et al., 2011; Gebala et al., 2016).  
Notably, endothelia also pattern around nephrogenic precursor cells in the 
same way in the human kidney (based on data accessed from 
https://transparent-human-embryo.com; Munro and Davies, 2018), raising the 
possibility that this patterning mechanism is conserved. 
There are numerous questions relating to my new model of vascularisation 
that remain unresolved. For example, I did not determine whether all renal 
endothelial cells originate from the original endothelial vessels in the peri-
Wolffian mesenchyme (as noted by Mohamed and Sequeira-Lopez, 2018). 
Endothelial precursors within the metanephric mesenchyme may contribute to 
vascular plexus formation (Sims-Lucas et al., 2013; Mohamed and Sequeira-
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Lopez, 2018); however, even if this is the case, if these vessels are generated 
from pre-existing vessels (as my data suggest), then this would still, by 
definition, be angiogenesis (albeit a hybrid form of angiogenesis). Moreover, 
in later stages of kidney development, I only explored the vessels at the 
peripheral ‘vascular front’ (where new vessels actively form) and did not 
explore new vessel formation in non-peripheral kidney regions.  
My ‘angiogenesis-only’ hypothesis is based entirely on the development of the 
kidney in vivo and I do not claim that vasculogenesis does not occur in kidney 
organoids. 
 
Figure 5.1. New model of kidney vascularisation. (a) The first renal vessels form a 
ring around the ureteric bud stalk at E11. These vessels form (via angiogenesis) into 
the renal interstitium as it first forms, when the nephron progenitor population splits. 
These early vessels continue to migrate through the renal interstitium, avoiding cap 
mesenchyme populations. (b) By E13.5 the nephrogenic zone has formed. From here 
on, new blood vessels form in cycles as the ureteric bud branches at its tips, and the 
cap mesenchyme populations split. Based on my model, I propose that all of this occurs 
via angiogenic mechanisms.  
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5.3. Linking kidney vascularisation to F480hiCD206hi and Mac2hi cell 
arrival 
Macrophage precursor cells often enter developing tissues via intravascular 
transport (Stremmel et al., 2018) and my data suggest that monocytic cells are 
trafficked into the embryonic kidney in this way (Figure 4.2.16).  
Many Mac2hi are found within the interstitium and vasculature of the peripheral 
nephrogenic zone of the developing kidney (Figure 4.2.16). Previous studies 
have suggested that peripheral renal vessels form via vasculogenesis, before 
connecting with angiogenic vessels that have formed through the medullary 
portion of the kidney (Abrahamson, 2009; Bates et al., 2014; Stolz and Sims-
Lucas, 2014; Tufro and Gulati, 2015). It has also been suggested that these 
peripheral renal vessels do not carry blood (Rymer, Paredes, Halt, Schaefer, 
Wiersch, Zhang, D. Potoka, et al., 2014) and do not have a lumen (in rabbit; 
Kloth et al., 1997). Based on these views, it is challenging to conceive how 
monocytic cells would get from the fetal liver (Hoeffel et al., 2015; Rantakari et 
al., 2016) to these peripheral renal vessels without being carried there via the 
circulation. Based on my model of renal vascularisation, these peripheral 
vessels carry blood and are connected to the circulation, providing an 
explanation of how these monocytes/monocyte-derived cells can access the 
nephrogenic zone of the kidney from exogenous sources. 
Blood vessels carry different cell types, oxygen, nutrients, and growth factors. 
Based on pre-existing concepts, these factors would not be transported to the 
periphery of the developing kidney via the circulation. In contrast, my model 
suggests that blood-perfused vessels are always present in the renal periphery 
and that factors such as oxygen can be transported to this site. Tissue 
development and stem cell differentiation are regulated in part by blood-
derived factors (Simon and Keith, 2008) and it is possible that circulating blood 






5.4. Expanding our understanding of the nephrogenic zone 
The cortical nephrogenic zone is critical for renal organogenesis and has been 
extensively investigated. Within this zone, the relationship between nephron 
progenitor populations, the ureteric bud, and developing nephrons are 
relatively well understood (Herring, 1900; Short et al., 2014; Lindström, De 
Sena Brandine, et al., 2018). Furthermore, the requirements for Foxd1+ 
interstitial/stromal cells in the nephrogenic zone have been described (Hatini 
et al., 1996; Levinson et al., 2005; Das et al., 2013). In contrast, the diversity 
of cell types residing within the interstitium, and their specific functions, have 
not been explored in detail. Here, I have shown that many macrophages and 
blood vessels can be found within the cortical interstitium. How these cell types 
facilitate kidney organogenesis is largely unknown and there is ample scope 










Figure 5.2. Expanding our understanding of cell types within the cortical 
interstitium. I have shown that perfused blood vessels and macrophages reside within 
the cortical interstitium of the nephrogenic zone. There is evidence that these cell types 
all derive from extra-renal sources (Kobayashi et al., 2014; Hoeffel et al., 2015). 
Percentage values indicate the % of monocyte-like Mac2hi cells (blue) and % of 
F4/80hiCD206hi macrophages (green) that are in different regions of the nephrogenic 
zone (% is not relative to all cells within this region). For illustrative purposes, other 
interstitial cell types, such as pericytes, are not shown in this cartoon. RBC = red blood 
cell.  
 
5.5. What do these results mean for renal organoid generation?  
Due to kidney disease progressing into kidney failure, approximately 80% of 
individuals on the organ transplant waiting list in the United Kingdom require a 
kidney (based on NHS 2017/2018 statistics at 
https://www.organdonation.nhs.uk/). Scientists are pursuing new approaches 
to provide transplantable kidneys, with one long-term possibility being to build 
kidney organoids from the patient’s own cells for transplantation (Morizane and 
Bonventre, 2017).  
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A limitation of current kidney organoid models is that they do not generate 
accurate vascular systems that can enable the removal of unwanted material 
from blood. Recent studies have made advances in this area by transplanting 
kidney organoids into pre-vascularised hosts and relying on exogenous 
invasion of organoids by host-derived vessels (Xinaris et al., 2012; Bantounas 
et al., 2018; van den Berg et al., 2018); however, organoid maturation and 
vascularisation in culture must be enhanced before their potential therapeutic 
use may be realised.  
Endothelia, monocytes, and macrophages are important for renal development 
(Rae, Woods, Sasmono, Campanale, Taylor, Dmitry A Ovchinnikov, et al., 
2007; Alikhan et al., 2011) and are argued to have extra-renal origins 
(Kobayashi, Joshua W Mugford, et al., 2014; Hoeffel et al., 2015). A question 
that arises from these findings is: if these cell types primarily (or entirely) arise 
from exogenous sources in vivo, should this be recapitulated in kidney 
organoids to promote their maturation? Future studies should characterise the 
diversity of cell types present in pre-existing kidney organoid models and 
compare organoid maturation when immune cells and blood vessels are 
exogenously added to these systems.  
 
5.6. Final remarks 
                     ‘the true medium in which we live is neither air nor water, but the 
plasma or liquid part of the blood that bathes all the tissue elements.’ 
Homer W Smith (1953; From Fish to Philosopher;  
citing the physiologist, Claude Bernard) 
 
For homeostasis to be maintained, blood must journey through the kidneys 
throughout life. To allow for this, the integrity of the renal vascular architecture, 
which is arranged and defined during development, must be maintained 
throughout adulthood. Where renal vessels become faulty, kidney function 
declines, resulting in hypertension and the build-up of waste, fluids, and toxins 
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in the blood. Without intervention, this can lead to end-stage renal disease and 
death.  
Understanding renal vascular development may not be of much clinical use for 
the treatment of kidney disease but may be useful for disease prevention. 
Aspects of kidney development, such as nephron endowment, are determined 
developmentally, and low nephron number is associated with clinical outcomes 
such as hypertension and kidney disease in the adult (Brenner et al., 1988; 
Vehaskari et al., 2001; Hoy et al., 2005; Luyckx et al., 2011). If we can 
understand how to optimise the intrauterine environment to promote kidney 
vascularisation, it may be possible to encourage organogenesis to increase 
the kidney’s functional capacity and resilience to damage/disease in later life. 
Likewise, it may be possible to enhance kidney development and disease 
resistance by taking advantage of the pro-growth, pro-regenerative capabilities 
of fetal macrophages.  
Collectively, the work presented in this thesis increases our understanding of 
the morphogenetic events required for metanephric kidney vascularisation. 
Additionally, new links between immune cells and the vasculature during 
kidney development were uncovered. Immunovascular communication is 
poorly understood in organogenesis and many questions related to this topic 
are still to be addressed. As well as improving understanding of developmental 
processes, these results may provide fresh perspectives for better 
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Cycles of vascular plexus formation 
within the nephrogenic zone of the 
developing mouse kidney
David A. D. Munro  1, Peter Hohenstein  2 & Jamie A. Davies1
The renal vasculature is required for blood filtration, blood pressure regulation, and pH maintenance, as 
well as other specialised kidney functions. Yet, despite its importance, many aspects of its development 
are poorly understood. To provide a detailed spatiotemporal analysis of kidney vascularisation, 
we collected images of embryonic mouse kidneys at various developmental time-points. Here we 
describe the first stages of kidney vascularisation and demonstrate that polygonal networks of vessels 
(endothelial plexuses) form in cycles at the periphery of the kidney. We show that kidney vascularisation 
initiates at E11, when vessels connected to the embryonic circulation form a ring around the ureteric 
bud. From E13.5, endothelial plexuses organise around populations of cap mesenchymal and ureteric 
bud cells in a cyclical, predictable manner. Specifically, as the ureteric bud bifurcates, endothelia form 
across the bifurcation site as the cap mesenchyme splits. The plexuses are vascular, carry erythrocytes, 
are enclosed within a basement membrane, and can always be traced back to the renal artery. Our 
results are a major step towards understanding how the global architecture of the renal vasculature is 
achieved.
Adult mouse kidneys receive 9–22% of cardiac output1–3. Most of this blood travels into the glomerular capillaries 
in the renal cortex4, 5 where small molecules are filtered from the plasma. To filter blood, the kidneys must develop 
an extensive and intricately arranged vascular system during development, and the function and health of these 
vessels must be preserved throughout adulthood.
The development of the metanephric kidney begins at E10.5 when an epithelial tubule evaginates from the 
caudal portion of the Wolffian/nephric duct6. This epithelial outgrowth is the ureteric bud, a structure that devel-
ops into the ureter and collecting ducts of the adult kidney. The ureteric bud invades the metanephric mesen-
chyme (a mass of undifferentiated cells derived from the posterior intermediate mesoderm) at approximately 
E10.5-11, and starts to branch shortly thereafter. As it branches, progenitor cells within the metanephric mesen-
chyme are induced to differentiate. The nephrogenic progenitors, which are condensed around each ureteric bud 
tip (within the cap mesenchyme)7, 8, are prompted to undergo mesenchymal-to-epithelial transitions, resulting 
in the initiation of nephron formation. The inductive interactions between the ureteric bud and the cap mesen-
chyme are well understood9, but the mechanism by which endothelia organise alongside these cell types is less 
well characterised.
Blood vessels can form via vasculogenesis or angiogenesis. Vasculogenesis is the de novo formation of blood 
vessels via the differentiation and coalescence of endothelial precursors10, 11 and angiogenesis is the formation of 
new blood vessels via sprouting or splitting from pre-existing vessels12, 13. A major concept proposed to explain 
kidney vascularisation purports that the kidney is vascularised via a combination of vasculogenic and angiogenic 
processes14–18. According to this theory, blood vessels arise in situ via vasculogenesis around the periphery of the 
kidney from endogenous endothelial progenitors, whereas the endothelia of the major vessels and the medulla 
form via angiogenesis, by branching from extrinsic sources. Eventually, these angiogenic vessels are thought 
to communicate and connect with the vasculogenic vessels. Early support for this model came from Colberg 
(1863)19, who provided evidence for the existence of glomeruli not connected to the circulation, and Herring 
(1900)20, who proposed that blood vessels can develop endogenously in the kidney. More recently, this concept 
has been substantiated by studies that have identified endogenous endothelial and mural cell progenitors within 
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the metanephric mesenchyme21–25: this implies that the kidney has the potential to form blood vessels intrinsi-
cally. But this model of kidney vascularisation remains unproven, ambiguous, and somewhat controversial.
To better understand the relationship between endothelial and epithelial organisation during kidney devel-
opment, we analysed high-resolution images of normal CD-1 mouse kidneys that had developed in vivo from 
the initiation of metanephric organogenesis to birth. We demonstrate that the early embryonic kidney initially 
becomes vascularised via systemically connected blood vessels and that endothelia are patterned at the border 
of the kidney in a cyclical, non-stochastic manner. Collectively, these data provide a new conceptual model to 
explain how the renal blood vessels develop.
Results
The first renal blood vessels arise from a peri-Wolffian mesenchymal region and form a vascular 
ring around the ureteric bud stalk. Although previous studies have investigated the initial phases of kid-
ney vascularisation21, 25–28, the precise spatiotemporal origin of the first renal blood vessels remains unknown. By 
taking confocal images of whole-mount kidneys at various developmental time points with anti-CD31 (endothe-
lial marker) and anti-laminin (ureteric bud basement membrane marker), we have mapped the first steps of 
kidney vascularisation in the CD-1 mouse embryo.
The ureteric bud begins to develop at E10.5 as it evaginates from the Wolffian duct and invades the 
metanephric mesenchyme, marking the initial phase of metanephric organogenesis. Confocal z-projections of 
the E10.5 kidney show CD31+ capillaries to be present adjacent to the ureteric bud (Fig. 1A). At this time, the 
core of the presumptive metanephric mesenchyme is avascular, but scattered CD31+ endothelia, which have not 
connected to form vessels, can be detected around its border (Fig. 1B-B”), in agreement with previous reports26, 28.
The ureteric bud continues to extend from the Wolffian duct between E10.5 and E11.25 before undergoing its 
first bifurcation (forming a T-bud; Fig. 1C). By E11.25, CD31+ endothelial vessels have formed along the length 
of the ureteric bud and have arranged as a vascular ring around the top of the stalk (Fig. 1C,D). The metanephric 
mesenchyme remains predominantly avascular at this time, but it is notable that endothelial cell projections 
extend from the vascular ring towards the body of the kidney (Fig. 1C).
By E11.5, endothelial vessels had started forming within the metanephric mesenchyme: these vessels always 
entered the kidney from a capillary dense region that lies between the Wolffian duct and the metanephric mesen-
chyme, which we refer to as the peri-Wolffian mesenchyme (Fig. 1E-G”).
Considering the E11.5 ureteric bud as a ‘T’ shape, the cross-stroke of the ‘T’ elongated before its next round 
of branching initiated. While this elongation took place, many blood vessels had formed within the metanephric 
mesenchyme (Supplementary Fig. 1). Consequently, by E11.75 the metanephric mesenchyme was largely vascu-
larised, and 3D rendering showed that blood vessels were still connected to the blood vessels of the peri-Wolffian 
mesenchyme (in 8/8 kidneys analysed; Fig. 1H-H’). Moreover, blood vessels had developed in connection with 
the vascular ring surrounding the top of the ureteric bud stalk (Movie 1). By E12.5, blood vessels had formed 
throughout the metanephric mesenchyme (Fig. 1I-I”).
Collectively, these data demonstrate that the first renal blood vessels formed adjacent to the ureteric bud by 
E11.25, making a vascular ring around the top of the stalk. These vessels arose from the peri-Wolffian mesen-
chyme, and the entire metanephros was vascularised by E12.5.
The first renal blood vessels carry erythroid cells and connect to the embryonic circulation via 
the caudal and common iliac arteries. In congruence with our work, a recent study has demonstrated 
that the E11.5 embryonic kidney contains endothelial vessels26 but, to our knowledge, no studies have determined 
whether these early endothelial vessels are isolated or if they connect with larger vessels that are outside of the 
kidney.
To examine whether the first renal vessels are connected to the embryonic circulation, we immunostained the 
caudal regions of E11 and E11.5 mouse embryos for CD31 (endothelial marker), Gata3 (ureteric bud marker), 
and Six2 (cap mesenchyme marker) followed by tissue clearing with benzyl alcohol/benzyl benzoate (BABB) and 
confocal microscopy. At E11, the cranial pole of the kidney lies ventrally to the common iliac artery and the dorsal 
aspect of the kidney lies ventrolaterally to the caudal artery (Fig. 2A–D; Movie 2). The vascular ring had already 
formed around the ureteric bud stalk by E11 and it contained loose suspended cells that resembled erythroid cells 
(Fig. 2I,J; Movie 3). These loose suspended cells were also abundantly found within the major arteries. As BABB 
clearing does not act to remove the heme from haemoglobin, and because heme acts as a major chromophore 
under visible light29, 30, the observation of erythroid cells was unsurprising. These cells fluoresced under green 
and red light, so they appeared as yellow. We verified that these were erythroid cells by co-localisation analyses 
with the erythroid marker Ter119 (Supplementary Fig. 2). Additionally, conventional whole-mount staining for 
Ter119 at E11.5 and E12.5 verified that the early renal blood vessels carry red blood cells (Fig. 2K–M; Movie 4).
In the mouse embryo, primitive erythroblasts are gradually enucleated between E12.5 and E16.5, resulting in 
the generation of mature embryonic erythrocytes31, 32. In agreement with these studies, the Ter119+ cells within 
the E11.5 and E12.5 kidneys were nucleated (100% of Ter119+ cells were nucleated at E11.5 [n = 100 cells] and 
E12.5 [n = 100 cells]; for both ages, the 95% confidence intervals are ± 0.5%), indicating that they are primitive 
erythroblasts (Fig. 2K–M; Movie 4).
Scrolling through confocal z-planes of the caudal region of the E11 mouse demonstrated that the blood vessels 
of the vascular ring could be traced to either the caudal or common iliac arteries, so the vessels of the E11 kidneys 
must have been connected to the embryonic circulation (Movie 3).
By E11.5, the kidney had migrated caudally, and now lay directly ventrally to the common iliac artery (Fig. 2E–
H; Movie 5). Although the metanephric mesenchyme was predominantly avascular at E11.5 (with the exception 
of the blood vessels around the ureteric bud), it was completely surrounded by blood vessels (Supplementary 
Fig. 3). Confocal z-planes of the caudal portion of the E11.5 mouse demonstrated that the blood vessels around 
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Figure 1. Development of the first renal blood vessels. (A) At E10.5, CD31 expressing capillaries (arrowheads) 
are present adjacent to the ureteric bud (UB) and (B-B”’) the metanephric mesenchyme is surrounded 
by scattered endothelia. (C,D) By E11.25, Blood vessels had formed a vascular ring around the top of the 
ureteric bud stalk, and cell projections extended into the metanephric mesenchyme (arrowhead; D is a 3-D 
rendered version of C). (E) Cartoon representing the different tissue regions discussed in this section. (F) 
Immunostaining for Six2 in the E11.5 metanephric mesenchyme and peri-Wolffian mesenchyme illustrates 
that these tissue regions are distinct. (G-G”) By E11.5, blood vessels had begun to invade the metanephric 
mesenchyme, always entering from a peri-Wolffian mesenchymal region. (H-H’) Blood vessels continue to 
invade the metanephric mesenchyme by E11.75 from the peri-Wolffian mesenchyme (H’ shows the region 
in the blue box in H; white arrowheads in H’ show connection between peri-Wolffian and metanephric 
mesenchymal blood vessels). (I-I”) By E12.5, the metanephric mesenchyme is vascularised throughout. UB, 
ureteric bud; WD, Wolffian duct; MM, metanephric mesenchyme; PWM, peri-Wolffian mesenchyme. Scale 
bars: (A–E) = 100 µm; (G–M) = 50 µm.
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the ureteric bud connected to either the caudal or common iliac arteries (Supplementary Fig. 3C) and that these 
blood vessels contained erythroid cells (Movie 6).
Together, these data demonstrate that the blood vessels of the E11 and E11.5 kidneys are connected to the 
embryonic circulation via the caudal and common iliac arteries and that these blood vessels carry primitive 
erythroblasts.
Endothelial plexuses form around ureteric bud tips in the nephrogenic zone of the kidney. By 
E12.5, the metanephric mesenchyme is vascularised (Fig. 2M). At this point in development, a region termed 
the nephrogenic zone forms around the periphery of the kidney. Within this zone, ureteric bud tips undergo 
rounds of divisions with concomitant nephron induction and formation9. From E13.5 and throughout embry-
onic development, polygonal endothelial networks, or endothelial plexuses, surrounded ureteric bud ampullae 
in the nephrogenic zone (Fig. 3A–E). By performing area coverage quantifications and subsequent statistical 
testing, we determined that there was a decrease in the average size of the endothelial plexuses with embryonic 
age (P < 0.001; Fig. 3F). Using linear regression analyses, a slope value for the ‘best-fit’ line was calculated that 
indicated that the average endothelial plexus area decreased by 0.0011 mm2 every two days from E13.5 to P0 
(slope = −0.0011 mm2; 95% confidence interval = −0.0013 to −0.00076 mm2; r2 = 0.99). Additionally, there was 
a near perfect inverse-correlation between the average endothelial plexus size and embryonic age (r = −0.996; 
P < 0.01). We then examined the relationship between the rate of decrease of endothelial plexus areas and ampulla 
Figure 2. The E11 and E11.5 kidneys are vascularised by blood vessels that carry erythroid cells and connect to 
the caudal and common iliac artery. (A–D) E11 kidney and the surrounding tissue. (B) Rendered image from 
A, showing the E11 metanephric mesenchyme, ureteric bud, and Wolffian duct. (C) Rendered image from A, 
showing the location of the major blood vessels in relation to the kidney. (D) Cartoon illustrating the region 
displayed in A-C (dashed white box) in relation to the caudal part of the mouse embryo (kidneys in yellow). 
(E-H) E11.5 kidney and the surrounding tissue. (F) Rendered E11.5 kidney, from E. (G) Rendered kidney and 
major blood vessels, from E. (H) Cartoon illustrating the region displayed in E-G (dashed white box) in relation 
to the caudal part of the mouse embryo (kidneys in yellow). (I–L) Erythroid cell carrying blood vessels form a 
ring around the ureteric bud at E11 and E11.5. Arrowhead in J shows the vascular ring carrying erythroid cells. 
(M) The E12.5 kidney is vascularised by blood vessels carrying erythroid cells (inset image in M shows that 
the erythroid cells in the E12.5 kidney are nucleated). UB, ureteric bud; WD, Wolffian duct; MM, metanephric 
mesenchyme; PWM, peri-Wolffian mesenchyme. Scale bars: 100 µm.
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cell numbers (using data from ref. 33) across kidney development. Using a linear regression analysis, we did not 
find evidence that the slopes differ (p = 0.266; Fig. 3G).
Collectively, these results show that endothelial plexuses develop around ureteric bud tips throughout kidney 
development and that the area covered by endothelial plexuses decreases in a manner that corresponds to the 
decreasing cell numbers of ureteric bud ampullae during kidney development.
Endothelial plexuses spatially arrange around the cap mesenchyme. Newly formed ureteric bud 
ampulla are coated by a population of cap mesenchymal cells7. As an ampulla matures, it bifurcates, leading to the 
generation of two new ampullae. This division is matched by the splitting of the overlaying cap mesenchymal pop-
ulation so that each newly formed ampulla inherits a population of cap mesenchymal cells. Our confocal images 
demonstrate that, as the cap mesenchymal population splits, CD31+ endothelia form between the two daughter 
cap mesenchymal populations at the bifurcation site (Fig. 4A-A”’). Endothelia also neatly arranged around the 
outer boundaries of cap mesenchymal populations (Fig. 4A-A”’). By analysing individual z-plane images we noted 
that the CD31+ cells at the bifurcation site were in extremely close proximity to the ureteric bud. 3D rendering of 
confocal z-projections of the E17.5 kidney consistently indicated that the crossing vessel contacted the surface at 
the bifurcation site and appeared to distort the ureteric bud basement membrane along its course (Fig. 4B-B”’).
To examine how new plexuses form as the kidney expands, we counted the amount of endothelial projec-
tions that extended from the bifurcation point in comparison to the amount of endothelial projections that 
formed towards the bifurcation point in E17.5 kidneys. We found that 94.44% (s.e.m. = ±3.52%; n = 5 kidneys) 
of endothelial projections extended away from the bifurcation site (Fig. 4D–F). These projections extended before 
conjoining with other endothelia to form new vascular plexuses when the cap mesenchymal populations split 
(Fig. 4G–K). These findings demonstrate the timing of blood vessel development across the bifurcation site: that 
is, when the cap mesenchymal cells vacate this area, endothelia migrate across it. Endothelia project in the same 
orientation at E14.5 (Supplementary Fig. 4A–C), supporting the concept that this process is cyclical, reoccurring 
with each new generation of ureteric bud branching. Together, these data illustrate that the patterning of endothe-
lia within the nephrogenic zone relates to the arrangement of cap mesenchymal cells.
Endothelial plexuses form around the ureteric bud and cap mesenchyme in vitro. We inves-
tigated endothelial patterning in cultured E12.5 kidneys and re-aggregated kidneys to determine whether the 
patterning ‘rules’ we have shown in vivo are also obeyed in vitro. By culturing E12.5 kidneys for 2 and 4 days, we 
demonstrated that endothelial plexuses formed around the ureteric bud tips and cap mesenchymal populations in 
culture (Fig. 5A–D). Endothelia specifically formed plexuses around the epithelia of the ureteric bud, but not the 
Figure 3. CD31+ plexuses form around ureteric bud ampullae. (A–D) Plexuses form around ureteric bud 
ampullae from E13.5–P0. (E) Image illustrating the organisation of endothelial plexuses around ureteric bud 
tips at E17.5 (blend projection prepared using IMARIS; A = ampulla). (F) Decreasing size of endothelial 
plexuses with embryonic age. (G) Slopes showing the similarity in the rate of decrease of endothelial plexus 
area and the square root of cell numbers per ampulla across embryogenesis. Scale bars: (A–D) = 100 µm; 
(E) = 20 µm.
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Figure 4. Endothelial plexus patterning and cap mesenchymal dynamics. (A-A”’) Endothelia arrange around 
the border of the cap mesenchymal populations and form across the bifurcation site of the ureteric bud 
(arrowheads). (B-B”’) Endothelial vessels develop in contact with the basement membrane at the ureteric 
bud bifurcation site. B’-B”’ show 3-D rendered images produced from B. The CD31+ vessel crosses, and 
appears to distort, the basement membrane of the ureteric bud. (C) E17.5 kidney stained for CD31 and Six2. 
(D) Endothelia primarily send projections away from the bifurcation site (p = 0.0112; two-tailed Mann-
Whitney test; n = 5). (E,F) Cartoon illustrating what is meant by endothelia branching from versus towards 
the bifurcation site. (G,K) Representative images and cartoons illustrating our cyclical model of endothelial 
patterning that occurs each generation of ureteric bud branching and cap mesenchymal splitting. CM, 
cap mesenchyme; UB, ureteric bud; BP, bifurcation point. Scale bars: A-A”’ = 50 µm; B-B”’, (G–K) = 20 µm; 
C = 200 µm.
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epithelia of nephrons (Fig. 5C-C’). Additionally, Ter119+ erythroid cells were found within basement membrane 
enclosed vessels in the cultured kidneys, indicating that the vessels in culture were capable of carrying blood 
(Fig. 5E).
We then investigated if plexuses would form around ureteric bud tips and cap mesenchymal niches in kidneys 
re-aggregated from suspensions of renogenic stem cells (as produced in ref. 34), and determined that endothelia 
also pattern around ureteric bud tips and cap mesenchymal populations in this model (Fig. 5F).
These data show that endothelial plexuses formed around cap mesenchymal and ureteric bud cells in various 
in vitro models.
The plexus endothelia are vascular, erythrocyte carrying, enclosed by a basement membrane, 
and can be traced back to the renal artery. Since CD31 is a pan-endothelial marker35, it does not dis-
criminate between lymphatic or vascular endothelia. To examine if the endothelia are vascular, we performed 
co-localisation analyses of CD31+ cells with a specific marker of lymphatic endothelia (Lyve-1) and a typically 
vascular endothelial marker (Vegfr2). The plexus endothelia were Vegfr2+ (Fig. 6A,B), but Lyve-1− (Fig. 6C; E11.5 
yolk sacs were stained alongside kidneys as a positive control for anti-Lyve-1, Fig. 6D).
Previous work has shown that SCL/Tal1+ cells exist within the kidney and act as progenitors of blood cells 
and endothelia via haemovasculogenesis24. We examined whether any SCL/Tal1+ cells were present within the 
nephrogenic zone that might give rise to renal endothelia. We identified many SCL/Tal1+ nuclei within the 
nephrogenic zone. The nuclear SCL/Tal1+ staining always coincided with the fully differentiated CD31+ plexus 
endothelia, but we did not observe any SCL/Tal1+ cells that were not also CD31+ (Fig. 6E,F). Collectively, we 
Figure 5. Endothelial plexuses form around ureteric bud tips and the cap mesenchyme in vitro. (A) 
Representative images of an E12.5 + 2 days and (B) + 4 days cultured kidney. (C-C’) 4 days cultured kidney 
showing that plexuses formed in regions where ureteric bud tips are present, but not in regions devoid of 
ureteric bud tips. Note in C’ that endothelial plexuses do not form around the epithelia of the developing 
nephrons (green), they only form around ureteric bud epithelia (blue). (D) Endothelial plexuses formed around 
cap mesenchymal populations in culture. (E) Ter119+ erythroid cells were present in blood vessels in cultured 
kidneys. (F) Endothelia formed around cap mesenchymal populations in re-aggregated kidneys. Scale bars: 
100 µm.
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determined that the plexus endothelia are CD31+Vegfr2+Lyve-1−SCL/Tal1+, supporting the hypothesis that the 
plexus endothelia are vascular.
To provide further evidence that the endothelia are vascular, we examined whether erythroid cells were 
being carried in the vessels. The plexus vessels contained Ter119+ erythroid cells at E14.5 and E16.5 (Fig. 7A,B; 
Supplementary Fig. 4D). This was surprising as previous work had suggested that these peripheral vessels are of a 
vasculogenic origin, are predominantly non-perfused17, and do not have a lumen at this stage (in rabbit ref. 36). 
Therefore, we expected an absence of erythroid cells. Unlike the erythroid cells at E11.5 and E12.5, most erythroid 
cells at E16.5 were enucleated (94% were enucleated [n = 100 cells]; the 95% confidence interval is ±4.39%) which 
agrees with previous work showing that most erythroid cells have matured into primitive erythrocytes by this 
stage of mouse embryogenesis31, 32.
We lastly examined if the vascular plexuses were enclosed by a basement membrane. We found that a collagen 
IV basement membrane surrounded the vascular plexuses (Fig. 7C-C”’) and observed low levels of staining for 
the basement membrane marker laminin (Fig. 7C’; Supplementary Fig. 5; Supplementary Fig. 6).
Notably, at the various ages tested, all CD31+ endothelial cells could be traced to other CD31+ endothelial ves-
sels within the kidney, all the way back to the renal arteries (n = 50 traced vessels from E13.5–17.5; Movie 7). Even 
the most peripheral endothelia were connected to the pre-existing vasculature. Together, these results demon-
strate that the vascular plexuses contain erythrocytes, are enclosed by a basement membrane, and are connected 
to the pre-existing blood vessels.
Discussion
In this study, we took high-resolution images of whole-mount normal kidneys that had developed in vivo. By 
doing so, we provide a spatiotemporal analysis of endothelial development in the CD-1 mouse kidney from 
the initiation of its development to birth. This has improved our understanding of the first steps of kidney 
Figure 6. Characterisation of plexus endothelia. (A,B) Plexus endothelia are Lyve-1−. (C,D) Plexus endothelia 
are Vegfr2+. (E,F) Plexus endothelia are SCL/Tal1+. Due to high antibody background, the Despeckle tool in 
ImageJ was used to eliminate background signal in the Vegfr2 channel in C-D and the SCL/Tal1 channel in E-F. 
Scale bars: 100 µm.
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vascularisation, and has provided a conceptual model for endothelial patterning within the nephrogenic zone of 
the kidney.
The cyclical patterning of endothelial plexuses that we have shown during development (see Fig. 4G–K) will 
likely facilitate the proper assembly of the adult kidney’s vasculature. Future studies should investigate the con-
sequences of disrupting this patterning on adult kidney function. This patterning may also serve important roles 
in the development of other renal structures, such as nephrons. Oxygen promotes nephrogenesis17, 37, and the 
erythrocytes carried within the vascular plexuses may provide oxygen to drive nephron formation.
Our model of vascular plexus formation from pre-existing blood vessels is based on several findings. First, 
at no age did we observe any endothelia that were not already in connection with the pre-existing vasculature. 
Indeed, we show that even the most peripheral CD31+ endothelia can be traced all the way back to the renal 
artery. Second, SCL/Tal1+ endothelia were always also CD31+. Should vasculogenesis occur at the periphery of 
the kidney, we would expect to observe isolated SCL/Tal1+CD31− angioblasts within this region38. Third, the fact 
that the peripheral vascular plexuses were enclosed by a basement membrane and carried erythrocytes is more 
consistent with angiogenesis than with vasculogenesis. However, the erythrocytes within the plexuses could arise 
in part, or entirely, via haemovasculogenesis24, 39, rather than being transported there via the circulation.
A major finding of this study is that endothelia do not enter the Six2+ cap mesenchyme, and instead arrange 
around it. Even prior to E11.5, when the entirety of the metanephric mesenchyme is Six2+, endothelia arrange 
around, rather than through this population of cells (possibly explaining why the metanephric mesenchyme 
remains avascular at its earliest stages, despite it being surrounded by blood vessels). This may be a result of the 
Figure 7. The vascular plexuses contain erythrocytes and are enclosed by a collagen IV+ and lamininlow 
basement membrane. (A,B) Plexus endothelia carry Ter119+ erythrocytes. Due to high antibody background, 
the Despeckle tool in ImageJ was used to eliminate background signal in the Vegfr2 channel. (C-C”’) The 
vascular plexuses are collagen IV+ and lamininlow in E16.5 kidneys. (D) Cartoon depicting the side-view of the 
ureteric bud surrounded by cap mesenchymal populations and vascular plexuses. Scale bars: 100 µm (except for 
B, where it represents 50 µm).
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cap mesenchyme releasing an anti-angiogenic signal, or signals, that inhibit endothelial migration into the cap 
mesenchyme. Exposing the underlying mechanisms of endothelial patterning around the cap mesenchyme will 
greatly enhance our understanding of how the complex architecture of the renal vasculature develops.
Another intriguing result is that endothelial vessels form across, and it contact with, the bifurcation site of the 
ureteric bud (when the ureteric bud branches, and the cap mesenchymal populations split). In many branching 
organs, cell types that cross the bifurcation site play important roles in controlling branching stereotypy through 
a mechanical or signalling role40–42. It is possible that the crossing endothelia may play a similar role in ureteric 
bud branching in the kidney.
A long-standing question concerning kidney vascularisation is, whether the blood vessels form through 
angiogenesis, vasculogenesis, or a combination of both. In culture, the potential for extrinsic blood vessels to 
invade the kidney is eliminated, and factors that drive angiogenesis, such as blood flow43, can no longer influence 
endothelial organisation (perhaps explaining why glomeruli are predominantly avascular in culture)44, 45. Thus, 
kidney culture conditions might not offer an appropriate environmental milieu to study blood vessel formation, 
as it would seemingly thwart angiogenesis. However, we and others have shown that endothelia from the early 
embryonic kidney can survive in culture25, 46, and live tracing experiments of cultured kidneys from endothe-
lial cell-specific Tie1Cre;R26RYFP reporter mice illustrated that vessels develop from the pre-existing endothelia 
through a mechanism that is consistent with sprouting angiogenesis25.
In support of renal vascularisation by angiogenesis, cross-transplantation experiments have consistently indi-
cated that the kidney can attract the invasion of extrinsic blood vessels47–49. However, these studies did not exam-
ine whether endogenous vessels were also developing de novo, so were weighed against revealing vasculogenesis.
Other cross-transplantation studies have focused on investigating the kidneys ability to form blood vessels 
intrinsically by probing for specific genetic markers of endogenous endothelia24, 28, 47. In these studies, donor ves-
sels developed, and often these vessels were assumed to form via vasculogenesis, as the transplanted donor kid-
neys were believed to be avascular at the time of grafting (for example, E12 kidneys26, 28, 47, 50 and E12.5 kidneys24). 
However, based on our results, the transplanted kidneys would already have formed endothelial vessels prior 
to transplantation. In reality, it would be extremely difficult to transplant an embryonic kidney at any age (with 
the metanephric mesenchyme and ureteric bud) without also transplanting contaminating donor endothelia, as 
noted by Loughna et al.21. As the endothelia in the kidney are clonal51, it is possible that the pre-existing donor 
endothelia could have survived and contributed to blood vessel formation via angiogenic processes, rather than 
via vasculogenesis. This might explain why chimeric endothelial vessels, with host and donor endothelia, are often 
observed in cross-transplanted kidneys14, 26, 28, 52.
Regardless of the process of blood vessel formation, there is convincing evidence that endogenous endothelial 
cells do exist within the kidney22, 24, 25, and our results do not eliminate the possibility that vasculogenesis may 
contribute to the renal vasculature in some as yet undetermined way.
An example of a renal cell type with the capacity to differentiate into endogenous endothelia are the Foxd1+ 
stromal cells22, 25. Within the nephrogenic zone, vascular plexus formation occurs within the Foxd1+ populations 
of cells22. Perhaps the Foxd1+ cells that become endothelial are induced to differentiate and are recruited into the 
developing vascular plexuses via a process that combines angiogenic (vessels forming from pre-existing vessels) 
and vasculogenic principles (differentiation, migration, and coalescence of endogenous endothelia).
Overall, we show that the first blood vessels enter the kidney from capillaries situated within a peri-Wolffian 
mesenchymal region. We suggest that these vessels migrate to the periphery of the kidney by ~E12 and start 
organising as vascular plexuses around the ureteric bud/cap mesenchyme as the nephrogenic zone forms. As 
rounds of ureteric bud branching take place, new plexuses form cyclically throughout the remainder of embryo-
genesis. Future studies should examine the exact molecular mechanisms of vascular plexus formation and inves-
tigate how the plexuses are remodelled as the kidney develops.
Methods
Animals. Embryonic tissues were obtained from healthy CD-1 mice that were killed by qualified staff of 
the UK Home Office-licenced animal house following the guidelines set under Schedule 1 of the UK Animals 
(Scientific Procedures) Act 1986. All experiments were approved by the University of Edinburgh and performed 
in accordance with the institutional guidelines and regulations.
Dissection and organ culture. Embryonic kidneys were dissected using methods previously described53. 
For studies of normal development, kidneys were processed for immunofluorescence directly after dissection. For 
culture experiments, dissected kidneys were placed in Saxén-style culture54 for up to 4 days. Briefly, kidneys were 
placed on polycarbonate membrane filters (5 µm pores; Sigma, P9699-100EA), with these filters being supported 
by a metal grid in 35 × 10 mm culture plates (Greiner, 627–160). Kidneys were cultured in 2–2.5 ml of kidney 
culture medium (Minimum Essential Medium Eagle [Sigma, M5650] supplemented with 1% penicillin/strepto-
mycin [Sigma, P4333] and 10% foetal calf serum [Invitrogen, 10108165]). Kidneys were grown at 37 °C in a 5% 
CO2 environment. Medium was changed every 48 hours.
Generation of re-aggregated kidneys. Re-aggregated kidneys were generated as previously described34. 
Briefly, eight E11.5 kidneys were dissected and pooled. The pooled kidneys were trypsinised for 1 min at 37 °C 
in a 5% CO2 environment. Cells were manually dissociated and passed through a 40 µm pore sized cell strainer 
(Falcon, 352340). The dissociated cells were pelleted by centrifugation for 1 min 30 secs at 3000 RPM, and placed 
in Saxén-style culture for the indicated times. The ROCK inhibitor, glycyl-H1152-dihydrochloride (1.25 µM), was 
added to the medium for the initial 24 hours of culture.
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Conventional whole-mount immunofluorescence. Kidneys were fixed in methanol (pre-cooled at 
−20 °C) for 1 hr. Kidneys were then rinsed in 1x PBS (3 × 30 mins), and blocked with 1x PBS with 5% BSA 
(Sigma, A9647) and 10% donkey serum (Sigma, D9663) for 1 hr-overnight. Kidneys were incubated with primary 
antibodies overnight at 4 °C (for antibody information see Supplementary Table 1). Kidneys were then rinsed 
in 1x PBS (3 × 1 hr) and subsequently incubated in secondary antibodies for 2–4 hrs at room temperature or 
overnight at 4 °C. Finally, kidneys were washed in 1x PBS (4 × 1 hr), before being mounted onto glass slides using 
Vectashield (Vectorlabs, H1000) as a mounting medium.
BABB clearing whole-mount immunofluorescence. Samples were fixed in Dent’s bleach for 2 hrs, 
then stored in Dent’s fixative at −20 °C. Samples were washed with 1x PBS-T (3 × 30 mins) and blocked with 1x 
PBS-T with 5% BSA, 10% donkey serum, and 5% DMSO (AppliChem, A3672-0100) overnight. Samples were 
incubated with primary antibodies diluted in the blocking buffer for 1–5 days at 4 °C. Samples were then washed 
in 1x PBS-T for 3 × 2 hrs. Samples were subsequently incubated in secondary antibodies for 24 hrs at 4 °C diluted 
in the blocking buffer, were washed for 4 × 1 hrs with 1x PBS-T, and dehydrated in a series of 15 min methanol 
dehydration steps (20%, 50%, 75%, and 100%). They were then cleared in a glass vial in 50% BABB (1:2 benzyl 
alcohol/benzyl benzoate)/Methanol and then 100% BABB until transparent. Finally, samples were mounted onto 
a slide and covered with a drop of BABB prior to imaging.
Imaging. Images were generated using the Nikon A1R confocal microscope with NIS elements software. 
Objectives of 4–60x were used. The objective lens was oil-immersed from 40x upwards. ImageJ (FIJI) and 
IMARIS were used to process and analyse images.
Vascular plexus area measurements. The area covered by each vascular plexus was defined using the 
freehand selections tool in ImageJ. Using this tool, each region was traced three times and the mean of the three 
measurements (determined using Analyse > Measure) was taken as the area covered by that vascular plexus. 
Subsequently, the area of each vascular plexus at each embryonic age was pooled so that a mean could be cal-
culated and compared for each age. To compare the decrease in plexus area to the decrease in ampulla size, the 
square root of the number of cells per 3-D ampulla (using data from ref. 33) was related to the area calculation.
Statistical analyses and data presentation. For the vascular plexus area studies, D’Agostino-Pearson 
omnibus normality tests were used followed by a one-way ANOVA with the post-hoc Tukey’s Multiple 
Comparison Test. For the directionality of endothelial migration study, a two-tailed Mann-Whitney 
test was employed. 95% confidence intervals for percentage counts were calculated using the formula 
t = 1.64SQRT(pq/n) + 1/2n, where t is the 95% confidence interval, p is the proportion positive, q is 1−p, and n 
is the number examined. GraphPad prism (version 5) was used for data analyses and graph preparation. Adobe 
illustrator CC 2015 was used to prepare figures. IMARIS (version 8.2.1) and Adobe premiere pro CC 2015 were 
used to prepare videos.
Data availability. The datasets generated and analysed during the current study are available from the cor-
responding author on reasonable request.
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PATTERNS & PHENOTYPES
Refuting the Hypothesis that Semaphorin-3f/Neuropilin-2
Exclude Blood Vessels from the Cap Mesenchyme in the
Developing Kidney
David A.D. Munro ,1* Peter Hohenstein,2 Thomas M. Coate,3 and Jamie A. Davies1
1Centre for Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom
2The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom
3Georgetown University, Department of Biology, Washington, DC
Background: During murine kidney development, new cortical blood vessels form and pattern in cycles that coincide with
cycles of collecting duct branching and the accompanying splitting of the cap mesenchyme (nephron progenitor cell popula-
tions that “cap” collecting duct ends). At no point in the patterning cycle do blood vessels enter the cap mesenchyme. We
hypothesized that the exclusion of blood vessels from the cap mesenchyme may be controlled, at least in part, by an anti-
angiogenic signal expressed by the cap mesenchyme cells. Results: We show that semaphorin-3f (Sema3f), a known anti-
angiogenic factor, is expressed in cap mesenchymal cells and its receptor, neuropilin-2 (Nrp2), is expressed by newly forming
blood vessels in the cortex of the developing kidney. We hypothesized that Sema3f/Nrp2 signaling excludes vessels from the
cap mesenchyme. Genetic ablation of Sema3f and of Nrp2, however, failed to result in vessels invading the cap mesenchyme.
Conclusions: Despite complementary expression patterns, our data suggest that Sema3f and Nrp2 are dispensable for the
exclusion of vessels from the cap mesenchyme during kidney development. These results should provoke additional experi-
ments to ascertain the biological significance of Sema3f/Nrp2 expression in the developing kidney. Developmental Dynamics
246:1047–1056, 2017. VC 2017 Wiley Periodicals, Inc.
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Introduction
In his Collected Essays, T.H. Huxley referred to “The great tragedy
of science—the slaying of a beautiful hypothesis by an ugly fact.”
This report describes just such a slaying, of a hypothesis about
how the arrangement of blood vessels is controlled in the devel-
oping kidney.
The major function of the adult kidney is to filter blood. Blood
enters the kidneys via the renal arteries before being transported
to the glomerular capillaries, where small molecules are filtered
into the Bowman’s capsule. After filtration, useful molecules are
reabsorbed by tubular cells and collected by peritubular capillar-
ies, while waste and toxins are excreted as urine. This task
requires a complex vasculature that must be assembled accurately
during development.
Mouse metanephric (permanent) kidney development begins at
embryonic day (E) 10.5, when the ureteric bud, the precursor of
the collecting duct and ureter, evaginates from the caudal end of
the Wolffian/nephric duct in response to glial cell line–derived
neurotrophic factor (GDN) (Sainio et al., 1997; Costantini and
Kopan, 2010). The ureteric bud invades a mass of undifferentiated
cells, the metanephrogenic mesenchyme, and begins to branch.
As the ureteric bud branches, it induces nephron formation by
provoking groups of nephron progenitor cells to undergo
mesenchymal-to-epithelial transitions (Carroll et al., 2005). The
nephron progenitor cells reciprocate by inducing branching of
the ureteric bud (Majumdar et al., 2003; Costantini and Shakya,
2006; Cebrian et al., 2014). Prior to their differentiation, nephron
progenitor cells situate around ureteric bud tips in cell popula-
tions known as the cap mesenchyme (they “cap” the ureteric tips)
(Reinhoff, 1922). As the ureteric bud bifurcates, the overlaying
cap mesenchymal population splits so that each new ureteric tip
inherits a population of cap mesenchymal cells; this occurs in
cycles throughout kidney development (Short et al., 2014).
Recently, we have shown that blood vessels pattern in cycles
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of the ureteric bud in the developing kidney (Munro et al., 2017).
Vascular plexuses form around the cap mesenchyme, but they do
not enter it. As the cap splits, endothelia migrate through the fis-
sure to form new vascular plexuses. The mechanism by which
this happens is not understood, but we hypothesized that at least
part of the pattern, the avoidance of the cap mesenchyme by the
vasculature, may arise through the cap mesenchyme expressing
anti-angiogenic signaling molecules.
Certain class-3 semaphorins have a known capacity to act as
anti-angiogenic signaling molecules. An example is semaphorin-
3f (Sema3f) (Bielenberg et al., 2004; Guttmann-Raviv et al., 2007;
Parker et al., 2010; Buehler et al., 2013; Guo et al., 2013).
Although classically thought of as an axonal guidance molecule,
Sema3f is highly expressed in multiple non-neuronal organs dur-
ing development, such as the skin, lung, and kidney (Giger et al.,
1998). Its functions in these tissue types are poorly understood.
In vascular development, Sema3f inhibits angiogenesis by
interacting with its receptors on the endothelial cell membrane
neuropilin-1 (Nrp1), its low-affinity receptor, and neuropilin-2
(Nrp2), its high-affinity receptor (Guo et al., 2013; Sakurai et al.,
2012). Sema3f/Nrp signaling results in the suppression of endo-
thelial cell survival, proliferation, and migration (Guttmann-
Raviv et al., 2007; Procaccia et al., 2014; Nakayama et al., 2015).
Here, we characterize the expression patterns of Sema3f, Nrp1,
and Nrp2 in the developing kidney. We show that they are
expressed in a manner perfectly compatible with the hypothesis
that they mediate exclusion of vasculature from caps, but go on
to show that they are not, in fact, required for this aspect of vas-
cular plexus patterning.
Results and Discussion
Selection of a Cap Mesenchyme-expressed
Anti-angiogenic Candidate Gene
We previously demonstrated that renal endothelia pattern
around, but do not enter, the cap mesenchyme in the nephrogenic
zone of the developing kidney (Munro et al., 2017) (Fig. 1A). Pat-
terning occurs in cycles throughout most of embryonic kidney
development, and we hypothesized that anti-angiogenic signals
produced by the cap mesenchyme might be responsible for it
being avascular. To test this, we generated a list of criteria to be
met by cap mesenchyme–expressed candidate genes whose pro-
teins might inhibit angiogenesis (Fig. 1B). We reviewed the litera-
ture to produce a list of 39 known anti-angiogenic genes and





















Fig. 1. Selection of Sema3f as a candidate gene for vascular plexus patterning in kidney development. A: Cartoons portraying the relevant cell
populations in the nephrogenic zone of the kidney (modified GUDMAP cartoons). Note that the vasculature forms within the nephrogenic intersti-
tium and around the cap mesenchyme. B: Criteria for candidate gene selection. C: GUDMAP microarray heat map data showing the expression
of the top three anti-angiogenic candidate genes by the cap mesenchyme at E15.5 and P0–P4 (reproduced under the terms of the GUDMAP
license for re-use). D: Expression of the top three candidate genes in the nephrogenic interstitium at E15.5 (relative to the cap mesenchyme). E:
Expression of the receptors for Ism1 (Grp78 and Itgav) and Sema3f (Nrp1 and Nrp2) by various renal endothelial beds at E15.5.
1048 MUNRO ET AL.
Molecular Anatomy Project (GUDMAP) database (Brunskill et al.,
2008; Harding et al., 2011) to assess their relative expression in
the cap mesenchyme (Fig. 2). Of the genes investigated, isthmin-1
(Ism1), Sema3f, and suppressor of cytokine signaling-3 (Socs3)
met our initial criteria as candidate genes, as they are highly
expressed in the cap mesenchyme during the embryonic (E15.5)






















Fig. 2. Microarray heat map data from GUDMAP showing the relative expression of anti-angiogenic genes by the cap mesenchyme at E15.5 and
P0–P4. This list of anti-angiogenic genes is not exhaustive. (Heat map data is reproduced under the terms of the GUDMAP license for re-use.)
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The next condition to be met was that the relative expression of the
gene had to be lower in the nephrogenic interstitium (which becomes
vascularized) than the cap mesenchyme (which does not); this was
true for all three of these candidate genes at E15.5 (Fig. 1D). The anti-
angiogenic function of the protein also had to be mediated through
cell non-autonomous signaling (i.e., via secretion from the cap mes-
enchyme or presentation on cap mesenchyme membranes so it can
exert its effect on the nearby endothelia). Socs3 is a stat-inhibiting
intracellular protein (Starr et al., 1997), and its anti-angiogenic effect
is endothelial-cell autonomous (Stahl et al., 2012; Rao et al., 2015); it
was therefore discounted as a possible candidate gene.
Ism1 and Sema3f are secreted proteins, and their anti-angiogenic
properties are exerted when they bind to their receptors on the endo-
thelial cell membrane: Receptor-ligand binding leads to the activation
of signaling pathways that prevent endothelial cell survival and prolif-
eration (Guttmann-Raviv et al., 2007; Xiang et al., 2011; Rao et al.,
2015). Consequently, the receptors for Ism1 and Sema3f would need
to be expressed in the plexus endothelia for them to transduce their
signals. The receptors for Ism1 are integrin alpha-V (Itgav; Zhang
et al., 2011) and 78 kDa glucose-regulated protein homolog (Grp78)
(Chen et al., 2014), and, based on microarray data, they were expressed
weakly in renal endothelia (Fig. 1E). In contrast, the expression of the
Sema3f receptors, Nrp1 and Nrp2, was high in renal endothelia (Fig.
1E). Based on these data, we further investigated the Sema3f/Nrp sig-
naling pathway in vascular patterning in the nephrogenic zone.
Complementary Expression Pattern of Sema3f and
Nrp2 in the Developing Kidney
The GUDMAP microarray data indicating that Sema3f is highly
expressed in the cap mesenchyme at E15.5 has been validated at
the RNA level by in situ hybridization of whole-mount kidneys
(data made available on GUDMAP by the McMahon lab) (Fig.
3A). Although GUDMAP has little data on renal Sema3f expres-
sion prior to E15.5, data from the Allen Brain Atlas (Lein et al.,
2007) show that Sema3f is also expressed in the kidney at E11.5
and E13.5 (Fig. 3B–C’). At the earliest stages of renal organogene-
sis (E10.5–E11.5), the kidney is predominantly avascular, despite
being surrounded by blood vessels (Munro et al., 2017). As
Sema3f is expressed throughout the metanephrogenic mesen-
chyme at E11.5 (Fig. 3B–B’), its anti-angiogenic function could
prevent premature renal vascularization.
To investigate the localization of the Sema3f protein, we stained
whole-mount kidneys at E12.5 and E15.5 with anti-Sema3f. Kidneys
were cleared with benzyl alcohol/benzyl benzoate (BABB) prior to
imaging. At E12.5, Sema3f localizes in tubular epithelia (in agree-
ment with Villegas and Tufro, 2002) and in the presumptive cap mes-
enchyme (Fig. 3D). At E15.5, we assessed colocalization of Sema3f
with the cap mesenchyme marker integrin alpha-8 (M€uller et al.,
1997). Sema3f staining was not exclusive to the cap mesenchyme; it
was observed in tubular epithelia, the cap mesenchyme, and the
nephrogenic interstitium (Fig. 3E). This is unsurprising, as Sema3f is
a secreted protein whose localization is not restricted to the cell that
produces it. Indeed, Sema3f would be required to exit the cap to bind
to, and inhibit, endothelia in the nephrogenic interstitium.
To respond to Sema3f, the endothelia in the nephrogenic inter-
stitium would have to express either Nrp1, Nrp2, or both. Confo-
cal z-stack images of an E15.5 Nrp2-EGFP transgenic mouse
kidney, made available on GUDMAP by Steven Potter’s lab, indi-
cated that Nrp2 is expressed in proximal tubules and by an
unknown cell type within the nephrogenic interstitium (Supp.





















Fig. 3. Confirmation that Sema3f is expressed in the cap mesenchyme of the developing kidney. A: In situ hybridization images showing Sema3f
expression in the cap mesenchyme of the E15.5 kidney (from GUDMAP; submitted by the McMahon lab). B–C’: In situ hybridization images show-
ing Sema3f expression in the (B,B’) E11.5 and (C,C’) E13.5 kidney (image credit: Allen Institute). D: E12.5 kidney co-stained with anti-Sema3f and
anti-Gata3. Red blood cells are yellow (due to heme autofluorescence in the red and green channels as a result of tissue clearing). E: E15.5 kidney
co-stained with anti-Sema3f and anti-integrin alpha-8 (ITGA8). Negative control (secondary only) image was taken using identical microscope set-
tings. Scale bars¼ 100 mm (except B–C’, where scale bar values are stated).
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examined whether the Nrp2þ cells within the nephrogenic intersti-
tium were endothelial by co-staining with anti-Nrp2 and anti-CD31
(an endothelial marker). The Nrp2þ cells were endothelial and were
always present across the bifurcation site of the ureteric bud (42/42,
100%, CI95% 6 1.19%; n¼ 42 bifurcation sites analyzed in one kid-
ney) (Fig. 4A–C). Because new vascular plexuses form when endo-
thelial cells migrate away from the bifurcation site (Munro et al.,
2017; Fig. 4D), these Nrp2þ endothelia were situated in the precise
location we would anticipate for them to be responding to Sema3f.
Expression of Nrp1 and Nrp2 in the Developing Kidney
and Ureter
Studies suggest that Nrp1 and Nrp2 are differentially expressed
in arterial, venous, and lymphatic endothelia (Herzog et al.,
2001). Nrp2 is preferentially expressed in lymphatic vessels and
veins, whereas Nrp1 is expressed in arteries. We corroborated
these findings by co-staining Nrp1þ and Nrp2þ endothelia with
venous and lymphatic markers in the ureter (Fig. 5A–C’). The
Nrp2þ endothelia in the ureter are lymphatic and venous (based
on morphology [Fig. 5A], and as shown by co-staining with anti-
LYVE-1 [Fig. 5B] and anti-EphB4 [Fig. 5C], markers for lymph
and vein, respectively). The Nrp1þ endothelia in the ureter are
arterial (as shown by lack of co-staining with anti-Nrp2 and
anti-EphB4) (Fig. 5C’).
In the E11.5 and E12.5 kidney, almost all renal blood vessels
expressed Nrp2, but few vessels expressed Nrp1 (Fig. 6A,B). By
E13.5, Nrp1 had become highly expressed in renal arteries (Fig.
6C–E). The endothelial plexuses in the E13.5 kidney had many





















Fig. 4. Expression of Nrp2 by endothelial cells in the nephrogenic interstitium. A: Nrp2þ cells within the nephrogenic interstitium are endothelial. B: As
the cap mesenchyme splits, Nrp2þ endothelia are present at the bifurcation site where new vascular plexuses form (white arrowhead shows an example).
C: Nrp2þ endothelia are positioned around the cap mesenchyme. D: Cartoon illustrating the complementary expression pattern of Nrp2 and Sema3f in the
nephrogenic zone. Green arrowheads indicate the direction of endothelial migration as cap mesenchymal populations split. Scale bars¼ 100mm.
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the plexus endothelia expressed Nrp2 as well as Nrp1 (Fig. 6E,F).
Nrp2 is highly enriched in endothelial tip cells (Siemerink et al.,
2012). Based on the location of the Nrp2þ plexus endothelia at
the vascular front (the site of new blood vessel formation), we
speculate that these Nrp2þ cells are the endothelial tip cells in the
kidney; however, there are no known specific endothelial tip cell
markers to verify this hypothesis.
In the ureter, anti-Nrp2 staining is very strong in lymphatic
vessels (Fig. 5A–C). We next explored whether Nrp2þ lymphatic
vessels form within the kidney. To do this, we cleared whole-
mount E15.5 kidneys with BABB prior to imaging. We demon-
strate that Nrp2þ lymphatic vessels form rings around the ureter
and that these vessels connect with the lymphatic vessels in the
renal pelvis (Fig. 7A–B). In agreement with previous studies
(Tanabe et al., 2012), renal Nrp2þ lymphatic vessels extend along
the segmental vasculature from the renal pelvis (Fig. 7C). The
Nrp2þ lymphatic vessels in the kidney and ureter are in connec-
tion with a network of Nrp2þ lymphatic vessels that supply the
adrenal gland, gonad, mesonephros, and ureter (Fig. 7A; Supp.
Movie S2).
Sema3f and Nrp2 are not Required for Exclusion of
Endothelia from the Cap Mesenchyme
After confirming the complementary expression pattern of
Sema3f and Nrp2 in the nephrogenic zone, we tested the hypoth-
esis that their interaction repels endothelia from the caps. Genetic
ablation of Sema3f did not result in vessels entering the cap mes-
enchyme, as shown by co-staining for anti-Six2 (cap mesen-
chyme marker), anti-collagen IV (blood vessel and ureteric bud
basement membrane marker), and anti-CD31 (endothelial marker)
(Fig. 8A,C). Endothelial patterning was also normal in Nrp2-null
mouse kidneys (Fig. 8B,D), providing validation that signaling
through the Sema3f/Nrp2 pathway is not required for normal
vascular plexus patterning around the cap mesenchyme.
In conclusion, we have demonstrated that, although Sema3f
and its receptors (Nrp1/2) are expressed in a manner compatible
with the hypothesis that their interaction excludes endothelia
from the cap mesenchyme, signaling through the Sema3f/Nrp
pathway is not required for vasculature repulsion from the cap.
This lack of requirement for Sema3f and Nrp2 could be the result
of redundancy with another pathway, the result of compensatory
expression of other genes (such as other class-3 semaphorins) in
response to their loss, or show simply that they are not involved
in this aspect of vascular patterning.
We investigated the consequences of Sema3f and Nrp2 dele-
tion on vascular plexus patterning around the cap mesenchyme;
however, Sema3f is also expressed by tubular cells in the kidney
(Villegas and Tufro, 2002), and we have not eliminated the possi-
bility that tubular expression of Sema3f could guide blood vessel
patterning around nephrons/collecting ducts. Future studies
should aim to reveal the significance of Sema3f and Nrp2 expres-
sion in the development of the kidney.
Experimental Procedures
Databases
Cap mesenchyme-expression of anti-angiogenic genes was
examined using GUDMAP’s gene expression search tool (http://
www.gudmap.org/gudmap/pages/database_homepage.html). The
microarray heat map data for each gene was taken from the
“Developing Kidney (MOE430)” and “Developing Kidney (ST1)”
data sets (data retrieved May 2017). The normalized heat map
data (red indicating high expression, blue indicating low expres-
sion, and black indicating expression that is close to the median)
represent the binary logarithm of the average expression value of
a given gene across an entire data set. For each probe set, experi-
ments were performed in triplicate. Where there were two probe
sets available for the expression of a given gene, the probe set
with the most consistent data between replicate samples was
shown. Where there were more than two probe sets available for
the expression of a given gene, the probe set with the median val-
ues and/or color was chosen for the analysis. The in situ hybridi-
zation images showing Sema3f expression in the E15.5 kidney
was submitted by the McMahon group (data retrieved from GUD-
MAP in May 2017) and can be found at http://www.gudmap.org/
gudmap/pages/gene.html?geneId=MGI%3A1096347. The confo-
cal z-stack movie of the Nrp2-EGFP kidney was produced by the
Potter group and can be found at http://www.gudmap.org/
Resources/MouseStrains/Mouse_Strains_Summary.html under





















Fig. 5. Expression of Nrp1 and Nrp2 in the endothelia of the ureter. A:
Based on vessel morphology in the E18.5 ureter, veins (V; larger-diameter
vessel with loosely packed endothelia) are CD31þNrp2þ, whereas arter-
ies (A; smaller-diameter vessel with tightly packed endothelia) are
CD31þNrp2-. B–C’: Based on co-staining in the E18.5 ureter, (B) lym-
phatic vessels are Nrp2þLYVE-1þCD31þ, (C–C’) veins are
Nrp2þEphB4þNrp1-, and arteries are Nrp1þNrp2-EphB4-. Macrophages
(MF) are also present in B. A, artery; V, vein; LV, lymphatic vessel; MF,
macrophages. Scale bars¼ 100 mm.





















Fig. 6. Nrp1 and Nrp2 expression in the developing kidney. A–C: Expression of Nrp1 and Nrp2 by renal endothelia at E11.5–E13.5. D: Cartoons
illustrating the expression patterns of Nrp1 and Nrp2 and the position of the cap mesenchyme (CM) in the E11.5–E13.5 kidney. E–F: Nrp1 and
Nrp2 expression in plexus endothelia at (E) E13.5 and (F) E18.5. Scale bars¼ 100 mm.
Fig. 7. Nrp2 expression in lymphatic endothelia. A: A network of Nrp2þ lymphatic vessels surrounds the major arteries in the kidney, mesoneph-
ros, gonad, and adrenal gland (stitched confocal z-stacks; 2 2 tiles; 57 images per tile). B: Renal Nrp2þ lymphatic vessels connect with the
Nrp2þ lymphatic vessels in the ureter (representative image of n¼ 4 confocal z-stack images). C: Lymphatic vessels form alongside the segmental
vasculature. Red blood cells are magenta (due to heme autofluorescence in the red and blue channels as a result of tissue clearing). AG, adrenal





















Fig. 8. Sema3f and Nrp2 are not required for exclusion of blood vessels from the cap mesenchyme in the nephrogenic zone. A–B: Genetic abla-
tion of Sema3f had no effect on vascular patterning around the caps (representative images from n¼ 2–3 P0 mice; 4–6 kidneys per genotype; 9–
12 total fields of staining per genotype). C–D: Genetic ablation of Nrp2 had no effect on vascular patterning around the caps (representative
images from n¼ 1–3 E18.5 embryos; 2–6 total fields of staining per genotype). Asterisks in the genotyping gel images represent the embryos/pups
whose kidneys are shown in the representative images. Scale bars¼ 100 mm.
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retrieved from GUDMAP in May 2017). The in situ hybridization
images from the Allen Brain Atlas showing Sema3f expression at
E11.5 can be found at http://developingmouse.brain-map.org/
experiment/show/100093437 (section 12/20, accessed May
2017), and E13.5 can be found at http://developingmouse.brain-
map.org/experiment/show/100076578 (section 7/16, accessed
May 2017). Using the above Allen Brain Atlas links, renal Sema3f
expression can be observed in sections 11–13 and 16–17 of the
E11.5 mouse (out of 20 sections), and in sections 6–10 and 15–16
of the E13.5 mouse (out of 16 sections).
Mice
Wild-type embryonic tissues were obtained from CD-1 mice that
were killed by qualified staff of a UK Home Office–licensed ani-
mal house following the guidelines set under Schedule 1 of the
UK Animals (Scientific Procedures) Act 1986. Experiments were
approved and performed in accordance with the institutional
guidelines and regulations as set by the University of Edinburgh.
Tissue from P0 Sema3f knockout embryos was obtained from
Georgetown University facilities according to locally approved
procedures. The Sema3f mutant line was maintained in accor-
dance with the NIH Animal Care and Use Committee. The caudal
portions of euthanized P0 Sema3f mice were sent at 4 8C to the
University of Edinburgh, where the kidneys were dissected and
immunostained (for details, see Davies, 2006). The Sema3f
knockout mouse line has previously been described (Walz et al.,
2007). Sema3f mutant mice were bred for more than nine genera-
tions into a C57BL/6 genetic background (Charles River Laborato-
ries, Frederick, MD). Tissue from E18.5 Nrp2 transgenic mouse
embryos was kindly provided by Alex Kolodkin and Qiang Wang
(Johns Hopkins University). Nrp2 mutant mice were bred into the
C57BL/6 genetic background, and this mouse line has previously
been described (Giger et al., 2000).
Immunohistochemistry
Embryonic kidneys were dissected as previously described
(Davies, 2010). Kidneys were then fixed in methanol (pre-cooled
at -20 8C) for 1 hr. Fixed kidneys were either stored in methanol
at -20 8C (for up to 6 months) or directly processed following fix-
ation. Phosphate-buffered saline (PBS) was used to rinse off the
methanol from the kidneys (3 20 mins), and the kidneys were
blocked with 1PBS with 5% donkey serum (Sigma, D9663) and
2.5% bovine serum albumin (Sigma, A9647) for 1 hr–overnight.
Kidneys were incubated with the following primary antibodies
overnight at 4 8C: rat-anti-CD31 (1:100; BD Pharmingen;
550274), goat-anti-collagen IV (1:100; Merck Millipore; AB769),
rat-anti-EphB4 (1:100; Abcam; ab73259), rabbit-anti-laminin
(1:100; Sigma; L9393), rabbit-anti-LYVE1 (1:100; Abcam;
ab33682), rabbit-anti-Nrp1 (1:100; Abcam; ab81321), goat-anti-
Nrp2 (1:100; R&D Systems; AF567), mouse-anti-pan cytokeratin
(1:100; Sigma; C2562), rabbit-anti-Sema3f (1:100; Abcam;
ab39956), rabbit-anti-Six2 (1:250; Proteintech; 11562-1-AP),
and goat-anti-mouse-integrin alpha 8 (1:100; R&D Systems;
AF4076). Kidneys were then rinsed in 1 PBS (3 5 mins, then
3 1 hr) and subsequently incubated in Alexa Fluor–conjugated
secondary antibodies overnight at 4 8C (emission l of 350, 488,
594, 647; dilution of 1:200; Thermo Fisher Scientific). Finally,
kidneys were washed in 1 PBS (3 5 mins, then 4 1 hr) before
being mounted onto glass slides using Vectashield (Vector Labs;
H1000) as a mounting medium. BABB clearing whole-mount
immunofluorescence was performed as previously described
(Munro et al., 2017). BABB clearing was used for Figure 3D–E
and Figure 7.
Microscopy
Images were captured using the Nikon A1R and Zeiss LSM800
confocal microscopes. Objective lenses of 4–60were used
(lenses were oil-immersed from 40 upward).
Statistics and data presentation
95% confidence intervals for binary (yes/no) data were calculated
using the formula t¼1.64SQRT(pq/n)þ1/2n, where t is the 95%
confidence interval, p is the proportion positive, q is 1-p, and n is
the number examined. Imaris (version 8.3.1) and Adobe Premiere
Pro CC (2015) were used to prepare the supplementary movies.
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Sakurai A, Doçi CL, Gutkind JS. 2012. Semaphorin signaling in
angiogenesis, lymphangiogenesis and cancer. Cell Res 22:23–
32.
Short KM, Combes AN, Lefevre J, Ju AL, Georgas KM, Lamberton
T, Cairncross O, Rumballe BA, McMahon AP, Hamilton NA,
Smyth IM, Little MH. 2014. Global quantification of tissue
dynamics in the developing mouse kidney. Dev Cell 29:188–202.
Siemerink MJ, Klaassen I, Vogels IM, Griffioen AW, Van Noorden
CJ, Schlingemann RO. 2012. CD34 marks angiogenic tip cells in
human vascular endothelial cell cultures. Angiogenesis 15:151–
163.
Stahl A, Joyal JS, Chen J, Sapieha P, Juan AM, Hatton CJ, Pei DT,
Hurst CG, Seaward MR, Krah NM, Dennison RJ, Greene ER,
Boscolo E, Panigrahy D, Smith LE. 2012. SOCS3 is an endoge-
nous inhibitor of pathologic angiogenesis. Blood 120:2925–2929.
Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ,
Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. 1997.
A family of cytokine-inducible inhibitors of signalling. Nature 387:
917–921.
Tanabe M, Shimizu A, Masuda Y, Kataoka M, Ishikawa A,
Wakamatsu K, Mii A, Fujita E, Higo S, Kaneko T, Kawachi H,
Fukuda Y. 2012. Development of lymphatic vasculature and mor-
phological characterization in rat kidney. Clin Exp Nephrol 16:
833–842.
Villegas G, Tufro A. 2002. Ontogeny of semaphorins 3A and 3F and
their receptors neuropilins 1 and 2 in the kidney. Mech Dev 119:
S149–153.
Walz A, Feinstein P, Khan M, Mombaerts P. 2007. Axonal wiring of
guanylate cyclase-D-expressing olfactory neurons is dependent
on neuropilin 2 and semaphorin 3F. Development 134:4063–
4072.
Xiang W, Ke Z, Zhang Y, Cheng GH, Irwan ID, Sulochana KN,
Potturi P, Wang Z, Yang H, Wang J, Zhuo L, Kini RM, Ge R.
2011. Isthmin is a novel secreted angiogenesis inhibitor that
inhibits tumour growth in mice. J Cell Mol Med 15:359–374.
Zhang Y, Chen M, Venugopal S, Zhou Y, Xiang W, Li YH, Lin Q,
Kini RM, Chong YS, Ge R. 2011. Isthmin exerts pro-survival and
death-promoting effect on endothelial cells through alphavbeta5





















1056 MUNRO ET AL.
REVIEW
published: 25 October 2017
doi: 10.3389/fphys.2017.00837
Frontiers in Physiology | www.frontiersin.org 1 October 2017 | Volume 8 | Article 837
Edited by:
Alexander Staruschenko,




Vanderbilt University Medical Center,
United States
Hui Y. Lan,
The Chinese University of Hong Kong,
Hong Kong
*Correspondence:
David A. D. Munro
s1471287@sms.ed.ac.uk
Specialty section:
This article was submitted to
Renal and Epithelial Physiology,
a section of the journal
Frontiers in Physiology
Received: 14 September 2017
Accepted: 09 October 2017
Published: 25 October 2017
Citation:
Munro DAD and Hughes J (2017) The





The Origins and Functions of
Tissue-Resident Macrophages in
Kidney Development
David A. D. Munro 1* and Jeremy Hughes 2
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The adult kidney hosts tissue-resident macrophages that can cause, prevent, and/or
repair renal damage. Most of these macrophages derive from embryonic progenitors
that colonize the kidney during its development and proliferate in situ throughout
adulthood. Although the precise origins of kidney macrophages remain controversial,
recent studies have revealed that embryonic macrophage progenitors initially migrate
from the yolk sac, and later from the fetal liver, into the developing kidney. Once in
the kidney, tissue-specific transcriptional regulators specify macrophage progenitors into
dedicated kidney macrophages. Studies suggest that kidney macrophages facilitate
many processes during renal organogenesis, such as branching morphogenesis and
the clearance of cellular debris; however, little is known about how the origins and
specification of kidney macrophages dictate their function. Here, we review significant
new findings about the origins, specification, and developmental functions of kidney
macrophages.
Keywords: metanephros, renal, phagocyte, monocyte, ontogeny, branching morphogenesis, angiogenesis,
nephron
INTRODUCTION
Macrophages are specialized (“professional”) phagocytic cells that facilitate wide-ranging processes
in diverse species. As well as their roles in host immunity and inflammation, macrophages are
important in processes such as limb regeneration in salamanders (Godwin et al., 2013), stripe
formation and blood vessel repair in zebrafish (Liu et al., 2016; Eom and Parichy, 2017), and
synaptic pruning during brain development in the mouse (Paolicelli et al., 2011; Zhan et al., 2014).
Macrophages were first described in detail by Ilya Metchnikoff, who discovered their
ability to engulf, digest, and destroy cellular components from living and dead microbial and
host cells (Metchnikoff, 1905; Gordon, 2008). In 1924, the term “reticuloendothelial system”
was coined to describe the system of phagocytic cells and their antecedents (based on the
observation that phagocytes often form reticular networks around endothelia; Aschoff, 1924;
Yona and Gordon, 2015). Subsequently, in 1969, prominent immunologists decided that the term
“reticuloendothelial” was no longer adequate to describe this system; it was therefore relabeled
as “the mononuclear phagocyte system” to reflect increased knowledge about the functions and
morphology of monocytes, dendritic cells, and macrophages, and the derivation of these cells from
the bone marrow (van Furth et al., 1972; Yona and Gordon, 2015). More recently, the notion that
phagocytic cells derive chiefly from adult bone marrow-derived monocytes has been challenged,
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as evidence has accumulated showing that most adult tissue-
resident macrophages derive from embryonic macrophages
(Schulz et al., 2012; Hashimoto et al., 2013; Epelman et al., 2014a;
Hoeffel et al., 2015; Sheng et al., 2015).
The first data highlighting that macrophage precursors exist
in the yolk sac and fetal liver of the early embryo were published
over 40 years ago (Moore and Metcalf, 1970; Cline and Moore,
1972). We now have a detailed understanding of how these
cells contribute to various adult tissue-resident macrophage
populations, and there are many informative reviews on this
subject (Epelman et al., 2014b; Hoeffel and Ginhoux, 2015;
Varol et al., 2015; Ginhoux et al., 2016). However, no reviews
have focused specifically on describing the origins of kidney
macrophages. Moreover, limited information is available about
the functions of macrophages within the developing kidney.
Here, we provide a comprehensive overview of the available
data regarding the origins, specification, and functions of kidney
macrophages in renal development. In this review, we also relate
recent findings to emerging concepts in the field of macrophage




During embryogenesis, macrophages colonize developing organs
in overlapping waves (Schulz et al., 2012; Hoeffel et al., 2015;
Sheng et al., 2015). Due to their remarkable capacity to self-
renew in situ, many of these embryonic macrophages remain in
adult tissues (Merad et al., 2002; Ajami et al., 2007; Hashimoto
et al., 2013; Sieweke and Allen, 2013; Hoeffel et al., 2015). This
fact contradicts the long-held belief that adult tissue-resident
macrophages derive from, and are continually replenished
by, circulating monocytes (van Furth and Cohn, 1968; van
Furth et al., 1972). In this review, we describe tissue-resident
macrophage origins in the mouse, as there is a paucity of
information about their origins in the human.
The yolk sac provides the first wave of macrophages during
development, commencing at embryonic day 7 (E7), before
the embryonic circulation is established (Moore and Metcalf,
1970; Palis et al., 1999; McGrath et al., 2003). Erythro-myeloid
progenitors (EMPs) emerge from the blood islands and capillary
endothelia of the yolk sac (Kasaai et al., 2017). These cells
form independently of c-Myb, a master transcriptional regulator
of hematopoiesis (Sumner et al., 2000; Sandberg et al., 2005;
Gomez Perdiguero and Geissmann, 2013). Rather than passing
through an intermediate monocytic phase, c-Myb-independent
EMPs directly acquire a core macrophage transcriptional
programme and differentiate into pre-macrophages (pMacs)
before maturing into tissue-resident macrophages (Takahashi
et al., 1989; Schulz et al., 2012; Mass et al., 2016). At E8.5,
when the yolk sac vasculature connects with the embryonic
vasculature, these yolk sac macrophages migrate throughout
the embryo and enter tissues such as the early brain
and liver (Kierdorf et al., 2013; Gomez Perdiguero et al.,
2015).
From mouse E8.5, a second set of EMPs, which are c-
Myb-dependent, emerge from hemogenic endothelia in the yolk
sac (Hoeffel et al., 2015). Many of these EMPs travel through
the embryonic vasculature to colonize the fetal liver (McGrath
et al., 2015; Mass et al., 2016). Due to their rapid expansion
in the liver, by E11.5, the number of liver-EMPs exceeds the
number of yolk sac-EMPs by 25-fold (Gomez Perdiguero et al.,
2015). Concurrent with their expansion in the liver, the c-Myb-
dependent EMPs differentiate into monocytic intermediates
(Hoeffel et al., 2015) and/or into pMacs (Mass et al., 2016). To exit
the fetal liver, pMacs/monocytes must pass through diaphragms
in the fenestrae of liver sinusoidal endothelium (Rantakari et al.,
2016). Once through the diaphragms, they travel through the
vasculature to all embryonic tissues (except the brain, which is
now isolated by the blood-brain barrier). These fetal liver-EMPs
represent the second wave of macrophages during development.
Adding to the ontogenetic diversity, hematopoietic stem cells
(HSCs) are generated by hemogenic endothelium, primarily
in the dorsal aorta in the aorta-gonad-mesonephros region
(Medvinsky and Dzierzak, 1996; Yokomizo and Dzierzak,
2010). Fetal HSCs represent a third developmental wave of
macrophages contributing to tissue-resident macrophage pools
(Sheng et al., 2015). They enter the fetal liver from E10.5,
expand and differentiate into monocytic intermediates, and then
colonize tissues and mature into tissue-resident macrophages
(Kumaravelu et al., 2002; Kieusseian et al., 2012; Sheng et al.,
2015). During embryogenesis, HSCs also populate the bone
marrow and spleen, where they are maintained postnatally as
progenitors that can generate a constant supply of monocytes
that can be released into the circulation. These HSC-derived adult
circulating monocytes contribute to tissue-resident macrophage
pools during tissue homeostasis in specific organs, such as the
heart and intestine (Bain et al., 2014; Epelman et al., 2014a).
In cases of injury and/or inflammation, an organ will recruit
additional circulating monocytes that may worsen or limit the
damage inflicted on the tissue (Tsou et al., 2007; Li et al., 2008;
Shi and Pamer, 2011; Seok et al., 2013).
Recently, another bone marrow-derived source of adult
macrophage progenitors has been discovered (Audzevich et al.,
2017). These cells are bi-phenotypic early pro-B cells that
express both myeloid and lymphoid markers. Like HSC-
derived monocytes, early pro-B cells exit the bone marrow,
travel through the circulation, and contribute to certain tissue-
resident macrophage populations (such as in the peritoneum,
pleural cavity, and intestine) during tissue homeostasis and
inflammation (Audzevich et al., 2017).
Thus, in most adult organs, tissue-resident macrophages
derive from (1) fetal-generated macrophages that self-renew
in situ (descending from the waves of progenitors) and (2)
the engraftment of adult circulating macrophage progenitors
(Figure 1).
ORIGINS OF KIDNEY MACROPHAGES
From the start of kidney development to the end of life,
kidney-resident macrophages derive from all the progenitor
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FIGURE 1 | Overlapping waves of macrophage progenitor cells colonize the developing embryo. Wave 1: Yolk sac-derived erythro-myeloid progenitors (EMPs)
differentiate into pMacs and migrate through the early embryo. Wave 2: EMPs, derived from hemogenic endothelium in the yolk sac, enter the fetal liver. In the fetal
liver, EMPs expand and differentiate into pMacs and/or monocytes. pMacs/monocytes then egress from the fetal liver and travel through the vasculature into
developing organs. Wave 3: Haematopoietic stem cells (HSCs) from the aorta-gonad-mesonephros region also enter the fetal liver and contribute to resident
macrophage populations. Some HSCs migrate into the bone marrow and the spleen where they are maintained before being released into the bloodstream
postnatally as circulating monocytes that can contribute to tissue-resident macrophage populations. Early pro-B cells are also released from the bone marrow in
adulthood and can contribute to certain tissue-resident macrophage populations. Depending on where they engraft, macrophage progenitors start to express
transcriptional regulators that define their genetic programme in a tissue-specific manner. EMP, erythro-myeloid progenitor; HSC, haematopoietic stem cell; pMac,
pre-macrophage; Camera lucida drawings adapted, with permission, from illustrations by Perry (Gordon et al., 1988).
waves described above: early yolk sac EMP-derived macrophages
(Schulz et al., 2012; Hoeffel et al., 2015), fetal liver EMP-derived
macrophages (Epelman et al., 2014a; Hoeffel et al., 2015), HSC-
derived macrophages (Epelman et al., 2014a; Sheng et al., 2015),
and adult bone marrow-derived circulating monocytes (Jang
et al., 2013; de Cortie et al., 2014; Hoeffel et al., 2015; Sheng et al.,
2015). The relative proportion of progenitors from each wave,
however, changes dramatically throughout kidney development,
adulthood, and in periods of disease.
The mouse metanephric (permanent) kidney begins to
develop at ∼E10.5, when the ureteric bud (the precursor of
the collecting duct and ureter) emerges from the caudal end of
the Wolffian/nephric duct in response to glial cell-line-derived
neurotrophic factor (GDNF; Sainio et al., 1997). The ureteric
bud invades the metanephric mesenchyme, a cell population
comprised of nephron and stromal progenitors, and begins
to branch. Throughout kidney development, signals from the
metanephric mesenchyme induce further branching of the
ureteric bud (Sainio et al., 1997;Majumdar et al., 2003; Costantini
and Shakya, 2006). Simultaneously, ureteric bud branching
induces nephron formation (Carroll et al., 2005) and guides
vascular patterning (Munro et al., 2017).
There are no data regarding macrophage origins in the
E10.5-E12 mouse kidney, possibly because so few macrophages
are present in the kidney at this early developmental stage
(Rae et al., 2007). At E12.5, however, flow cytometry analyses
have revealed that kidney macrophages are yolk-sac EMP-
derived (CD45+CD11bloF4/80hiLy6C− cells). At this stage,
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FIGURE 2 | Contribution of yolk sac-derived and monocyte-derived macrophages to the embryonic and postnatal kidney. The trends shown in the yolk sac-derived
and monocyte-derived macrophage graphs are based on fate-mapping experiments by Hoeffel et al. (2015). Trends for the origins of brain macrophages (microglia),
which are yolk sac-derived, are shown as a comparison. Adapted with permission from Hoeffel et al. (2015).
FIGURE 3 | Multiple origins of kidney macrophages. Murine kidneys contain macrophages that are derived from multiple sources, with their relative proportions
fluctuating throughout development and adulthood. Based on the niche competition hypothesis of macrophage origins (Guilliams and Scott, 2017), we argue that the
mixed ontogeny of kidney macrophages is the result of kidney niches being both accessible and available to macrophage precursors throughout kidney development
and phases of adulthood. The “?” in some of the yellow bone marrow-derived monocytes denotes that we do not know whether these cells are maintained in the
kidney after the resolution of inflammation/disease. The increasing volumes of the cups represent the increasing capacity of the kidney to house macrophages.
no monocytes (CD45+CD11bhiF4/80loLy6C+ cells) are present
within the kidney (Hoeffel et al., 2015). In fate-mapping
studies with timed injections of hydroxytamoxifen (4′OHT) into
tamoxifen-inducible Runx1Cre/EYFP and Csf1rCre/EYFP mice (at
E7.5 and E8.5, respectively; to label yolk sac macrophages and
their progeny), the percentage of yolk sac-derived macrophages
in the kidney was found to decrease exponentially from E13.5 to
postnatal week 6 (Hoeffel et al., 2015). Runt-related transcription
factor 1 (Runx1) is expressed by yolk sac-derived macrophage
progenitors as they bud from hemogenic endothelium, and
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FIGURE 4 | Kidney macrophage specification. During development, the
tissue-specific signals that kidney macrophages are exposed to provoke the
expression of a unique array of transcriptional regulators. Compared to other
tissue-resident macrophages, kidney macrophages have increased expression
of transcriptional regulators such as Nfatc1, Nfatc2, Ahr, and Irf9. In adulthood,
macrophages are exposed to various exogenous stress signals because of
factors such as disease, diet, and infection. Based on the multidimensional
model of macrophage activation, a macrophage is specified by the integrated
effects of the endogenous and exogenous signals within its micro-anatomical
site. The macrophage colors are used to show the heterogeneity of
macrophage activation status in response to endogenous and exogenous
signals in the kidney. DAMPS, damage-associated molecular pattern
molecules; PAMPS, pathogen-associated molecular pattern molecules.
induction of labeling at E7.5 in Runx1Cre/EYFP mice leads to
specific EYFP-labeling of these cells (for details, see Hoeffel and
Ginhoux, 2015). Colony stimulating factor 1 receptor (Csf1r)
is expressed by all yolk sac-derived macrophage progenitors,
and induction of labeling at E8.5 in Csf1rCre/EYFP mice leads to
exclusive EYFP-labeling of these cells (for details, see Epelman
et al., 2014b; Hoeffel et al., 2015). These data agree with
the findings of Epelman et al. (2014a), who used similar
techniques (i.e., timed injections of 4′OHT into tamoxifen-
inducible Csf1rCre/GFP mice at E8.5) to show that yolk sac-
derived macrophages make a minimal contribution to the pool
of kidney macrophages by postnatal week 10. As yolk sac-derived
macrophages are highly proliferative (based on flow cytometry
analysis of Fucci-reporter embryos), and do not exhibit high
rates of apoptosis (based on Annexin-V labeling followed by
flow cytometry analysis), it has been speculated that this rapid
decrease in the proportion of yolk sac-derivedmacrophages must
be explained by their dilution by the marked later arrival of fetal
monocytes (Hoeffel et al., 2015; Figure 2).
Fetal monocytes begin to populate the mouse kidney by E13.5
(Epelman et al., 2014a; Hoeffel et al., 2015). Between E13.5
and E16.5, the proportion of monocyte-derived macrophages
within the kidney progressively increases, and rapidly exceeds
that of yolk sac-derived macrophages (Epelman et al., 2014a;
Hoeffel et al., 2015). Indeed, multiple studies have shown that
adult kidney macrophages are almost exclusively fetal monocyte-
derived (Epelman et al., 2014a; Hoeffel et al., 2015; Sheng et al.,
2015); however, it is not clear whether these monocytes are
generated from EMPs, HSCs, or a combination of both sources.
The precise origins of monocyte-derived kidney macrophages
have been explored using various fate-mapping mouse models.
In support of a HSC-derived source of adult kidneymacrophages,
Sheng et al. (2015) generated a tamoxifen-inducible c-KitCre/EYFP
mouse strain to fate-map the progeny of HSCs (all HSCs
express c-Kit and induction of labeling leads to specific EYFP-
labeling of these cells; for details, see Sheng et al., 2015);
by labeling cells at several time-points they concluded that
adult kidney macrophages derive from the HSC-precursor wave,
rather than from EMPs. However, as c-Kit is expressed by
EMPs as well as HSCs (Gomez Perdiguero et al., 2015), it
is unclear whether this mouse model can reliably distinguish
HSC-progenitors from EMP-progenitors (Hoeffel and Ginhoux,
2015). In another study by Epelman et al. (2014a), fate-mapping
experiments were performed using Flt3Cre/GFP mice. Flt3 is
expressed transiently by all HSCs (Boyer et al., 2011), so an
assumption of this model is that any monocyte/macrophage that
goes through a Flt3+ stage (Flt3Cre/GFP+) can be classed as HSC-
derived, whereas those that do not go through a Flt3+ stage
(Flt3Cre/GFP−) can be said to be HSC-independent. Epelman
et al. (2014a) demonstrated that recombination rates driven
by Flt3 in adult kidney macrophages were ∼50%, suggesting
that there is a large contribution from both HSC-derived
monocytes and HSC-independent, EMP-derived, monocytes to
the pool of kidney-resident macrophages (Epelman et al., 2014a).
Lastly, Hoeffel et al. (2015) determined that adult kidney
macrophages predominantly arise from late c-Myb+ EMP-
derived fetal monocytes. After injecting 4′OHT at E8.5 in the
tamoxifen-inducible Runx1Cre/EYFP fate-mapping mouse model,
EMPs and their progeny were efficiently labeled, while there
was only minor labeling of HSCs. Many of the labeled EMPs
reached the fetal liver, and a significant proportion of these cells
converted into the monocytes and macrophages that ultimately
colonize various developing organs such as the kidney (Hoeffel
et al., 2015). Together, these studies suggest that both EMP- and
HSC-derived monocytes enter the kidney to generate mature
kidney macrophages. However, the relative contribution of each
progenitor type remains unclear. To explain the incongruent
conclusions presented by these studies, further analyses of the
specific drawbacks and limitations of the various fate-mapping
models are necessary (as reviewed by Hoeffel and Ginhoux,
2015).
In adulthood, bone marrow-derived circulating monocytes
colonize the healthy kidney at low levels (Sheng et al., 2015).
When the kidney becomes diseased/inflamed/injured, monocyte
infiltration dramatically increases, as has been shown in multiple
experiments where the engraftment of bone-marrow derived cells
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FIGURE 5 | Functions of macrophages in kidney development. Processes including branching morphogenesis, cell proliferation/death (and clearance of cellular
debris), nephron formation, and vascular development (blood and lymphatic) are important in renal development. Few studies have directly investigated the roles of
kidney macrophages in these processes; however, based on available evidence, it is likely that macrophages will facilitate most, if not all, of these processes. Black
stars indicate the strength of evidence that macrophages function in each process in kidney development (0 stars, no direct evidence; 5 stars, very strong evidence).
was assessed in irradiated mice (Jang et al., 2013; de Cortie et al.,
2014; Hoeffel et al., 2015).
In summary, kidney macrophage origins are diverse: the
early kidney is colonized by yolk sac-derived macrophages, but
the resident macrophages in the early postnatal kidney are
predominantly derived from EMP- and HSC-derived monocytic
precursors (Figure 2). These fetal-generated macrophages self-
maintain throughout adulthood and are only partially replaced
by bone marrow-derived circulating monocytes.
WHAT DICTATES KIDNEY MACROPHAGE
ORIGINS?
Although macrophage origins clearly differ between organs
(Schulz et al., 2012; Hashimoto et al., 2013; Epelman et al., 2014a;
Hoeffel et al., 2015), the origin of a tissue-resident macrophage
does not seem to play a large role in determining its lifespan or
functions (van de Laar et al., 2016; Guilliams and Scott, 2017).
This begs the question, “why do macrophage origins differ?”
A recent hypothesis proposed to explain the differences in
macrophage origins between tissues is the niche competition
model, as proposed by Guilliams and Scott (2017). In this
model, macrophage precursors populate a niche depending on its
accessibility, its availability, and macrophage precursor plasticity.
As macrophage precursors are extremely plastic (van de Laar
et al., 2016; Guilliams and Scott, 2017), the question about
macrophage ontogeny comes down to niche accessibility (e.g., can
macrophage precursors access the organ via the circulation?) and
availability (e.g., are there unoccupied niches in this organ for
macrophage progenitors to exploit?).
Because the kidney is accessible to macrophage precursors
via the systemic circulation throughout most of embryonic
development (from ∼E11.5; Munro et al., 2017) and adult life,
it is unsurprising that kidney-resident macrophages derive from
multiple waves of progenitors (Schulz et al., 2012; Ginhoux
et al., 2016). In contrast, other organs, most notably the brain,
become inaccessible to blood-borne cells during development:
macrophage entry into the brain becomes restricted due to
the establishment of the blood-brain-barrier and, consequently,
brain macrophages (microglia) derive solely from the early yolk
sacmacrophages (Alliot et al., 1999; Hoeffel et al., 2015; Figure 2).
As the kidney enlarges developmentally, its capacity
for macrophage niches, and therefore its availability to
house macrophages, will increase (Figure 3). Consequently,
macrophages will colonize and fill these “developmental
macrophage niches” as the kidney matures (from E10.5-P4; Short
and Smyth, 2016). As kidney development ends, macrophage
niches become fully occupied and, as a result, the macrophages
that become resident within the kidney are predominantly
embryonically/neonatally-derived (Epelman et al., 2014a;
Hoeffel et al., 2015; Sheng et al., 2015). As these macrophages
are long-lived and self-renew in situ, few circulating monocytes
are provided with the opportunity to engraft within the
kidney in adulthood (Figure 3). An exception to this might be
during renal disease/inflammation/injury when niches become
temporarily available due to the drainage of macrophages from
the kidney via the lymphatics (Lan et al., 1993) and surges of
macrophage-recruiting chemokines (Petrovic-Djergovic et al.,
2015; Figure 3).
As well as being accessible and available to macrophages, an
organ must produce signals to recruit macrophages. Signaling
through Cx3c chemokine receptor 1 (Cx3cr1), the receptor
for chemokine Cx3c motif ligand 1 (Cx3cl1), is important for
macrophage migration and colonization of the early embryo
(Imai et al., 1997; Mass et al., 2016). Caudal tissues, limbs, and
the head of Cx3cr1-deficient embryos have decreased numbers
of macrophages at E9.5 and E10.5 (Mass et al., 2016). However,
most organs (lung, liver, and brain) in Cx3cr1−/− embryos have
normal macrophage numbers by E14.5 and in adulthood (relative
to Cx3cr1+/− littermates). Conversely, kidneys of Cx3cr1−/−
embryos have greatly diminished macrophage numbers at E14.5
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and in adulthood (relative to Cx3cr1+/− littermates; Mass et al.,
2016). In agreement, Lionakis et al. (2013) also found that
adult kidneys of Cx3cr1−/− mice have reduced macrophage
numbers. Moreover, kidneys of Cx3cr1−/− mice recruited fewer
macrophages in response to systemic infection with the fungus
Candida albicans (relative to Cx3cr1+/+ mice). In Cx3cr1-
deficient mice, this fungus was cleared from all organs tested
apart from the kidney. Consequently, Cx3cr1−/− mice uniformly
succumbed to infection due to uncontrolled fungal proliferation
in the kidney and renal failure (Lionakis et al., 2013). These data
indicate that the Cx3cl1/Cx3cr1 signaling pathway is uniquely
important for the recruitment of macrophages to the kidney
during development, at steady state, and in response to infection.
SPECIFICATION OF KIDNEY
MACROPHAGES
The expression of transcriptional regulators in a tissue-resident
macrophage is regulated in a tissue-specific manner (Lavin et al.,
2014; Amit et al., 2016; Mass et al., 2016). This regulation
results in macrophages being specialized according to the needs
of their specific organ of residence. Bulk RNA-seq data have
identified candidate transcriptional regulators that might act to
control kidney macrophage programming and differentiation
(Mass et al., 2016).
In comparison to those in other developing organs (i.e., brain,
liver, skin, and lung), kidney macrophages exhibit increased
expression of the transcriptional regulators aryl hydrocarbon
receptor (Ahr), nuclear factor of activated T cells 1 and 2 (Nfatc1
and Nfatc2), and interferon regulatory factor 9 (Irf9) (Mass et al.,
2016). Ahr influences macrophage activation and production of
nitric oxide and arginine (Climaco-Arvizu et al., 2016). Irf9 also
influences macrophage activation (Ganta et al., 2017). Nfatc1
and Nfatc2 are involved in macrophage cytokine expression and
the inflammatory response (Minematsu et al., 2011; Elloumi
et al., 2012). However, althoughmore highly expressed in kidney-
resident than other resident macrophages, the effects of these
transcriptional regulators on kidney macrophage specification
and function have not been investigated.
A complication regarding the study of macrophage
specification is the heterogeneity of macrophages, even
within a single organ. In the adult kidney, there are at least five
types of tissue-resident macrophages (Kawakami et al., 2013).
Based on the multidimensional model of macrophage activation,
macrophage specification depends on the integration of the
environmental signals to which it is exposed, rather than being
based on macrophage ontogeny (Ginhoux et al., 2016). The
chemokine environment within the kidney will not be spatially
uniform, and the micro-anatomical site of a macrophage will
dictate its specification. For example, a macrophage is not
exposed to identical signals in the renal cortex and the renal
medulla (Berry et al., 2017). Furthermore, exogenous stress
signals, such as small immune complexes (Stamatiades et al.,
2016) that are carried into the kidney via the blood will also
control macrophage specification in an environment-specific
manner (Figure 4). Future studies should investigate how
the integration of endogenous and exogenous signals dictates
the phenotypes and functions of kidney macrophages in
development and adulthood.
FUNCTIONS OF MACROPHAGES IN
KIDNEY DEVELOPMENT
While numerous reviews have detailed the functions of kidney
macrophages in the healthy and diseased adult kidney (Rogers
et al., 2014; Cao et al., 2015; Guiteras et al., 2016), there are
few descriptions of the functions of kidney macrophages in
renal development. In other developing organs, macrophages
are critical in processes such as branching morphogenesis,
angiogenesis, and the clearance of dead cells (Gouon-Evans
et al., 2000; Kawane et al., 2003; Pollard, 2009; DeFalco et al.,
2014; Sathi et al., 2017). It is now becoming clear that these
processes are also facilitated by kidney macrophages during renal
organogenesis.
CELL DEATH AND CLEARANCE
An appropriate balance between cell death, survival, and
proliferation is crucial for organ growth and remodeling during
development (Penaloza et al., 2006). Cell death in the developing
kidney peaks at E14.5 (0.25% of cells are apoptotic) and then
drops considerably after birth (by postnatal day 14, only 0.06%
of cells are apoptotic; Foley and Bard, 2002). Apoptosis during
kidney development may facilitate the reciprocal signaling
between the ureteric bud and nephron progenitor cells (Coles
et al., 1993; Foley and Bard, 2002; Stewart and Bouchard,
2011). Inhibition of apoptosis in kidney explants, via blockade
of caspase −3 and −9, reduces branching morphogenesis and
nephrogenesis (Araki et al., 1999, 2003). The cellular debris
released from these apoptotic cells is cleared via a process
termed efferocytosis (Latin for “to take to the grave” or “to
bury”).
During renal development, efferocytosis is carried out
by kidney macrophages (Camp and Martin, 1996; Erdösová
et al., 2002). “Find me” chemokine signals and “eat me”
cell surface signals that are expressed by dying cells attract
macrophages to phagocytose them (Truman et al., 2008;
Nagata et al., 2010), resulting in the degradation of their
cellular components (A-Gonzalez and Hidalgo, 2014). Where
efferocytosis is defective, the innate immune system becomes
activated, which leads to inflammation (Green et al., 2016).
This can have negative consequences on a developing
organ; indeed, in the developing thymus, it impairs thymic
organogenesis, reducing thymocyte number, and thymus
size (Kawane et al., 2003). However, the consequences of




Macrophages contribute to branching morphogenesis in the
developing lung, mammary gland, and submandibular gland
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(Gouon-Evans et al., 2000; Pollard, 2009; Jones et al., 2013; Sathi
et al., 2017). Evidence suggests that kidneymacrophages similarly
contribute to ureteric bud branching in the kidney (Rae et al.,
2007; Muthukrishnan et al., 2017).
The addition of colony stimulating factor-1 (Csf-1) accelerates
growth and ureteric bud branching in cultured kidney explants
(Rae et al., 2007). Binding of the Csf-1 ligand to its membrane
receptor, Csf1r, results in the activation of the Csf1r pathway
and the stimulation of macrophage proliferation, survival, and
differentiation (Dai et al., 2002; Mouchemore and Pixley, 2012).
Macrophage numbers were increased in the Csf-1 treated kidney
explants and their expression profile was consistent with them
being alternatively activated, pro-proliferative M2 macrophages
(Rae et al., 2007). Although the M1/M2 model of macrophage
activation is imperfect (Murray et al., 2014), anM2-like activation
status is associated with trophic/tissue remodeling macrophages
(Mantovani et al., 2004; Marchetti et al., 2011). However, Rae
et al. (2007) did not establish whether the trophic effects on
kidney growth and ureteric bud branching were the result of the
increased macrophage numbers, the alternative activation status
of the macrophages, the exogenous addition of Csf-1 per se, or
a combination of these possibilities. In support of the proposed
trophic role of Csf-1 on kidney development, in vivo treatment
of neonatal mice with Csf-1 resulted in the development of
larger, heavier kidneys (Alikhan et al., 2011); as with the kidney
explants, this growth was associated with increased numbers
of tissue macrophages. Correspondingly, Csf1r-null mice have
lighter kidneys compared to wild type mice (Alikhan et al., 2011)
and male mice injected with an anti-Csf1r blocking antibody 3×
weekly for 6 weeks have decreased kidney:body weight ratios
(Sauter et al., 2014).
Kidney macrophages may also directly stimulate ureteric
bud branching during development. Populations of nephron
progenitor cells that cap ureteric bud tips (Reinhoff, 1922)
secrete glial cell line-derived neurotrophic factor (Gdnf)
to promote branching morphogenesis via activation of Ret
receptor tyrosine kinase (Ret) on the membrane of ureteric
bud epithelia (Schuchardt et al., 1994; Sainio et al., 1997).
Following experimental ablation of nephron progenitor
cells, macrophages compensate for their loss by localizing
around ureteric bud tips and secreting Gdnf to maintain
ureteric bud branching (Muthukrishnan et al., 2017). Whether
macrophages play a similar role to directly stimulate ureteric
bud branching during normal kidney development is currently
unknown.
NEPHRON FORMATION
In the developing kidney, many macrophages are found near
renal tubules (Rae et al., 2007). A direct role of macrophages
in facilitating nephron formation has not been described during
normal renal organogenesis, but, as with ureteric bud branching,
Csf-1 treated kidney explants developed greater numbers of
nephrons (Rae et al., 2007). Furthermore, macrophages are
recruited to the nephrogenic zone (the site of nephron formation)
when nephron progenitor cells are experimentally ablated where
they stimulate nephron progenitor proliferation (Muthukrishnan
et al., 2017). However, the relevance of this experimental model
to normal kidney development is unknown.
As nephron formation is unique to the kidneys (pronephros,
mesonephros, and metanephros), it is difficult to relate
macrophage functions in other developing mammalian organs
with the creation of new nephrons. Here, some invertebrate
species, such as the fruit fly (Drosophila melanogaster), are
providing insights. In D. melanogaster, the Malpighian tubules
perform the function of the kidney and hemocytes are analogous
to macrophages. Hemocytes deposit type IV collagen around
the developing renal tubules, which sensitizes tubular cells to
the BMP ligand, Decapentaplegic (Dpp; Bunt et al., 2010).
Without hemocytes, or collagen IV, failure of BMP signaling
leads to the misrouting of the anterior Malpighian tubules
(Bunt et al., 2010). Whether this process is conserved in the
mammalian kidney has not been investigated, but the nephron
tubular basement membrane is rich in collagen IV (Abrahamson
and Leardkamolkarn, 1991) and both human and murine
macrophages can facilitate the deposition of almost every type of
collagen (Vaage and Lindblad, 1990; Schnoor et al., 2008).
BLOOD AND LYMPHATIC VESSEL
DEVELOPMENT
Macrophages facilitate the vascularization of many developing
organs (Fantin et al., 2010; Rymo et al., 2011; DeFalco et al., 2014).
In the developing kidney, many macrophages localize around
blood and lymphatic vessels (Rae et al., 2007; Lee et al., 2011),
but their interactions have not been examined.
In angiogenesis, functional blood vessels form through a
two-step process: endothelial tip cells first sprout from pre-
existing vessels and then secondly, fuse with other blood vessels
(anastomosis). Macrophages facilitate endothelial anastomosis in
development (Fantin et al., 2010) and in response to vascular
rupture (Liu et al., 2016). They do this by directly adhering to
endothelia before generating mechanical traction forces to pull
vessels together (Liu et al., 2016).
Moreover, macrophages are sensitive to low oxygen levels,
and can promote angiogenesis in response to hypoxia (Cattin
et al., 2015). When oxygen levels are low, signaling via the
p110γ isoform of phosphoinositide 3-kinase (PI3K), which is
predominantly expressed in macrophages, stabilizes hypoxia-
inducible transcription factor 1/2-alpha (HIF1α and HIF2α;
Joshi et al., 2014). This results in HIF1/2α translocation to
the macrophage nucleus, where it binds to hypoxia-responsive
elements to induce the expression of pro-angiogenic genes such
as VEGF (Joshi et al., 2014). Macrophage-derived VEGF-A
stimulates angiogenesis by promoting endothelial proliferation
and migration to resolve hypoxia (Cattin et al., 2015). Hypoxia
plays a role in developmental angiogenesis in the kidney
(Abrahamson, 2009), and future studies should investigate
whether kidney macrophages respond to hypoxia by guiding
angiogenesis.
A subset of macrophages in the developing kidney express
lymphatic vessel endothelial hyaluronan receptor 1 (Lyve-1; Lee
et al., 2011). Lyve-1 is an endocytic receptor for hyaluronan
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that is also highly expressed by lymphatic endothelia. Lyve-
1+ macrophages are reportedly pro-angiogenic and pro-
lymphangiogenic (Cho et al., 2007; Harvey and Gordon,
2012). Lee et al. (2011) demonstrated that Lyve-1+ lymphatic
endothelia are closely associated with Lyve-1+ macrophages
in the developing kidney, and they speculated that the latter
facilitate lymphatic development during renal organogenesis.
This idea is supported by evidence that macrophages can
express VEGF-C to stimulate lymphangiogenesis (Kerjaschki,
2005; Alishekevitz et al., 2016) and that macrophages can act as
lymphatic endothelial progenitors that integrate into sprouting
lymphatic vessels (Ran and Montgomery, 2012). Furthermore,
a subtype of VEGF-C-expressing interstitial macrophages has
previously been associated with lymphangiogenesis in human
kidney transplants (Kerjaschki et al., 2004). Based on these data,
kidney macrophages could play a role in stimulating lymphatic
development in a VEGF-C dependent and/or independent
manner.
Although it seems likely that kidney macrophages will
facilitate the processes described above, more studies are
undoubtedly required before we fully appreciate the functional




In many organs, including the kidney, tissue-resident
macrophages are predominantly derived from embryonic
macrophages. In the kidney, these embryonic macrophages
are mainly generated from fetal monocytes, which are
specified and self-renew in situ throughout development
and adulthood. Kidney macrophages are endowed with a unique
genetic programme that allows them to promote normal renal
organogenesis and to maintain the health and function of the
adult organ. It will be extremely challenging to fully characterize
the factors involved in kidney macrophage specification, and
to understand how this dictates the functions of a given
macrophage. Nevertheless, this is a challenge that should be
faced, as it may expose new therapeutic opportunities to prevent
and treat a range of developmental and pathological conditions.
To better understand kidney macrophage specification, future
studies should utilize single-cell transcriptomic technologies to
spatiotemporally classify the phenotypes of distinct macrophage
populations in the developing kidney. By identifying clusters
of macrophages with distinct gene expression patterns, and
determining where they localize in the kidney, it may be possible
to link environment-specific signals to the phenotypes and
functions of a macrophage.
As macrophages can promote kidney growth, they could
potentially be used therapeutically to assist renal development
in babies at risk of preterm birth. Increasing macrophage
recruitment to the developing kidney through treatment with
chemokines such as Csf-1 and/or Cx3cr1 could conceivably
promote kidney growth and nephron endowment. However,
macrophages can also promote abnormalities in kidney
development, such as cyst formation (Karihaloo et al., 2011), and
their recruitment has previously been associated with disease
progression in Wilms tumor (Liou et al., 2013); in these cases,
the elimination of macrophages may be more therapeutic.
Accordingly, macrophage-based therapies for developmental
abnormalities will have to be context-dependent and will
necessitate an in-depth understanding of kidney macrophage
specification and function.
The inflammatory properties of kidney macrophages and
recruited circulating monocytes are implicated in the initiation
and progression of injury and scarring in the adult kidney as
well as kidney regeneration and healing (reviewed in Rogers
et al., 2014). Although beyond the scope of this review, it is
of interest that the recruited monocyte-derived macrophages,
but not kidney-resident macrophages, are pro-fibrotic in the
obstructed kidney (Lin et al., 2009). In addition, commonalities
exist between macrophages in the healing adult kidneys and
the developing kidney (Alikhan et al., 2011). As well as
the therapeutic potential of using macrophages to mitigate
abnormal kidney development, studying the specification, and
function of kidney macrophages in development may also
provide new therapeutic/preventative options to minimize renal
complications in adulthood.
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Asymmetric BMP4 signalling 
improves the realism of kidney 
organoids
Christopher G. Mills1,2, Melanie L. Lawrence  1, David A. D. Munro  1, Mona Elhendawi1,3, 
John J. Mullins2 & Jamie A. Davies1
We present a strategy for increasing the anatomical realism of organoids by applying asymmetric cues 
to mimic spatial information that is present in natural embryonic development, and demonstrate it 
using mouse kidney organoids. Existing methods for making kidney organoids in mice yield developing 
nephrons arranged around a symmetrical collecting duct tree that has no ureter. We use transplant 
experiments to demonstrate plasticity in the fate choice between collecting duct and ureter, and show 
that an environment rich in BMP4 promotes differentiation of early collecting ducts into uroplakin-
positive, unbranched, ureter-like epithelial tubules. Further, we show that application of BMP4-
releasing beads in one place in an organoid can break the symmetry of the system, causing a nearby 
collecting duct to develop into a uroplakin-positive, broad, unbranched, ureter-like ‘trunk’ from one 
end of which true collecting duct branches radiate and induce nephron development in an arrangement 
similar to natural kidneys. The idea of using local symmetry-breaking cues to improve the realism of 
organoids may have applications to organoid systems other than the kidney.
Here we present a strategy for increasing the anatomical realism of organoids by applying asymmetric cues that mimic 
spatial information present in embryonic development. We demonstrate the strategy by constructing kidney orga-
noids of unprecedented realism in which nephrons are arranged around a collecting duct tree leading to a ureter-like 
trunk. The idea may be adaptable to a range of other organoid systems in developmental and regenerative research.
There is intense interest in producing kidney organoids to illuminate mechanisms of basic development1, to 
detect nephrotoxicants2,3 and to produce kidneys for renal replacement therapy4–6. The most basic type of orga-
noid is produced when a suspension of progenitor cells is aggregated in culture. Using either mixed ex-fetu mouse 
nephrogenic, uretogenic and stromogenic cells7, or human iPS cells differentiated towards a renal fate2,6, the 
resulting organoid contains multiple, disconnected, immature collecting ducts, multiple immature nephrons, and 
stromal cells. The micro-anatomy is realistic but macroscopic organization is absent. More advanced, multi-stage 
techniques developed for mouse cells produce better macroscopic anatomy, producing nephrons in a distinct 
cortex connected to a single collecting duct tree radiating from the medulla, and loops of Henle dipping from the 
cortex into that medulla8,9. Nephrons in these cultures show physiological activity10 but a significant unrealistic 
feature remains: there is no ureter so the collecting duct tree has no exit.
In normal development, the ureter outside the kidney, and the collecting ducts within it, share a common 
origin, the ureteric bud, which evaginates from the Wolffian duct and enters the kidney as a coherent epithelial 
tubule11. Within the presumptive kidney, the bud causes metanephrogenic mesenchyme to arrange itself around 
the bud tips12 as ‘cap mesenchymes’13,14 and mesenchyme-derived signals cause the bud to branch to make a col-
lecting duct system15. The ureteric bud left outside the kidney becomes ureter. There is evidence that fate choice 
between collecting duct and ureter is under mesenchymal control: the presumptive ureter becomes collecting 
duct if surrounded by metanephrogenic mesenchyme16, and treatment of whole kidney rudiments with bone 
morphogenetic protein 4 (BMP4), produced in peri-Wolffian mesenchyme but not in the metanephrogenic mes-
enchyme, causes the inner branches of the collecting duct system to express ureter-type markers17.
We have therefore tested, and confirmed, the hypothesis that imposition of an asymmetrical environment of 
BMP4 signalling onto a renal organoid will cause one branch of the collecting duct tree to take a ureter fate while 
1Deanery of Biomedical Science, University of Edinburgh, Edinburgh, EH8 9XB, UK. 2Centre for Cardiovascular 
Science, University of Edinburgh, Edinburgh, EH16 4TJ, UK. 3Clinical Pathology Department, Faculty of Medicine, 
Mansoura University, El-Mansoura, Egypt. Correspondence and requests for materials should be addressed to 
C.G.M. (email: cgmills@ed-alumni.net) or J.A.D. (email: jamie.davies@ed.ac.uk)
Received: 26 June 2017
Accepted: 13 October 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7: 14824  | DOI:10.1038/s41598-017-14809-8
the other branches develop as collecting ducts. As well as providing a solution to the specific problem of engineer-
ing renal organoids that have a ureter, the results provide a good illustration of the general approach of providing 
selected asymmetric cues to increase the realism of organoids.
Materials and Methods
Animals. No living animals were used in these experiments. All tissue used in this study was isolated from embry-
onic mice obtained from healthy CD1 adults which were culled, by methods listed under Schedule 1 of the UK Animals 
Scientific Procedures Act 1986, by trained staff licenced by the UK Home Office. All experiments were approved by the 
University of Edinburgh and performed in accordance with the institutional guidelines and regulations.
Organ culture. Metanephric kidneys were isolated from E11.5 CD1 mouse embryos and, except in trans-
plantation experiments, the Wolffian duct was removed. Kidney rudiments were cultured on 24 mm, 0.4 µm-pore 
membranes (Transwells, Corning 3450) in kidney culture medium (KCM: MEM [Sigma M5650], with 10% FBS, 
1% penicillin/streptomycin). Ganeva-type organoids8 were made by incubating 8 embryonic kidneys in trypsin/
EDTA (0.5 g/L trypsin:0.2 g/L EDTA, Sigma T4174), 37 °C, 2 min, rinsing them in KCM and dissociating them 
by trituration using a 200 μl tip and passage through a cell strainer (40 μm, BD Falcon). A pellet of these cells 
(3 mins, 8000 × g) was cultured overnight in 1.25 μM glycyl-H1152 dihyrochloride (ROCK inhibitor) in KCM on 
Isopore filters at the medium/gas interface (Trowell culture). Next morning, fresh KCM was applied for 4 h, 37 °C, 
5% CO2, to produce ‘Unbekandt organoids’7. A single collecting duct progenitor epithelium was isolated from 
Unbekandt reaggregates and surrounded by mesenchyme isolated from 9–10 E11.5 kidneys, disaggregated and 
reaggregated as above, to produce Ganeva cultures. These were cultured 24 hr in Trowell culture before transfer 
to polyester membrane inserts (Transwells, Corning 3450). Grobstein cultures18 were made similarly but using an 
isolated ureteric bud tip of an E11.5 kidney instead of a ureteric bud sphere/tubule from a primary reaggregate.
Tubule transplantation. Embryonic kidneys were cultured overnight in KCM containing rhodamine- 
conjugated peanut agglutinin (20 μg/ml, Vector Labs RL-1072). Labelled ureteric bud (UB) tubules were isolated 
manually, transplanted into either the metanephric- or the peri-Wolffian mesenchyme of a host E11.5 embryonic 
kidney, and cultured for 5 days on Transwell inserts (Corning 3450).
BMP4 treatment. E11.5 mouse metanephric kidneys were cultured as above for 24hrs prior to BMP4 addi-
tion to the medium (5020-BP-010; R and D systems, reconstituted in 0.1% BSA (Bovine serum albumin), in PBS). 
BMP4 (concentrations used are described in the relevant results section) treatment was repeated daily until the 
end of the experiment (5 days).
Bead Treatment. Protein loaded beads were prepared as follows: 5 Affi-gel beads (152–7302, Bio-Rad) were 
washed twice with PBS then incubated in 40 μl of BMP4 (5 μg/ml BMP4, 0.05% BSA, PBS), Gremlin (50 µg/ml, 
PBS), BSA (0.05%, PBS) or PBS for 1hr at room temperature, and rinsed in PBS. Gremlin beads were placed on 
embryonic kidneys that had been cultured for 24 hrs and beads were replaced daily until the end of the experi-
ment. For experiments on natural kidneys, BMP4-soaked beads were also added to kidneys cultured for 24 hrs 
but replacement was found not to be necessary. BMP4-soaked beads were added to Grobstein kidneys (see above) 
once branching was observed, which was 24 hrs after being placed on polyester membranes. For Ganeva kidneys, 
BMP4-soaked beads were replaced daily for up to 4 days. In all those experiments involving beads, samples were 
cultured for 5 days after bead addition.
Immunofluorescence. Samples were fixed in methanol at −20 °C, allowed to warm towards room tem-
perature over 30 mins, washed in PBS, blocked in 5% BSA in PBS for 1hr and incubated in primary antibodies 
(Table S1) in 5% BSA overnight at 4 °C. They were washed in PBS, incubated with secondary antibodies (Table S2) 
in 5% BSA for 2hrs, washed 2x with PBS, mounted in H-1000 (Vecta shield) and imaged using a Zeiss Axiovert 
fluorescence microscope (Axiovision software) or a Nikon A1R confocal microscope (NIS elements software).
Statistics. For categorical (feature present/ absent) data, 95% confidence intervals (CI95%) were calculated as 
±1.96√(p(1 − p)/n) + 1/2n19. Hypothesis testing for these data was performed using N-1 Chi Squared tests20. All counts 
were generated by scoring absence/ presence of uroplakin expression, or branching, depending on the experiment.
Data availability. The datasets can be found at: http://datashare.is.ed.ac.uk/handle/10283/2343.
Results and Discussion
Developing collecting ducts possess the plasticity required for conversion into ureter-type 
epithelium. The strategy of producing a ureter-like exit in a kidney organoid by converting one collecting 
duct branch into ureter-type epithelium depends on plasticity of the developing collecting duct. We and others 
have published evidence that the presumptive ureter can be induced to switch to a branching, nephron-induc-
ing, collecting duct state by transferring it from the peri-Wolffian mesenchyme that normally surrounds it to 
metanephrogenic mesenchyme16,21. Can the opposite switch, from collecting duct to ureter, also be induced by 
changing mesenchymal environment? To test this, we performed a series of transplantation experiments in which 
sections of immature ureter or collecting duct epithelium, labelled with a fluorescent lectin for identification, 
were transplanted to the opposite type of mesenchyme.
First, we performed control transplantations: grafting a section of E11.5 + 24 hr presumptive collecting 
duct into the metanephrogenic mesenchyme of a host E11.5 kidney resulted in its forming a branching tree 
(3/3 branched; 100%. CI95% ± 17%) that did not express the ureter marker uroplakin (0/3 expressed uroplakin; 
0%, CI95% ± 17%) (Fig. 1A,B). Grafting presumptive E11.5 + 24 hr ureter from one kidney into the peri-Wolffian 
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mesenchyme of a host resulted in it remaining unbranched (0/3 branched) and expressing uroplakin (3/3 expressed 
uroplakin, 100%. CI95% ± 17%: Fig. 1C,D) demonstrating that the mere mechanics of grafting did not change fate. 
Grafting E11.5 + 24 hr presumptive ureter stalk into host metanephrogenic mesenchyme caused it to branch (5/5 
branched 100%, CI95% ± 10%) and to refrain from expressing uroplakin (4/5 did not express uroplakin; 80%, 95% 
CI95% ± 39%: Fig. 1E,F), confirming (p = 0.040 by N-1 Chi-Square test) plasticity in the ureter-to-collecting duct 
direction. Critically, grafting a section of E11.5 + 24 h presumptive collecting duct into peri-Wolffian mesen-
chyme resulted in it remaining unbranched (0/2 branched; 0%, CI95% ± 25%) and activating uroplakin expression 
(2/2 expressed uroplakin; 100%, CI95% ±  = 25%, Fig. 1G,H). Reciprocal plasticity of the developing renal epithe-
lium was quantified as those numbers of ureteric stalks that showed the collecting duct-like behavior of branching 
and those numbers of collecting ducts that showed the ureter-like behavior of expressing uroplakin. Reciprocal 
plasticity was not detected in renal epithelia transplanted into their natural mesenchyme (0/6: 0%, CI95% ± 8.3%) 
but was in those transplanted into their unnatural mesenchyme (6/7; 85%, CI95% ± 28.8%). This difference is 
significant (p = 0.003 by N-1 Chi-Square test).
BMP4 can substitute for peri-Wolffian mesenchyme to induce uroplakin expression in pre-
sumptive collecting ducts. The results described above suggest that the development of distinct ureter and 
collecting duct from the same progenitor tissue might therefore arise simply from the asymmetry of mesenchy-
mal influences: in the kidney, the bud is surrounded by metanephric mesenchyme and becomes collecting duct 
Figure 1. Renal mesenchyme dictates the identity of developing ureteric epithelium. Epithelia from the ureteric 
branches (A and G) or the ureteric stalk (C and E) were labelled with Rhodamine-conjugated Peanut agglutinin, 
isolated and transplanted into the metanephric mesenchyme (A,B and E,F) or the ureteric mesenchyme (C,D 
and G,H) of E11.5 kidneys. (A,C,E,G) show the position of transplanted epithelium (Red), with the approximate 
division between metanephric mesenchyme (MM) and prospective ureter mesenchyme (UM) annotated. 
(B,D,F and H) show development 5 days post transplantation: only grafts to peri-Wolffian mesenchyme become 
uroplakin-positive. UPK, Uroplakin. PCK, Pan-cytokeratin. Scale = 200 µm.
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but the embryonic origins of the bud mean that one section of it crosses peri-Wolffian mesenchyme and so expe-
riences a unique environment. If it were possible to identify the critical signal in the peri-Wolffian mesenchyme, 
it may be possible to apply it asymmetrically to an organoid and convert one collecting duct to ureter.
Peri-Wolffian mesenchyme secretes BMP422 and culture of kidney rudiments in medium with high concen-
trations of BMP4 causes an expansion of the domain of uroplakin expression from the ureter, proximally, into 
the larger collecting ducts17. We confirmed this result (Fig. 2A). In kidneys cultured in standard medium or in 
medium supplemented with BSA, uroplakin expression was restricted to the ureter and did not extend to the first 
branch point of the collecting duct. In 25 ng/ml BMP4, uroplakin expression included the ureter and the primary 
branches of the collecting duct while in 100 ng/ml BMP4, expression extended even into secondary branches. To 
confirm that the uroplakin-inducing activity was indeed acting via BMP signalling (and not, for example, by an 
unknown contaminant in the BMP solution) we repeated the above experiments using 100 ng/ml BMP4 in the 
medium but placed an Affi-Gel bead soaked in either PBS or 50 µg/ml Gremlin, an inhibitor of BMP423, at one 
side of the kidney rudiment. PBS-soaked beads had no effect on the BMP4’s ability to induce uroplakin expression 
and most or all of the branching ureteric buds expressed uroplakin (Fig. 2B, 5/5: 0%, CI95% ± 10%, showed urop-
lakin expression near a PBS-soaked bead). Gremlin-soaked beads, on the other hand, protected nearby collecting 
ducts from BMP4-mediated induction of uroplakin (0/5, 0%, CI95% ± 10%, showed uroplakin expression local to 
the Gremlin-soaked bead). Ducts distant from the bead still responded to BMP4. In addition, Gremlin restored 
nephron development, repressed by BMP4, in the area around the bead releasing it. Rescue by Gremlin indicates 
that BMP signalling does indeed mediate the uroplakin-inducing activity of medium supplemented by BMP4.
Miyazaki et al. applied BMP4-soaked Affi-Gel beads to kidneys and reported local inhibition of nephron 
development but did not assess effects on collecting duct/ ureter differentiation24. To explore the possibility 
of driving local ureter-type differentiation, we treated intact cultured E11.5 + 24 h kidney rudiments with a 
Figure 2. BMP4 induces expression of uroplakin in the developing collecting ducts. Developing collecting 
ducts were treated globally with BMP4 and uroplakin expression was investigated after 5 days of culture. (A) 
E11.5 kidney rudiments were cultured in media containing vehicle only (BSA), 25 ng/ml of BMP4 or 100ng/
ml of BMP4. (B) Globally BMP4-treated E11.5 kidney rudiments were cultured in the presence of a Gremlin 
soaked bead or vehicle only soaked bead. *Bead location, n = a few examples of developing nephrons. Scale 
(unless otherwise stated) = 100 µM.
www.nature.com/scientificreports/
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BMP4-soaked Affi-Gel bead located near one specific secondary ureteric bud branch point (Fig. 3A and B), and 
observed the behaviour and uroplakin expression of nearby and distant collecting ducts. Control beads carrying 
only BSA had no effect on branching, nephrogenesis or uroplakin expression (Fig. 3C, 0/14 expressed uroplakin; 
Figure 3. Local administration of BMP4 induces expression of Uroplakin in targeted developing collecting 
duct. Developing collecting ducts were exposed to BMP4 beads. (A) Illustration of the treatment method 
(*Bead). (B) Nomenclature of branches. (C) and (D) E11.5 kidneys cultured for 24hrs then given a bead 
soaked in either BSA (Vehicle: C) or BMP4 (D) at a secondary branch point. (E) Application of the beads to 
Grobstein culture; (F) Untreated; (G) BSA-treated; (H) BMP4 treated. Inserts: isolated uroplakin channel. 
UPK, Uroplakin. PCK, Pan-cytokeratin. Lam, Laminin. Arrows indicate induced uroplakin expression. Scale 
bar = 200 µm.
www.nature.com/scientificreports/
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Figure 4. Unbekandt-culture-derived ureteric bud spheres respond to BMP4 to express uroplakin. (A) and (B) 
Ureteric bud structures (outlined by dashed lines), isolated from Unbekandt orgranoids7 were transplanted into host 
metanephric (A) or peri-Wolffian (B) mesenchyme of E11.5 kidneys and cultured for 5 days. Induction of uroplakin 
is seen when transplanted into peri-Wolffian mesenchyme. (C) Generation and bead treatment of Ganeva kidneys: 
ureteric spheres are obtained from 1-day Unbekandt organoids then isolated and surrounded by e11.5 metanephric 
mesenchyme to form Ganeva kidneys, which were treated 2 days later with BMP4 soaked beads changed daily for up 
to three days. The dashed box highlights differences between the Ganeva and Grobstein method. (D) Ganeva kidney 
with no treatment; (E) treatment with a BSA-soaked bead; (F) A BMP4-soaked bead induces the nearby tubule 
to become an unbranched, uroplakin-positive, nephron-free tubule. (G) Nephron patterning of natural cultured 
kidneys is comparable to BMP4-treated Ganeva kidneys (H). Outlines of developing nephrons has been drawn on 
and approximate sections annotated (Dist, Distal tubule; Med, Medial tubule; and Prox, Proximal tubule). UPK, 
Uroplakin. PCK, Pan-cytokeratin, Col4, Collagen Type IV. Arrows indicate induced uroplakin. Scale bar = 200 µm.
www.nature.com/scientificreports/
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0%, CI95% ± 3.6%). BMP4-soaked beads reduced branching and nephrogenesis locally and drove an expansion of 
uroplakin expression from the ureter into the collecting duct near the bead (Fig. 3D, 13/13: 100%, CI95% ± 3.8%).
This expansion of the uroplakin-expressing domain might reflect ureter-type differentiation of collecting duct 
cells, or it might be caused by beadward migration of already uroplakin-positive cells from the ureter stalk. To 
discriminate between these possibilities, we used a culture method from Grobstein18, isolating E11.5 ureteric tips 
which do not express uroplakin and surrounding them with metanephrogenic mesenchyme (Fig. 3D). These 
cultures formed an anatomy like that of Ganeva-type renal organoids (see below), in that they contained a col-
lecting duct system with no uroplakin-positive cells (Fig. 3F). Treatment of such kidneys with a control bead 
did not affect branching or nephron formation and did not induce uroplakin (Fig. 3G, 0/3 expressed uroplakin: 
0%, CI95% ± 17%). Application of a BMP4-soaked bead to such kidneys induced a nearby collecting duct to grow 
straight and to express uroplakin (Fig. 3H, 5/5 expressed uroplakin: 100%, CI95% ± 10%). A N-1 Chi Square test 
between the control and BMP4 bead-treated populations yields p = 0.0082, allowing us to reject the hypothesis 
that BMP4 fails to induce uroplakin expression in cells derived from bud type. What is more, this tubule was 
nephron-free along its uroplakin positive segment. This suggests that BMP4 induces a ureter-type differentiation 
in immature collecting duct, and that BMP4- soaked beads are a viable method of generating an asymmetric 
environment that can cue local ureter formation.
BMP4-soaked beads break the symmetry of Ganeva-type renal organoids and produce a ureter-like 
trunk for the collecting duct tree. The most anatomically realistic renal organoids are made using a method 
based on Ganeva et al.8, in turn based on Unbekandt et al.7. The Unbekandt method aggregates a suspension of renal 
progenitor cells, under temporary anti-apoptotic pharmacological support, and results in formation of many scattered 
epithelial spheres, tubules and small trees characteristic of primitive collecting duct and, shortly afterwards, many 
developing nephrons scattered among and connecting to them. The micro-anatomy of the system is realistic but the 
formation of many independent collecting duct tubules instead of one coherent tree means realistic large-scale anatomy 
is missing. If one presumptive collecting duct tubule is isolated from an Unbekandt-type organoid and combined with 
reaggregated or intact renal metanephrogenic mesenchyme, it produces a single, coherent tree that organizes realistic 
large-scale anatomy. Like Grobstein culture (Fig. 2F), these Ganeva-type organoids still lack a ureter because the collect-
ing duct develops in a symmetric environment. This raises the possibility that imposition of an appropriately asymmet-
rical environment may be a way to persuade one end of the organoid to make a ureter (we use the term ‘asymmetry’ in 
the sense of making the environment of one end of an organoid different from that of the other).
To determine whether BMP4-soaked Affi-Gel beads might be used to impose the necessary asymmetry, we first 
performed a small-scale experiment to test whether collecting duct progenitor epithelia isolated from Unbekandt-type 
organoids could be induced to express uroplakin. We did this by transplanting them into host cultured kidney 
rudiments. Grafted into the metanephric mesenchyme they formed small branching trees (2/2 branched; 100%, 
CI95% ± 25%) that induced nephrons and did not express uroplakin (Fig. 4A, 0/2 expressed uroplakin; 0%, CI95% ± 25%). 
Grafted into the peri-Wolffian mesenchyme of a host kidney, they did not branch (0/2 branched; 0%, CI95% ± 25%) and 
did not induce nephrons, but they did express uroplakin (Fig. 4B, 2/2 expressed uroplakin; 100%, CI95% ± 25%).
Having established that collecting duct progenitors isolated from Unbekandt-type renal organoids are capable 
of being induced to express uroplakin, we went on to test whether BMP4-soaked Affi-Gel beads could induce 
local ureter-type differentiation when collecting duct progenitors of this type are used as the basis for producing 
Ganeva-type organoids (Fig. 4C). Ganeva-type organoids that included no beads produced symmetrical cultures 
with nephrons around a collecting duct tree that had no ureter-type trunk (Fig. 4D, 0/8 expressed uroplakin or 
possessed a trunk; 0%, 95% CI95% ± 6.3%). Those incorporating a control bead were similar (Fig. 4E, 0/3 expressed 
uroplakin or possessed a trunk; 0%, CI95% ± 17%). Those treated with BMP4-soaked Affi-Gel beads, replaced 
daily for up to 3 days, showed a dramatically different anatomy. Away from the bead, collecting duct branching 
and nephron formation proceeded normally but, critically, the collecting duct near the bead did not branch or 
induce nephrons but instead grew thick and showed strong expression of uroplakin (Fig. 4F, 15/23 expressed 
uroplakin; 65%, CI95% ± 28%). A comparison of cultures treated with BMP4 beads with pooled control cultures, 
using a N-1 Chi Squared test, allows us to reject the null hypothesis of no difference at p = 0.0004.
As a check that induction of uroplakin at one end of an organoid, by local BMP treatment, did not affect seg-
mentation of nephrons produced at the other end of the culture, we stained them for Jagged1 and E-cadherin. 
Normally, Jagged1 is expressed in the medial segment of a maturing nephron25,26, while E-cadherin is expressed 
in the distal segment and the collecting duct25. We confirmed this in normal cultured kidneys (Fig. 4G). In orga-
noids selected for those that showed BMP4-induced uroplakin expression, E-cadherin was still expressed in col-
lecting ducts and distal tubules, and Jagged 1 was still expressed in medial segments (Fig. 4H). This suggests that 
BMP4-soaked beads do not disrupt nephron patterning.
We acknowledge that there is a difference between having a uroplakin-expressing tubule and having a 
fully-functional ureter, and much remains to be done to produce a properly structured urothelium with attendant 
smooth muscle etc. Nonetheless, here we have shown that the application of a local signal, designed to mimic an asym-
metry present in the natural embryo but absent from self-organized organoid systems, can be used to produce a more 
realistic organoid with features that do not appear when self-organization alone is used. This idea could be applied to 
other renal organoids (for example, those produced from human iPS cells3) and to organoids made from other parts of 
the embryo and adult. The technique can be used both to explore the limits of self-organization, and to transcend them.
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Despite much debate, there remains no
clear consensusonhow thekidneybecomes
vascularized. In general, blood vessels form
by one of two processes: vasculogenesis (as-
sembly of vessels de novo frommesodermal
precursors) and angiogenesis (branching of
new vessels from existing ones). In princi-
ple, renal endotheliamay assemble through
vasculogenesis-only mechanisms (improb-
able and not supported), angiogenesis-only
mechanisms (conceivable but overlooked),
or a combination of both processes (the
option favored by most accounts; a sum-
mary of pertinent reviews since 1995 is at
http://dx.doi.org/10.7488/ds/2307).
Although the combination option is fa-
vored, opinions are inconsistent regarding
the relative contribution of each mecha-
nism. We challenge this prevailing view-
point and argue that the renal vasculature
(specifically, the endothelial component)
instead develops through angiogenesis-
only mechanisms.
An early proponent for kidney vascu-
logenesis was Herring,1 who speculated
that glomerular capillaries are generated
from in situ precursors within the cleft
of the S-shaped nephron. This concept
persists, despite electron microscopy and
immunohistochemistry images suggest-
ing that these early glomerular capillaries
instead stem from local, preexisting ves-
sels.2,3 Of course, still images only show
cellular arrangement in the kidney at a
single moment (at the point of fixation)
and cannot prove or disprove dynamic
processes, such as angiogenesis or vascu-
logenesis. Here, time-lapse imaging of
cultured embryonic kidneys has provided
insights, showing fluorescence-tagged
endothelia forming via angiogenesis4
and migrating from preexisting vessels
into the S-shaped cleft5 (Figure 1A).
More recent support for vasculogen-
esis comes from crosstransplantation ex-
periments. In transplanted embryonic
kidneys, both host- and graft-derived
vessels usually developed, and observa-
tions of graft-derived vessels were taken
as support for vasculogenesis. However,
these studies assumed that the transplan-
ted kidney rudiments were avascular, even
when using embryonic day 12 (E12)–
E12.5 mouse kidneys. We find these to
be highly vascularized (Figure 1B). In
fact, even the earliest kidney contains
blood vessels (E11) (Figure 1C).More sig-
nificantly, even if truly avascular kidneys
were transplanted and vasculogenesis oc-
curred, this does not necessarily mean
that it is the normal mechanism of kidney
vascularization. Transplanted kidneys are
put into artificial environments that may
encourage vasculogenesis—it is unclear
how this relates to “natural” development,
and we suggest that investigating kidney
vascularization during normal develop-
ment in vivo might be more revealing.
In vivo, mouse kidney vascularization
starts by E11, when systemically connec-
ted vessels wrap around the ureteric
bud6 (the precursor of collecting ducts
and ureter). Over the next day, blood
vessels continue to disperse throughout
the kidney mesenchyme in connection
with extrinsic vessels6 (Figure 1B). Later,
vessels at the border of the kidney form
polygonal networks around populations
of nephron progenitor cells6 (they orga-
nize this way in human embryos as well7;
https://transparent-human-embryo.
com/?p=1001) (Figure 1, D and E),
whereas cortical and medullary vessels
are simultaneously developing.
On the basis of our data, normal kidney
vascularization relies on growth and remod-
elingofpreexistingvessels(angiogenesis)and
does not depend on vasculogenesis at any
point. When assessing the entire three-di-
mensional vascular tree, isolated endothelia
are never observed.6 Even when immunos-
taining for stem cell leukemia, a marker of
the most primitive endothelial progeni-
tors,8 staining is observed onlywithinma-
ture vessels that are traceable to the renal
artery.6 Other studies, however, suggest
that a small population of renal endothelia
is stroma derived,9 and the mechanisms
by which these cells contribute to vascular
development should be explored.
Uncovering the mechanisms of kidney
vascularization may allow us to better
recapitulate developmental processes to
vascularize kidney organoids. Althoughor-
ganoids are generally improving, they lack
anatomically realistic vascular systems. On
the basis of the “angiogenesis-only” hy-
pothesis, we suggest that, rather than trying
to induce vasculogenesis, methodologic
advances should promote invasion of renal
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organoids by exogenous vessels inboth cul-
ture and transplantation settings.
Illustrating theneedforkidneyorganoid
invasionbyexogenousvessels, vandenBerg
et al.10 generated pluripotent stem cell–
derived kidney organoids and showed that
long periods of culture (where exogenous
vessels are lacking) led to gradual loss of
endothelia, whereas transplantation into
prevascularized host tissue (beneath the
murine renal capsule) led to the develop-
ment of a functional perfused vasculature.
van den Berg et al.10 proposed that
maturation of large kidney organoids
in culture is limited due to hypoxia and
metabolic deficiencies. To facilitate
continued maturation in culture, it
may be possible to generate perfused en-
gineered vessels that can invade the or-
ganoid. Perfused vessels could supply
oxygen and nutrients to the organoid,
while also generating shear forces to en-
courage vessel maturation. This could be
achieved by connecting engineered
Figure1. Evidence for the“angiogenesis-only”hypothesis in kidney vascularization. (A)Earliest glomerularendothelia forming into thecleftof
an S-shapednephron frompreexisting vessels in time-lapse culture (white arrowheads).Modified fromref. 5,withpermission. (B)Model of early
kidney vascularization in vivo. Some argue that the first vessels form via vasculogenesis, but our results suggest otherwise.6 Blood vessels are
shown in red. PWM,peri-Wolffianmesenchyme; UB, ureteric bud;WD,Wolffian duct. (C) The embryonic day 11 (E11) kidney is vascularizedby
systemically connected vessels surrounding the ureteric bud (black arrowhead; these vessels carry erythrocytes and connect tomajor arteries),
which calls into question whether avascular kidneys can be dissected at any age. Scale bar, 100 mm. Modified from ref. 6, with permission.
(D) Representative image of the vascular network at the periphery of the E16.5 kidney. Some argue that these peripheral vessels form via
vasculogenesis; however, they carry blood, are always enclosed by basement membrane, and connect with preexisting vessels that can be
traced to renal arteries.6 Scale bar, 50 mm. (E) As with mouse embryonic kidneys, peripheral vessels in human embryonic kidneys arrange as
polygonal networks around nephron progenitors (prepared from data accessed at https://transparent-human-embryo.com7).
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vessels to a pumping system, where the
flow input could be stringently controlled.
Improved in vitro vascularization and
maturation before transplantationwould al-
low for the engraftment of a functionally
enhanced organoid. On transplantation,
host-derived blood vessels can invade and
connect with kidney organoid–derived ves-
sels.10 If a vascularized organoid with func-
tioning glomeruli and nephrons can be
transplanted and its flow can quickly be re-
established via anastomoses with the host’s
vasculature, the regenerative potential of
kidney organoids may begin to be realized.
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